SATURDAY WUOF PROGRAMME October 15 - Hashemite … · WUOF PROGRAMME 5th Global Uro-Oncology Meeting Under the auspices of ... 0815–1000 SESSION ONE Prostate Cancer Prevention Moderator:

BERLIN SIU 2011 35

SATURDAYOctober 15 WUOF PROGRAMME

5th Global Uro-Oncology Meeting Under the auspices of The World Urologic Oncology FederationOct. 15–16, 2011 - Berlin, Germany

Saturday, October 150800–0815Chairman’s Welcome and IntroductionLaurence Klotz, Canada

0815–1000SESSION ONE

Prostate Cancer PreventionModerator: Hideyuki Akaza, Japan

0820–08355ARIs and Prostate Cancer Prevention Following the FDA DecisionNeil Fleshner, Canada

0835–0850Diet, Statins, CholesterolHanjong Ahn, South Korea

0850–0905Curcumin and Other MicronutrientsShigeo Horie, Japan

0905–0920Discussion

0920–0935Exercise in Prostate CancerArturo Mendoza-Valdés, Mexico

0935–0950Pre-Clinical Models of Prostate Cancer PreventionHirotsugu Uemura, Japan


1000–1015Break

1015–1125SESSION TWO

Town Hall ForumModerator: Laurence Klotz

1020–1025Screening in Men Over Age 65: IntroductionLaurence Klotz

1025–1035Overdiagnosis and How To Avoid ThisMonique Roobol, The Netherlands

1035–1045An Epidemiologic PerspectivePeter Albertsen, USA

1050_SIU2011_FinalProg_ScienProg_4single.indd 35 11-09-24 11:13 AM

36 31ST CONGRESS OF THE SOCIÉTÉ INTERNATIONALE D’UROLOGIE

SATURDAYOctober 15

WUOF PROGRAMME

1045–1105Pros and Cons of Screening Over Age 65Franz Recker, Switzerland

1105–1125Group Debate: Healthy Men: The Case for Continuing to Screen Over Age 65Peter AlbertsenMonique RoobolFranz ReckerChristopher Evans, USA

1125–1245SESSION THREE

Update on BiomarkersModerator: Peter Albers, Germany

1130–1140PCA3Inge Van Oort, The Netherlands

1140–1150Seminal Fluid MarkersFrank Gardiner, Australia

1150–1200Serum BiomarkersJohn Davis, USA


1215–1225Angiogenesis and Lymphangiogenesis in Prostate CancerDerya Tilki, Germany

1225–1235MRI as a Prostate Cancer Detection Tool: Where Are We Right Now?Mark Emberton, UK


1245–133040-Minute Lunch Break (lunch available for purchase on site)

1330-1520SESSION FOUR

Mechanisms of Castrate ResistanceModerator: David Gillatt, UK

1335–1350Intermittent vs Continuous Androgen Deprivation Therapy: Biological ImplicationsLaurence Klotz

1350–1405Autophagy and Prostate CancerChristopher Evans, USA

1405–1420Immune Escape and Prostate CancerRob Siemens, Canada



BERLIN SIU 2011 37

SATURDAYOctober 15 WUOF PROGRAMME

1435-1450Adapting Treatment Strategies for CRPCa in the ElderlyFred Saad, Canada

1450-1505Focal MR-Guided Thermotherapy: An UpdateJohn Trachtenberg, Canada

1505-1520Discussion

1520-1530Break

1530-1720SESSION FIVE

KidneyModerator: Marcelo Bendhack, Brazil

1535-1550Small Renal Masses: Indications for Intervention in Elderly PatientsAntonio Finelli, Canada

1550-1605Partial Nephrectomy in the ElderlyThomas Schwaab, USA

1605-1620Role of Biopsy in Management of Renal MassesMichael Jewett, Canada

1620-1635Case Discussion

1635-1650Incorporation of TKIs into Surgical ManagementAnil Kapoor, Canada

1650-1705Lessons Learned from Partial vs Radical Nephrectomy StudiesHendrik van Poppel, Belgium

1705-1720Case Discussion

1720Conclude



SUNDAYOctober 16

WUOF PROGRAMME

Sunday, October 160800–0950SESSION SIX

Bladder Cancer BiologyModerator: Michael Droller, USA

0805–0820Update on New Diagnostic MethodsFred Witjes, The Netherlands

0820-0835Tissue MarkersPeter Black, Canada

0835-0845Discussion

0845-0900Management of Invasive Bladder Cancer in the ElderlyShahrokh Shariat, USA

0900-0915Management of Non-Muscle Invasive Bladder Cancer in ChinaNingchen Li, China

0915-0930Considerations for Treatment Decisions in Bladder CancerMichael Droller

0930-0945Discussion

0945–1005Break

1005–1125SESSION SEVEN

Surgical Management of Invasive Bladder CancerModerator: Urs E. Studer, Switzerland

1010–1025Role of Extended Node DissectionWassim Kassouf, Canada

1025–1040Quality of Care in the Management of Bladder CancerBadrinath Konety, USA

1040-1055Orthotopic Bladder in Elderly Patients: Limits and ResultsRichard Hautmann, Germany

1055-1110Discussion


BERLIN SIU 2011 39

SUNDAYOctober 16 WUOF PROGRAMME

1110-1220SESSION EIGHT

Moderator: Christopher Cheng, Singapore

1115-1130Why and How To Do a Nerve-Sparing CystectomyUrs E. Studer

1130-1145Upper Tract TCC: Role of Neoadjuvant TherapySurena Matin, USA

1145-1200Neoadjuvant vs. Adjuvant Chemotherapy: Which is Preferable?Peter Albers, Germany

1200-1215Discussion

1220Wrap-upLaurence Klotz

1220Adjourn



BERLIN SIU 2011 41

SATURDAYOctober 15

SUNDAYOctober 16

0800–1230

WUOF CONFERENCE

Room: ICC Lounge

(see programme on page 38)

0800–1215

DEUTSCHE GESELLSCHAFT FÜR UROLOGIE (DGU) (GERMAN SOCIETY OF UROLOGY)Chairs: Maurice Stephan Michel, Germany

Bernd Wullich, Germany

Room: Hall 3

Introduction to the DGU0800–0810Structure and Boards of the DGUStefan Müller, DGU President

The Best of German Urology in 2011 in Clinical Practice and Research The Akademie der Deutschen Urologen

(Academy of German Urologists)0810–0830Organization of Structured Urological Education in GermanyMaurice Stephan Michel

High-Ranked German Guidelines and Development of Excellence Centres0830–0850S-3 Guideline: Prostate CancerManfred P. Wirth

0850–0910S-3 Guideline: Urinary Tract InfectionFlorian Wagenlehner

0800–1720

WUOF CONFERENCE

Room: ICC Lounge

(see programme on page 35)

0800–1700

SIU BOARD OF CHAIRMEN MEETING

Room: Salon Esperanto, Grand Hotel Esplanade



SUNDAYOctober 16

0910–0930S-3 Guideline: Prophylaxis of Deep Vein ThrombosisPeter Walz

0930–0950Certified Prostate Cancer Centres and Testicular Cancer Second Opinion CentreAxel Heidenreich Research in Urology

0950–1000Structural Concepts of Research Promotion by the German Society of UrologyBernd Wullich Highest-Ranking Urological Research in

Germany DGU Award Recipients Present Their Studies1000–1020Recipient of the Nitze Award 2011Jens Bedke

1020–1040Recipient of the “Science Around Thirty” Award 2011Edwin Herrmann

1040–1050Recipient of the AuF Award 2010 (I)Natalie Sampson

1050–1100Recipient of the AuF Award 2010 (II)Friedemann Zengerling

Top-Level Research by Network Concepts1100–1115Comprehensive Clinical and Molecular Characterization of Selective Renal Tumor EntitiesKerstin Junker, on behalf of the German Network for Renal Cell Tumors

1115–1130The Relevance of National Communication Platforms for Realization of Multicentre Research ProjectsPeter Olbert, on behalf of the German Bladder Cancer Research Network

1130–1145Training and Quality Control: Indispensable Tools for Outstanding ResearchGerd Unteregger, on behalf of the German Prostate Cancer Consortium

1145–1200Male Infertility Through Infectious and Inflammatory Diseases of the Urogenital TractFlorian Wagenlehner, on behalf of the Network for Urogenital Infection

1200–1215Network for Infertility: Today and TomorrowWolfgang Weidner, on behalf of the Network for Infertility

0800–1215

DEUTSCHE GESELLSCHAFT FÜR UROLOGIE (DGU) (GERMAN SOCIETY OF UROLOGY)


BERLIN SIU 2011 43

SUNDAYOctober 16

0900–1200

SOCIETY OF GENITOURINARY RECONSTRUCTIVE SURGEONS (GURS) SYMPOSIUM

Room: Stockholm

Treatment of Complications After the Treatment of Prostatic Disease: “How I Do It” Session 1: Urethral Stricture and Bladder Neck

Contracture After TURPDiscussant: Ronald Kodama, Canada

0900–0925Incidence, Causes, Endoscopic and Open TreatmentsChristopher Gonzalez, USA

0925–0930Discussion and Questions

Session 2: Anastomotic Stricture After RRPDiscussant: Kurt McCammon, USA

0930–0955Incidence, Causes, and Treatment (Radical Resection, Botox, Urolume and Open Repair)Richard Santucci, USA


Session 3: Artificial Urinary SphincterDiscussant: Frank Burks, USA

1000–1025Primary and Secondary Applications of AUSAllen Morey, USA


Session 4: Rectourethral FistulaDiscussant: Joel Gelman, USA

1030–1055Transperineal Repair of Complex Rectourethral FistulasKenneth Angermeier, USA


Session 5: The Devastated Outlet “I and II”Discussants: Joel Gelman, USA

Kurt McCammon, USA

1100–1125Complete Reconstruction vs Suprapubic Diversion (Outlet I)Margit Fisch, Germany

1125–1150Complete Reconstruction vs Suprapubic Diversion (Outlet II)Steven Brandes, USA




SUNDAYOctober 16

0900–1200

INTERNATIONAL SOCIETY FOR SEXUAL MEDICINE (ISSM) SYMPOSIUMChair: John Dean, UK

Room: Hall 7Peyronie’s Disease and Men’s Sexual Well-BeingClaudio Teloken, BrazilThe Impact of Chronic Diseases on Men’s Sexual HealthEkaterina Kulchvenya, RussiaAssessment and Management of Low Sexual Desire in MenJohn Dean, UK

0900–1200

THE MIDDLE EAST SOCIETY FOR ORGAN TRANSPLANTATION (MESOT) SYMPOSIUMChairs: Adib Rizvi, Pakistan

Nasser Simforoosh, Iran

Room: Hall 100900-0935Technical Aspects of Kidney Transplantation:Experience with 3400 CasesNasser Simforoosh

0935-1010Transplantation Complications and InfectionsAdib Rizvi

1010-1045Pediatric Kidney TransplantationBassam Saeed, Syria

1045-1120Transplantation in MESOT CountriesMarwan Masri, Lebanon

1120-1155Transplantation in Abnormal Lower Urinary TractPatientsAltaf Hashemi, Pakistan

0900–1200

PAN-AFRICAN UROLOGICAL SURGEONS ASSOCIATION (PAUSA) SYMPOSIUMChairs: Khaled Dabees, Egypt

Serigne Gueye, Senegal

Room: Hall 90900–0915Introduction and WelcomeSerigne Gueye, Programme Coordinator

Mohamed Eissa, PAUSA President

0915–0940Management of Penile CurvatureHisham Badawi, Egypt

0940–1005West African Lymphatic Filariasis Morbidity Management Project: History and OutcomeSunny D. Mante, Ghana


BERLIN SIU 2011 45

SUNDAYOctober 16

1005–1015Questions and Answers1015–1040New Approaches to Prostate Cancer Management in the Native AfricanE. Oluwabunmi Olapade-Olaopa, Nigeria

1040–1105Metastatic Castrate-Resistant Prostate Cancer: What Are the Options?Jean McDonald, UK

1105–1115Questions and Answers

1115–1140Robots, Laparoscopy and Lasers: Is High Tech Possible in Low-Resource Countries?Catherine deVries, USA


1150–1200Conclusion: The Way ForwardKhaled DabeesSerigne Gueye

1000–1200

SIU NATIONAL DELEGATES’ MEETING

Room: Hall 6

1200–1300

BREAK

1300–1600

EUROPEAN ASSOCIATION OF UROLOGY (EAU) SYMPOSIUMChair: Per-Anders Abrahamsson, Sweden

Room: Hall 71300–1320Screening for Prostate Cancer: An UpdateFritz Schröder, The Netherlands

1320–1340Robotics in Surgery: A Real Advance?Walter Artibani, Italy1340–1400Optimal Treatment of High Risk Prostate CancerHein van Poppel, Belgium1400–1420What’s New in the Treatment of Castration-Resistant Prostate Cancer?Bertrand Tombal, Belgium

1420–1440Break1440–1500Surgery for Stress Incontinence: Current Concepts and Future DirectionsWalter Artibani, Italy

1500–1520What’s New in Andrology?Wolfgang Weidner, Germany



SUNDAYOctober 16

1520–1540Management of Small Renal MassesDidier Jacqmin, France

1540–1600What Is the Role of Lasers in Management of Benign Prostate Disease?Rolf Muschter, Germany

1300–1700

JOINT EDUCATIONAL COURSE: INTERNATIONAL CONTINENCE SOCIETY (ICS) AND SOCIETY FOR URODYNAMICS & FEMALE UROLOGY (SUFU)Chairs: Eric Rovner, USA

Werner Schaefer, USA

Room: ICC Lounge1300–1330Urodynamics and Biomechanics of Female IncontinenceWerner Schaefer, USA

1330–1400Sonography in the Diagnoses of Pre- and Post-Operative Bladder DysfunctionRalf Tunn, Germany

1400–1430SUI Surgery in 2011: Does One OperationFit All?Eric Rovner, USA

1430–1500Break1500–1530Current Concepts of Prolapse SurgeryHeinz Koelbl, Germany

1530–1600Mesh Complications in SUI/POP SurgerySandip Vasavada, USA

1600–1630Evaluation of Patients with Neurogenic Bladder: Indications and ImplicationsGary Lemack, USA

1630–1700Panel Discussion

1300–1700

EUROPEAN SOCIETY FOR PAEDIATRIC UROLOGY (ESPU)Moderator: Rien Nijman, The Netherlands

Room: Hall 101300–1320European Reflux GuidelinesRien Nijman

1320–1340The Long-Term Results of Endoscopic Treatment of RefluxGöran Lackgren, Sweden

1300–1600

EUROPEAN ASSOCIATION OF UROLOGY (EAU) SYMPOSIUM


BERLIN SIU 2011 47

SUNDAYOctober 16

1340–1415Debate: What Are My Indications for Endoscopic Treatment of Reflux?Moderator: Rien Nijman

1340–1345Göran Läckgren, Sweden

1345–1350Antoine Khoury, USA

1350–1355Paolo Caione, Italy

1355–1400Raimund Stein, Germany

1400–1415Debate

1415–1445Laparoscopy for Paediatric Renal Pathologies: An UpdateAlaa el Ghoneimi, France

1445–1500Break1500–1530Current Management of PUVRaimund Stein, Germany

1530–1600Update on the Management of CryptorchidismChristian Radmayr, Austria

1600–1700Panel on Distal HypospadiasModerator: Barry Kogan, USAPanelists: Alaa el Ghoneimi, Margit Fisch,

Marc David Leclair, Emilio Merlini

1300–1700

SYMPOSIUM ON UROLOGICAL STENTS (SUS)Chair: Daniel Yachia, Israel

Room: Oslo1300–1310OpeningDaniel Yachia

1310–1340UpdatesIdentification of Conditioning Film Components on Indwelling Ureteral Stents and Their Role in Bacterial AdhesionDirk Lange, CanadaUpdate on Metallic Stents in the Urinary TractRavi Kulkarni, UK

1340–1410Biodegradable Materials in Urinary Tract StentingBiodegradable Urethral Stents: What's New?Taina Isotalo, FinlandDegradable Ureteral StentsBen Chew, Canada



SUNDAYOctober 16

1410–1440Panel on Post-Surgical Bladder Neck StenosisModerator: Gerald H. Jordan, USAPalliation or Definitive Surgery? Is There Another Approach?Gerald H. JordanMemokath 045TW Stent in Intractable Bladder Neck Stricture: Preliminary ExperienceCarlo Luigi Augusto Negro, UKAllium RPS in Recurrent Bladder Neck Stenoses: Preliminary ExperienceOfer Nativ, Israel

1440–1530New and Upcoming Stent Designs for the Urinary TractStenting Blood Vessels or the Urinary Tract: What Makes It Different?Taina IsotaloA Novel 3.0F Ureteral Stent with Drainage Characteristics of a 4.75 F JJ StentDirk LangeIs There a Need for New Materials or New Stent Designs in the Urinary Tract?Daniel Yachia

1530–1600

BREAK AND POSTER VIEWING

POSTER SESSIONGroup A: Ask the AuthorUtilization of Allium Ureteral Stent in the Endoscopic Treatment of Ureteral Stenosis: Our Experience and Preliminary ResultsMariarita Salvitti, ItalyThe Dilemma of Infected Hydronephrosis Treatment Due To Ureteric Calculi: To Stent or To Perc?Michael Nomikos, GreeceRate of Inaccessible Ureter and Effect of Passive Dilation by Pre-Stenting at Ureteroscopic Laser LithotripsyYuji Kato, JapanRetrograde-Anterograde Combined Catheterization in Ureteral InjuriesOmar Bilal Halawa González, SpainUrological Complications After Renal TransplantationMihai Christian Harza, RomaniaShort-Term Success Rates of Ureteral De-Obstruction in Patients with Primary Retroperitoneal Fibrosis Undergoing Medical or Surgical TreatmentHannes Cash, Germany

1300–1700

SYMPOSIUM ON UROLOGICAL STENTS (SUS)


BERLIN SIU 2011 49

SUNDAYOctober 16

1600–1700

POSTER SESSIONGroup B: Podium PostersPressure Transmission Through Ureteric Stents: A Novel In-Vivo Human StudyWael Sameh, EgyptNew Management of Upper Urinary Tract Obstruction by Using Allium® StentsJoachim Alefelder, GermanyOpen Label, Randomized Clinical Trial To Evaluate the Safety and Efficacy of “Herbmed Plus” for Ureteral Stent Discomfort Against TolterodineSuresh Patankar, IndiaOutcome of Dual Flange Metallic Sphincteric Urethral Stents in the Treatment of Neuropathic Bladder Dysfunction After Spinal Cord InjuryAndre Van Der Merwe, South AfricaCharacterization of Morbidity of Double-J Ureteral StentsKhaled Mursi Hammoud, Egypt

1800–1930

OPENING CEREMONIES

Hall 1

1930–2100

WELCOME RECEPTION

Exhibit HallHalls 15.1 and 16



BERLIN SIU 2011 51

MONDAYOctober 17

0630–0800

INSTRUCTIONAL COURSES IC01–IC04

IC01: Transforming Urology in Africa: Designing Clinical and Research Collaborations

Chair: Catherine deVries, USA

Room: Salon 11/120630–0650Why Initiatives Fail: Analysis of Success and Failure in Global UrologyCatherine deVries

0650–0710How to Develop Clinical and Research Collaborations to Build Capacity in Sub-Saharan AfricaSerigne Gueye, Senegal

0710–0730Male Circumcision for Prevention of HIV Transmission in AfricaIra Sharlip, USA

0730–0750The Concept of Periodic Modular Training in Improving Urology Care in AfricaStephen Watya, Uganda


IC02: Management of Post-Prostatectomy Incontinence

Chair: Ajay Singla, USA

Room: Salon 13/140630–0635IntroductionAjay Singla

0635–0650Non-Surgical ManagementStavros Charalampous, Greece

0650–0705Adjustable Male SlingsRodrigo Leyton, Chile

0705–0720Non-Adjustable Male Sling: AdVanceKurt McCammon, USA

0720–0735Non-Adjustable Male Sling: InVanceAjay Singla

0735–0750Artificial Urinary Sphincter: The Gold StandardDirk De Ridder, Belgium

0750–0800Round Table Discussion and ConclusionAjay Singla



MONDAYOctober 17

IC03: Prostate Cancer Diagnosis and Screening: New Methods To Approach an Old Problem

Chair: Badrinath Konety, USA

Room: Salon 15/160630–0635IntroductionBadrinath Konety

0635–0655New MarkersBadrinath Konety

0655–0715New Biopsy and Other Diagnostic Techniques: Practical PointersStephen Jones, USA

0715–0735Experience with ERSPCMonique Roobol, The Netherlands

0735–0755Meta-analysis and Evidence Synthesis on Prostate Cancer ScreeningPhil Dahm, USA

0755–0800ConclusionBadrinath Konety

IC04: Robotic-Radical Retropubic Prostatectomy

Chair: Ashutosh Tewari, USA

Room: Salon 17/180630–0635Introduction and WelcomeAshutosh Tewari

0635–0700Technical Tips To Optimize Oncologic and Functional OutcomesAshutosh Tewari

0700–0725The Role of Pelvic Lymphadenectomy and How It Is Done in Robotic ProstatectomyFrancesco Montorsi, Italy

0725–0750Management of Complications and Improving Quality of Life After Robotic ProstatectomyPeter Wiklund, Sweden

0750–0800Discussion and Concluding RemarksAshutosh Tewari


BERLIN SIU 2011 53

MONDAYOctober 17

0745–1000

PLENARY 1Prostate CancerChairs: Margit Fisch, Germany

Gerald H. Jordan, USAJoachim W. Thüroff, Germany

Room: Hall 10745–0755Welcome AddressJoachim W. Thüroff, SIU PresidentMargit Fisch, Chair, Local Organizing CommitteeGerald H. Jordan, Chair, SIU 2011 Scientific Programme

0755–0805Pharmacology of Adrenoceptor Subtypes Creates New Drugs Treating LUTS/BPH and OABToichi Takenaka, Japan

0805–0810Presentation of SIU-Astellas LectureToichi Takenaka

0810–0830SIU-Astellas Lecture: Early Versus Delayed Endocrine Treatment of Locally Advanced Prostate Cancer: 40 Years of Progress Through International CooperationFritz Schröder, The Netherlands

0830–0845Don’t We Die from Prostate Cancer Any Longer?Peter Albertsen, USA

0845–0900The Future of Screening for Prostate Cancer: An Optimistic ViewFritz Schröder

0900–0920EAU Lecture: Radical Cystectomy in Older Patients: What Is Important?Manfred P. Wirth, Germany

0920–1000Debate: Management of Low-Risk Localized Prostate CancerModerator: Per-Anders Abrahamsson, SwedenActive SurveillanceLaurence Klotz, CanadaRadiotherapyThomas Wiegel, GermanySurgeryPeter Scardino, USA

1000–1200

PARALLEL PLENARIES 1–3

PARALLEL PLENARY 1Focal Therapy of Prostate CancerChairs: Peter Hammerer, Germany

William Lynch, Australia

Room: Hall 31000–1015Does Clinical Unifocal PCA Translate into Prostatectomy pT2a Stage?Thomas Polascik, USA

1015–1030Transrectal MRI ImagingArnauld Villers, France

1030–1045What Biopsy Strategy Does Focal Therapy Demand?Mark Emberton, UK



MONDAYOctober 17

1045–1100Robot-Assisted Image Guided Focal Therapy of Prostate Cancer: Initial ResultsJohn Trachtenberg, Canada

1100–1115Trans-Urethral Ultrasound Thermotherapy with MR Thermometry and ControlLaurence Klotz, Canada

1115–1130Real-Time Ultrasound Monitoring of Tissue ChangesMichael Marberger, Austria

1130–1200Focal Therapy of Low-Risk Prostate Cancer Using MR Guided Focus Ultrasound: Initial Clinical ExperienceChristopher Cheng, Singapore

PARALLEL PLENARY 2Pediatric UrologyChairs: Mohamed Eissa, Egypt

Margit Fisch, Germany

Room: Hall 61000–1015Has Injection Therapy Changed Indications/Timing for Antireflux Surgery?Antoine E. Khoury, USA

1015–1030Is There Still a Role for Long-Term Antibiotic Prophylaxis?Jean Hollowell, USA

1030–1045Indications and Timing of Surgical Correction of UPJ ObstructionBarry Kogan, USA

1045–1125Pro-Con Debate: Open vs. Laparoscopic vs. Robotic Surgery in Toddlers: Advantages andLimitationsOpen Surgery: Margit Fisch, GermanyLaparoscopy: Marc David Leclair, FranceRobotic: Sarah Lambert, USA

1125–1140Non-Neurogenic Voiding Disorders in ChildrenPaolo Caione, Italy

1140–1155Strategies for Treating Neurogenic Detrusor Overactivity in Myelomeningocele Raimund Stein, Germany

PARALLEL PLENARY 3Testis CancerChairs: Peter Albers, Germany

Michael Jewett, Canada

Room: Hall 71000–1030Pro-Con Debate: The Contralateral Testis Should Always Be Biopsied

Pro: Niels Skakkebaek, DenmarkCon: Harry Herr, USA

1030–1110Pro-Con Debate: Active Surveillance vs. Chemotherapy vs. RPLND in Stage I-IIa NSGCTT

Active Surveillance: Alan Horwich, UKProphylactic Chemotherapy: Peter Albers, Germany

1000–1200

PARALLEL PLENARY 1Focal Therapy of Prostate Cancer


BERLIN SIU 2011 55

MONDAYOctober 17

RPLND: Paul Lange, USA

1110–1125When Should You Do Retroperitoneal Dissection After Chemotherapy of Stage IIb-III NSGCTT?Axel Heidenreich, Germany

1125–1140Fertility and Testis CancerJWA Ramsay, UK

1140–1155Testis-Sparing SurgeryStephen Riggs, USA

1200–1315

BREAK

SPONSORED SYMPOSIA

Astellas Pharma Inc.

Trust Me, I’m a Doctor: Clinical Decisions in OAB

Chair: Eric Rovner, USA

Room: Stockholm1200–1205Chairman’s IntroductionEric Rovner

1205–1225Trust Me, I Know the PatientElise De, USA

1225–1245Trust Me, I Know the Latest Developments and DataKarl-Dietrich Sievert, Germany

1245–1305Trust Me, I Know the Role of GuidelinesHidehiro Kakizaki, Japan

1305–1315DiscussionSummary and CloseEric Rovner

Sanofi

Optimizing Patient Care in mCRPC: Who, When and How To Treat

Chair: John Fitzpatrick, Ireland

Room: Oslo1200–1220Changing Management Strategies in mCRPCJohn Fitzpatrick

1220–1305Optimising Patient Care in mCRPC: A Case StudyParticipants: Amit Bahl, UK

Nicolas Mottet, FranceJohn Fitzpatrick

Risk Stratification to Guide Multidisciplinary Team Treatment Decisions in mCRPCNicolas MottetWhen and How To Use Chemotherapy in mCRPCAmit Bahl

1305–1310Interactive DiscussionAll

1310–1315Summary and Meeting CloseJohn Fitzpatrick



MONDAYOctober 17

1315–1445


PARALLEL PLENARY 4Male IncontinenceChairs: Dirk De Ridder, Belgium

Osamu Ogawa, Japan

Room: Hall 71315–1330Pathophysiology of Incontinence in MalesPaul Abrams, UK

1330–1345Physiotherapy and Electrical/Magnetic Stimulation–Do They Change Natural History of Post-Prostatectomy Incontinence?Christian Hampel, Germany

1345–1400Do Drugs in Post-Prostatectomy Incontinence Do Any Good?Karl-Erik Andersson, USA

1400–1440Panel Presentations and Discussion: Which Surgical Therapy for Which Patient?

1400–1410Injectables and BalloonsChristian Hampel, Germany

1410–1420Slings, Slings, SlingsKlaus Höfner, Germany

1420–1430Hydraulic Controllable SphinctersAnthony Mundy, UK

1430–1440DiscussionAll

PARALLEL PLENARY 5Potentially Lethal InfectionsChairs: Mete Cek, Turkey

Chris F. Heyns, South Africa

Room: Hall 61315–1330Fournier’s GangreneAmir Zarrabi, South Africa

1330–1345Emphysematous PyelonephritisDick Barnes, South Africa

1345–1400Retroperitoneal AbscessRedouane Rabii, Morocco

1400–1430Panel Discussion: Management of Multiply Resistant Infections in Urology Today

1400–1410MRSADaniel Shoskes, USA

1410–1420ESBL and FQ ResistanceKurt Naber, Germany


1430–1445Male Circumcision for the Prevention of HIVIra Sharlip, USA


BERLIN SIU 2011 57

MONDAYOctober 17

1315–1445

ABSTRACT SESSIONS

PODIUM SESSION 1Bladder CancerChair: Michael Stöckle, Germany

Room: Hall 91315–1325POD–01.01Invasion of Urothelial Carcinoma Cells: Standardized Evaluation in a Novel Electrophysiological AssayChristian Bolenz, Germany

1325–1335POD–01.02Transitional Cell Bladder Cancer Proteomic Mapping and Risk of ProgressionIsabel Galante Romo, Spain

1335–1345POD–01.03Role of Estrogen, Progesterone and Androgen Receptors on Formation and Progression of Urothelial Carcinoma of the BladderGholamreza Pourmand, Iran

1345–1355POD–01.04Does Neobladder Created from Short Ileal Segment Reduce Delayed Metabolic Complications After Cystectomy?Vladimir Bancevic, Serbia

1355–1405POD–01.05Apoptosis of Urinary Bladder Cancer Cells Caused by Effect of Gemcitabine-CisplatinOleksandr Iatsyna, Ukraine

1405–1415POD–01.06Our Experience in the Use of JJ-Stent after Resection of the Ureteric Orifice During TURBBarbara Cristina Gentile, Italy

1415–1425POD–01.07Challenging Boundaries: An Enhanced Recovery Programme for Radical CystectomySaheel Mukhtar, UK

1425–1435POD–01.08Upper Urinary Tract Tumour with or Without Previous Bladder Cancer: Does It Make a Difference?Joan Palou, Spain

1435–1445POD–01.09Trans-Urethral Resection of Bladder Tumour (TUR-BT) in Patients Taking Platelet Antiaggregant MonotherapyStefano Picozzi, Italy



MONDAYOctober 17

1315–1445

MODERATED POSTER SESSION 1StonesChairs: Ben Chew, Canada

Robyn Webber, UK

Room: Salon 11/12

MP–01.01Characterization of Morbidity of Double J Ureteral StentsKhaled Mursi Hammoud, Egypt

MP–01.02Nephrostomy Tubeless and JJ Stentless PCNL: Experience of 113 CasesMohammed Bhuiyan, Bangladesh

MP–01.03Vitamin D Receptor Gene Polymorphisms in CaOx Kidney Stone PatientsOmer Onur Cakir, Turkey

MP–01.04Non-Contact Infrared Temperature Measurement of Ultrasonic Lithotripters: A Comparison of Commonly Used Lithotripsy DevicesChristian Keil, Germany

MP–01.05Vscan: A Pocket-Sized Ultrasound Device in Examination of the Genito-Urinary TractJoerg Neymeyer, Germany

MP–01.06Medical Expulsive Therapy Reduces the Need for Surgery in the Management of Distal Ureteral StonesErkan Erkan, Turkey

MP–01.07Management of Ureteral Calculi and Medical Expulsive Therapy in Emergency DepartmentsStefano Picozzi, Italy

MP–01.08Endothelin Plasma Concentrations as Parameter of Changes in Renal Perfusion After Extracorporeal Shockwave LithotripsyHajrudin Spahovic, Bosnia and Herzegovina

MP–01.09Flexible Ureteroscopy Assisted Semi-Rigid Retrograde Intra-Renal Surgery: A Cost-Effective Option in the Management of Upper Tract Urinary Calculi of <2 cmAjay Bhandarkar, India

MP–01.10In vitro Comparison of Two New Mechanical Impulse Lithotripsy DevicesChristian Keil, Germany

MP–01.11Analysis of Clinical Factors Associated to Spontaneous Passage of Ureteral Calculi in Korean Patients: Long-Term, Single Institution ExperienceSang-Cheol Lee, South Korea


BERLIN SIU 2011 59

MONDAYOctober 17

MP–01.12Retrograde Intrarenal Surgery for the Management of Renal StonesMarcos Cepeda Delgado, Spain

MP–01.13Is Percutaneous Nephrolithotomy Really a Minimally Invasive Procedure?Youssef Dakkak, Morocco

MP–01.15Computing Stone Burden for Selecting Cases for Reducing PCNL Tracts for Staghorn CalculusRavindra Sabnis, India

MP–01.16Rate of Inaccessible Ureter and Effect of Passive Dilation by Pre-Stenting at Ureteroscopic Laser LithotripsyYuji Kato, Japan

MP–01.17The Capability of Antiretropulsion Devices to Redirect Fluid Irrigation During UreteroscopyDirk Lange, Canada

MP–01.18Bilateral Ureteroscopy: Evaluation After 100 ProceduresPetrisor Aurelian Geavlete, Romania

MP–01.19Changes in Renal Pressure with Ureteral Catheters and Antiretropulsion Devices During Percutaneous NephrolithotomyDirk Lange, Canada

MP–01.20Complications After 6000 Ureteroscopies: The Experience of “Saint John” Emergency Clinical HospitalPetrisor Aurelian Geavlete, Romania

MP–01.21Spinal Anesthesia and Intercostal Access for Percutaneous NephrolithotomySeyed Habibollah Mousavi-Bahar, Iran

MP–01.22Postoperative Chest X-Ray After Supracostal Puncture: Mandatory After Every Case of Percutaneous Nephrolithotomy?Santosh Kumar Singh, India



MONDAYOctober 17

1315–1445

MODERATED POSTER SESSION 2 Adrenal, Kidney, Ureter:

Benign & Malignant DiseaseChairs: Dieter Jocham, Germany

Anil Kapoor, Canada

Room: Salon 13/14

MP–02.01Is the Use of Metaiodobenzylguanidine Scintigraphy Necessary in the Diagnosis of Pheochromocytoma?Jorge Hugo Almonacid Grunert, Spain

MP–02.02Silodosin Reduces Pressure In Vivo of the Obstructed Rat Ureter and Inhibits Nerve-mediated Contractions of the Isolated Human UreterLuca Villa, Italy

MP–02.03The Effects of Warm and Cold Ischemia on the Function of the Operated Kidney in Patients Undergoing Nephron-Sparing SurgeryNuman Baydilli, Turkey

MP–02.04Use of Digestive Tract To Replace UreterNabil Mhiri, Tunisia

MP–02.05Laparoscopic Adrenalectomy for Adrenal Metastases: Points of ControversyMasahiko Takemura, Japan

MP–02.06Surgery of Renal Tumor with Intra-Atrial Tumor Thrombi Using Hypothermic Circulatory ArrestYutaka Takezawa, Japan

MP–02.07Calcium-Dependent Bone Metastases in Renal Cell CarcinomaWalburgis Brenner, Germany

MP–02.08Identification of Cancer-Stem-Cell-Like Cells in a Papillary Renal Cell Carcinoma-Derived Cell LineRüdiger Sorg, Germany

MP–02.09Long-Term Results of Percutaneous Radiofrequency Ablation (PRFA) of Small Renal Tumors in High-Risk Patients: A Single Institution ExperienceMaurizio Brausi, Italy

MP–02.10Difference Between Clinical and Pathologic Renal Tumour Size, Correlation with Survival and Implications for Patient ManagementSabine Brookman-May, Germany


BERLIN SIU 2011 61

MONDAYOctober 17

MP–02.11Collecting System Invasion and Fuhrman Grading but not Tumor Size Facilitate Prognostic Stratification of Patients with pT2 Renal Cell Carcinoma: Can the Current 7th Edition of TNM Classification Be Improved?Sabine Brookman-May, Germany

MP–02.12Active Surveillance of Small Renal Tumours: Clinical OutcomesMuhammad Elmussareh, UK

MP–02.13Oncological Long-Term Outcome of Patients Presenting with Chromophobe in Comparison to Non-Chromophobe Renal Cell CarcinomaSebastian Frees, Germany

MP–02.14Outcomes of Surveillance Strategy and Surgical Management in Small Renal Masses: A Population-Based Study in Tayside, UKChi Kit Chuen, UK

MP–02.15Outcomes and Tumour Growth Rate of Renal Masses Are Dependent on Size at Presentation in a Watchful Waiting CohortNaji Touma, Canada

1315–1445

MODERATED POSTER SESSION 3Prostate Cancer, Detection and StagingChairs: Jan Fichtner, Germany

Samir Taneja, USA

Room: Salon 15/16

MP–03.01Functional Role of PGP 9.5 as Tumor Suppressor Is Inactivated by Promoter CpG Methylation in Human Prostate CancerYozo Mitsui, Japan

MP–03.0217–allylamino–17–demethoxygeldanamycin, a Heat Shock Protein 90 Inhibitor Suppresses Castration-Resistant Prostate Cancer Invasion, and Enhances DTX Antitumor ActivityFuminori Sato, Japan

MP–03.03HMGA2 Upregulation Is Related To Tumor Progression and let–7 Downregulation in High Risk Prostate CarcinomaMartin Spahn, Germany

MP–03.04The Combination Treatment of Bicalutamide Plus Carbidopa Significantly Enhances the in vivo Antitumor Activity on LNCaP Castration-Resistant Prostate Cancer Xenograft Tumors Compared To Single Use of Each DrugChristian Thomas, Germany



MONDAYOctober 17

1315–1445

MODERATED POSTER SESSION 3Prostate Cancer, Detection and Staging

MP–03.05Can Prebiopsy MpMRI Be Used To Preferentially Detect Significant Prostate Cancer?Mohamed Abd Alazeez, UK

MP–03.06Can Photodynamic Diagnosis Using 5–Aminolevulinic Acid (ALA) Predict Malignancy of Prostate Cancer Cells in the Urine, Obtained Following Prostate Massage?Satoshi Anai, Japan

MP–03.07Cost/Benefit of Incorporating Circulating Prostate Cell Detection in a Screening Programme for Prostate CancerAlexander Andrusco, Chile

MP–03.08Incorporating Circulating Prostate Cell Detection in a Screening Programme for Prostate Cancer Does Not Detect Low Grade Small Volume TumoursAlexander Andrusco, Chile

MP–03.09Comparison Between PSA Kinetics and the Detection of Circulating Prostate Cells and Bone Marrow Micrometastasis To Determine Local or Systemic Biochemical Failure After Radical Prostatectomy: Clinical ImplicationsAlexander Andrusco, Chile

MP–03.10Can Pre-Biopsy Multi-Parametric MRI Reduce the Number of TRUS Cores Required to Diagnose Prostate Cancer in an “At-Risk” Population of Men?Louise Dickinson, UK

MP–03.11Predictive Value of Number of Cores with High-Grade PIN and Atypical Acinar Proliferation in Prostate Biopsy for the Diagnosis of Prostate CancerAlberto Hernando Arteche, Spain

MP–03.12The Value of Computer-Aided Ultrasonography in the Detection and Evaluation of Prostate CancerApostolos P. Labanaris, Germany

MP–03.13Every Three Years PSA Screening Is Sufficient to Detect Almost All Prostate Cancers While Still Curable in Men with Baseline PSA Less Than 2.1ng/mL: Findings of a Longitudinal Study in Natori, JapanSadafumi Kawamura, Japan

MP–03.14The Influence of Positive Core Density on Predicting the Pretreatment Stage of Prostate CancerJung Ki Jo, South Korea

MP–03.15Pre-Operative Staging of Prostate Cancer with Histoscanning™ Facilitates Nerve-Sparing Prostatectomy and May Increase Complete Excision of Prostate CancersLucy Simmons, UK


BERLIN SIU 2011 63

MONDAYOctober 17

MP–03.16Blinded Comparison of Histoscanning™ Volumetric Tumour Assessment with Whole Mount Step Sectioned Radical Prostatectomy SpecimensLucy Simmons, UK

MP–03.17Epidemiological Aspects, Anatomo-Clinic of Prostate Cancer in CameroonMekeme Mekeme Junior Barthelemy, CameroonMP–03.18Plasma Amino Acid Profile as a Novel Diagnostic Marker for Prostate Cancer: Multicentre StudyTakeshi Miura, JapanMP–03.19Efficacy of Transperineal Versus Transrectal 12–core Initial Prostate Biopsy with PSA Levels Between 4.0 and 20.0 ng/mlShin Ohira, Japan

MP–03.20Prostate Cancer Angiogenesis: A Preliminary Experience with 64–Row Multidetector CT Perfusion. Do Quantitative Measurements Distinguish Tumor?Antonio Luigi Pastore, Italy

MP–03.21Prostate Cancer Detection Using Cadence Contrast Pulse Sequencing Technology for Targeted BiopsiesGeorge Daniel Radavoi, Romania

MP–03.22Cryoanalgesia for Prostate BiopsySimon Robinson, UK

MP–03.23Prevalence and Classification of Prostatic Calcification and Correlation with Histology and Other ParametersMichal Smolski, UK

1315–1445

VIDEO SESSION 1: Minimally Invasive Surgery I

Room: Salon 17/181315–1325VID–01.01Laparoscopic Management of Symptomatic Paracalyceal DiverticulumAbbas Basiri, Iran

1325–1335VID–01.02Robotic Radical Prostatectomy: A Step-by-Step ApproachGianluca D’Elia, Italy

1335–1345VID–01.03Robotic Partial Nephrectomy: How to Reduce Ischemia TimeGianluca D’Elia, Italy



MONDAYOctober 17

1345–1355VID–01.04Knotless Three-Layer Anastomosis During Radical Robotic ProstatectomyGianluca D’Elia, Italy

1355–1405VID–01.05A Technical Description of the Steps to Perform Robotic Radical CystectomyGianluca D’Elia, Italy

1405–1415VID–01.06Laparoscopic Partial Cystectomy for Bladder Leiomyoma: Case ReportMarco Puglisi, Italy

1415–1425VID–01.07Expanding Indications of Transvesical LESS SurgeryRené Sotelo, Venezuela

1315–1455

VIDEO SESSION 2: BPO/LUTS and OncologyChairs: Jovan Hadzi-Djokic, Serbia

Ismail Khalaf, Egypt

Room: Hall 101315–1325VID–02.01Initial Experience of Prostate Resection with Bipolar Surgimaster Scalpel in a Centre with Over 2000 Bipolar TURPFrancesco Pisanti, Italy

1325–1335VID–02.02Initial Experience of Prostate Transurethral Vaporization with Botton TURis in a Centre with Over 2000 Bipolar TURPFrancesco Pisanti, Italy

1335–1345VID–02.03Laparoscopic Extraperitoneal Adenomectomy: Comparative Study with Open TechniqueAlejandro Garcia-Segui, Spain

1345–1355VID–02.04Cost-Effective Treatment of Stress Urinary Incontinence and Complete Reconstruction of Pelvic Floor with Non-Tailored MeshIvan Ignjatovic, Serbia

1315–1445

VIDEO SESSION 1:Minimally Invasive Surgery I


BERLIN SIU 2011 65

MONDAYOctober 17

1355–1405VID–02.05Adjustable Transobturator Sling (Argus T®) for the Treatment of Post Radical Prostatectomy Urinary IncontinenceFlavio Trigo Rocha, Argentina

1405–1415VID–02.06Complications in Minimally Invasive Radical CystectomyRené Sotelo, Venezuela

1415–1425VID–02.07Total Penectomy and Inguinal Lymphadenectomy: Step by StepLuis Brandao, Brazil

1425–1435VID–02.08Robotic Assisted Inguinal Lymph Node Dissection:Preliminary ReportPN Dogra, India

1435–1445VID–02.09Initial Experience with the Reusable X-Cone Single Port System for Laparoscopic Varicocelectomy, Pelvic Lymphadenectomy and Renal Cyst MarsupializationFlorian Fuller, Germany

1445–1455VID–02.10Inferior Vena Cava Resection and Reconstruction During PC-RPLND for NSGCT in a Patient with Horseshoe KidneyPaolo De Stefanis, Italy

1445–1515

BREAK

1515–1645

SURGICAL TIPS 1–2 Surgical Tips 1:Male Incontinence

SurgeryChair: Christian Hampel, Germany

Room: Hall 6Faculty: Dirk De Ridder, Belgium

Vincent Delmas, FranceWilhelm Hübner, Austria

Surgical Tips 2: Robotic SurgeryChair: TBC

Room: Hall 7Faculty: Vito Pansadoro, Italy

Ashutosh Tewari, USAJoachim W. Thüroff, Germany



MONDAYOctober 17

1515–1645

ABSTRACT SESSIONS

PODIUM SESSION 2: Prostate Cancer, Detection and

ScreeningChairs: Peter Carroll, USA

Peter Hammerer, Germany

Room: Hall 91515–1525POD–02.01Detection of Prostate Cancer by HistoScanning™

Robin Epplen, Germany

1525–1535POD–02.02A Novel Stereotactic Prostate Biopsy System Integrating Preinterventional MRI with Live US FusionBoris Hadaschik, Germany

1535–1545POD–02.03Operator-Dependent Correlation Between Biopsy and Prostatectomy Gleason Score: Potential Impact on Clinical ManagementBadar Mian, USA

1545–1555POD–02.04Predictive Value of Prostatic Inflammation in the Development of Prostate CancerBenoit Molimard, France

1555–1605POD–02.05Temporal Trends in Prostate Cancer: A 50–Year Period Database AnalysisIvo Lopes, Portugal

1605–1615POD–02.06A Novel Robotic Assisted Prostate Biopsy Device Allows Better Detection and Characterisation of Prostate Cancer in Patients with TRUS Biopsy-Detected HGPINAllen Sim, Singapore

1615–1625POD–02.07Development of a Risk-Based Decision Model for Prostate Cancer Gene 3 UsageMark Speakman, UK

1625–1635POD–02.08Indications for Transperineal Ultrasound-Guided Prostate Biopsy: Analysis Comparing Transperineal versus Transrectal 14–Core BiopsyHiromi Uno, Japan

1635–1645POD–02.09Living with Untreated Prostate Cancer: The Impact of Active Surveillance on Quality of Life Lionne Venderbos, The Netherlands


BERLIN SIU 2011 67

MONDAYOctober 17

1515–1645

MODERATED POSTER SESSION 4Bladder CancerChair: Ricardo Rendon, Canada

Room: Salon 11/12

MP–04.01Maintenance Bacillus Calmette-Guérin Intravesical Instillation Therapy Is Effective for Prevention of Recurrence in Japanese Non-Muscle-Invasive Bladder Cancer CasesTakehiko Okamura, Japan

MP–04.02Integrated Genetic Analysis of Allelic Imbalance and FGFR3 Mutation by SNP-Based Pyrosequencing in Urothelial CancerYoshitomo Chihara, Japan

MP–04.04Haematuria One Stop Clinic: First Experience in Italy with 150 CasesGiorgio Bozzini, Italy

MP–04.05The Clinical Significance of Serum and Urinary HER-2/neu Protein in Bladder Cancer PatientsTaek Sang Kim, South Korea

MP–04.06Value of a Combination Assay of Survivin, Calreticulin and Urokinase Type Plasminogen Activator as a Non-Invasive Diagnostic Tool in Non-Muscle Invasive Bladder CancerWael Sameh, Egypt

MP–04.07Clinical Usefulness of Multimodality Bladder-Preservation Therapy in Muscle-Invasive Bladder Cancer: Comparison of Outcome with Radical CystectomyYasuhiro Hirano, Japan

MP–04.08Predictive Capacity of Four Comorbidity Indices Estimating Perioperative Mortality After Radical Cystectomy for Urothelial Carcinoma of the BladderRoman Mayr, Italy

MP–04.09Robotic Radical Cystectomy in the Elderly: Acceptable Postoperative Outcome?Stefan Siemer, Germany

MP–04.10Prognostic Value of Smoking in Bladder Cancer Patients Who Received Radical CystectomyJu Hyun Lim, South Korea

MP–04.11Trends in Bladder Cancer Incidence and Mortality in England, 1990–2006Maike Eylert, UK

MP–04.12Transforming the Invasive Bladder Pathway: Implementation of the Enhanced Recovery After Surgery with Lean Management PrinciplesSamuel Grimsley, UK



MONDAYOctober 17

1515–1645

MODERATED POSTER SESSION 4Bladder Cancer

MP–04.13Pharmacokinetics, Pharmacological Stability, Safety and Efficacy of MMC Administered with a New Hyperthermia DevicePaolo Gontero, Italy

MP–04.14Endoscopic Resection of Bladder Cancer in Patients Receiving Double Platelet Antiaggregant TherapyStefano Picozzi, Italy

MP–04.16Uptake of Surface Modified Poly(Lactide-Co-Glycolide) Nanoparticles in Bladder Cancer Cells and in Human Ureter and Mouse BladderRobert Weiss, USA

MP–04.17Simultaneous siRNA-Mediated Inhibition of Antiapoptotic BCL2, BCL2L1, Survivin and XIAP in Different Bladder Cancer Cell LinesManfred P. Wirth, Germany

MP–04.18Radical Cystectomy in Patients > 75 Years with Significant Co-MorbiditiesManfred P. Wirth, Germany

MP–04.19Inter-Observer Variation in the Pathological Diagnosis of Non-Muscle Invasive Bladder Cancer Between Tertiary Care Centres and Central Pathology ReviewKazunori Hattori, Japan

MP–04.20The Role of Secondary TUR in High Risk, Non-Muscle-Invasive Bladder TumorsMircea Radu Botoca, Romania

MP–04.21Neoadjuvant Chemohyperthermia for the Treatment of High-Risk Non-Muscle-Invasive Bladder Cancer:A Phase I StudyAlejandro Souza Escandon, Spain


BERLIN SIU 2011 69

MONDAYOctober 17

1515–1645

MODERATED POSTER SESSION 5BPO/LUTS: Intervention TherapyChair: Claus Roehrborn, USA

Room: Salon 13/14

MP–05.01Evaluating the Efficacy and Safety of Fixed-Dose Combinations of Tamsulosin OCAS™ and Solifenacin in Male LUTS with Storage and Voiding Symptoms: An Overview of the NEPTUNE TrialMarcus Drake, UK

MP–05.02Combination Therapy with Tamsulosin OCAS™ and Solifenacin Is More Effective than Solifenacin Monotherapy as a Treatment for Male LUTS Associated with BPH: Results from the SATURN TrialJean Jacques Wyndaele, Belgium

MP–05.03The Effects of Tamsulosin OCAS™ Plus Solifenacin on Quality of Life (QoL) Parameters in Men with LUTS Associated with BPH Participating in the SATURN TrialPhilip Van Kerrebroeck, The Netherlands

MP–05.04Multicentre Prospective Study of the Evolve™: Dual 150W Laser for Bladder Outflow Obstruction: Preliminary ResultsLina Maria Carmona, UK

MP–05.05Serial Change of Sexual Function After Holmium Laser Enucleation of the Prostate: A Short-Term Follow-Up StudyMin Su Jeong, South Korea

MP–05.06Transurethral Electrovaporization of the Prostate (TUVP) Using the Olympus Button Vaporization Electrode: A Comparative StudyVikas Agarwal, India

MP–05.07Injection of Onabotulinumtoxin A in Patients with Benign Prostatic Enlargement Refractory to Standard Medical Therapy: Evaluation of a Single Injection During 24 MonthsTiago Gorgal-Carvalho, Portugal

MP–05.08Preservation of Ejaculation in Monopolar TUR and Laser Vaporesection of Prostate in the Treatment of Bladder Outlet ObstructionChristoph Lang, Germany

MP–05.09Experience of Thulium Laser Vaporesection of Prostate for the Treatment of Benign Prostatic HyperplasiaShing-Hwa Lu, Taiwan

MP–05.10TURis Botton Prostate Resection: Our Preliminary ExperienceFrancesco Pisanti, Italy



MONDAYOctober 17

1515–1645

MODERATED POSTER SESSION 5BPO/LUTS: Intervention Therapy

MP–05.112000 Endoscopic Resections of Prostate Using Bipolar System (Gyrus Plasma Kinetic): Critical Review of Our ExperienceFrancesco Pisanti, Italy

MP–05.12Gyrus Bipolar TURP and Post-Operative Erectile FunctionFrancesco Pisanti, Italy

MP–05.13GreenLight™ HPS Laser Prostatectomy for Chronic Retention of Urine: A Safe and Efficacious OptionCarlo Luigi Augusto Negro, UK

MP–05.14GreenLight™ HPS Laser 120 W Versus Diode Laser 150W Vaporization of the Prostate: Results of a Prospective, Randomized StudyGheorghe Nita, Romania

MP–05.15Long-Term Experience and Risk Factors for Reintervention in Photoselective Vaporisation of the Prostate (GreenLight™)Ionel Valentin Popeneciu, Germany

MP–05.16Hybrid LESS Prostatectomy for BPH: A Combined TechniquePradeep Rao, India

MP–05.17The Prostatic Urethral Lift: A New, Minimally Invasive Therapy for BPHClaus G. Roehrborn, USA

MP–05.18A Prospective Multi-Center Study of the Efficacy and Safety of the AMS Green Light Laser HPS in Men with Male LUTS and Clinical BPHClaus G. Roehrborn, USA

MP–05.19Identification of Incontinence Risk Factors After Holmium Laser Enucleation of the Prostate (HoLEP)Bernhard Schoensee, Germany

MP–05.20The Influences of Intravesical Prostatic Protrusion on Changes of Voiding and Storage Symptoms After Bipolar Transurethral Resection of the Prostate in Patients with Benign Prostatic HyperplasiaHong Seok Shin, South Korea

MP–05.21Patients with Prostate Cancer Have a Higher Incidence of Venous Thromboembolic Events Following TURP Than Patients with Clinical BPHHelen Simpson, UK

MP–05.22Holmium Laser Enucleation Prostate (HoLEP) Is Time-consuming – Myth or Reality?Anil Kumar Varshney, India


BERLIN SIU 2011 71

MONDAYOctober 17

MP–05.23Does Defining the Limits of Dissection Proximal To External Sphincter Prior To Enucleation of Prostate with Holmium Laser Minimize Incidence of Stress Urinary Incontinence (SUI)?Anil Kumar Varshney, India

1515–1645

MODERATED POSTER SESSION 6 Renal TransplantationChairs: Hassan Abol-Enein, Egypt

Nasser Simforoosh, Iran

Room: Salon 15/16

MP–06.01Real-Time Vascular Imaging Technique Using Indocyanine Green in Kidney TransplantationNaoko Arichi, Japan

MP–06.02Standard vs Variant Vascular Procedures in Renal TransplantationDragoslav Basic, Serbia

MP–06.03Urological Complications After Renal TransplantationMihai Christian Harza, Romania

MP–06.04Management of Localized Prostate Cancer by Retropubic Radical Prostatectomy in Kidney RecipientsJulien Fumey, France

MP–06.05Learning Curve in Laparoscopic Donor Nephrectomy: Outcomes of an Experienced vs. an Inexperienced Laparoscopic SurgeonFrank Friedersdorff, Germany

MP–06.06Management of Urolithiasis in Kidney DonorsArvind Ganpule, India

MP–06.07Utility of Multidetector Computerized Tomography (MDCT) Angiography for Preoperative Evaluation of Vascular Anatomy in Living Renal DonorsArvind Ganpule, India

MP–06.08Is Graft Outcome Affected by Donated Kidney Volume Following Live Donor Kidney Transplantation?Ravindra Sabnis, India

MP–06.09The Impact of Donor Factor on Graft Function in Kidney Transplantation from Diseased Donor After Cardiac DeathTakeshi Ishimura, Japan

MP–06.10Contemporary Experience with Renal AutotransplantationVenkatesh Krishnamurthi, USA



MONDAYOctober 17

1515–1645

MODERATED POSTER SESSION 6Renal Transplantation

MP–06.11Contemporary Vascular Bypass Approach for Treatment of Retroperitoneal Tumors with Inferior Vena Cava and Atrial Extension: A 20–Year Single Institution ExperienceVenkatesh Krishnamurthi, USA

MP–06.13A Comparison of the Outcomes of Renal Transplantation from Heart-Beating and Non-Heart-Beating Cadaveric Donors Who Present Irreversible Cardiac Arrest Occurring Outside the HospitalFederico De La Rosa Kehrmann, Spain

MP–06.14Non-Heart-Beating Donors (Type I and II Maastricht Category): Results of Our ProgramFederico De La Rosa Kehrmann, Spain

MP–06.16Preoperative eGFR May Be the Sole Predictive Factor for Stage 3 Chronic Kidney Disease After Nephrectomy in Japanese PatientsKazuhiro Nagao, Japan

MP–06.17Dynamic Renogram and Urological Complications in Kidney Transplant: Is There a Role? Results of a Preliminary Monocentric Retrospective StudyCarlo Luigi Augusto Negro, UK

MP–06.19A New Protocol for Immunoadsorption for AB0–Incompatible Kidney TransplantationChris Protzel, Germany

MP–06.20Influence of Advanced Donor Age on the Evolution of Renal TransplantationNabil Mhiri, Tunisia

MP–06.21Does Kidney Transplantation with Multiple Arteries Affect Graft Survival?Nabil Mhiri, Tunisia


BERLIN SIU 2011 73

MONDAYOctober 17

1515–1645

MODERATED POSTER SESSION 7Infertility/Male Sexual DysfunctionChair: Vipan Bhatia, UAE

Room: Hall 8

MP–07.04Pharmacological Treatment of Non-Obstructive Azoospermia Increases Rates of Sperm Availability for IVF/ICSIAlayman Hussein, Egypt

MP–07.06Effect of Vardenafil Treatment in the Plasma Proteome of Patients with Erectile Dysfunction and Diabetes MellitusRicardo Brime Menéndez, Spain

MP–07.09The Study of Cavernous Arteries in Virtual CavernoscopyKazuyoshi Izumi, Japan

MP–07.103D Cavernosography and Virtual Cavernoscopy With Low Pressure Dynamic Infusion Cavernosometry and CavernosographyYasuo Kawanishi, Japan

MP–07.11Efficacy and Safety of Combination Therapy with Mirodenafil and Alpha-Blocker for Benign Prostatic Hyperplasia Accompanied by Erectile Dysfunction: A Multicenter, Open-Label, Prospective StudyJung Ki Jo, South Korea

MP–07.14Erectile Dysfunction and Metabolic Syndrome: Two Entities Related to Each OtherClara Lahoz Garcia, Spain

MP–07.15Evaluation of Effect of Photoselective Vaporization of Prostate on Sexual Function in a Prospective Study: A Single Centre Experience of 150 PatientsNayan Mohanty, India

MP–07.16Can Sexual Bother After Radical Prostatectomy Be Predicted Pre-Operatively?E. Andreas Svaboe Steinsvik, Norway

MP–07.17The Impact of Statins in Erectile DysfunctionLuis Figueiredo, Portugal

MP–07.18Original Technique for Penile Curvature without Circumcision: Ten Years’ ExperienceGiovanni Alei, Italy



MONDAYOctober 17

1515–1645

MODERATED POSTER SESSION 7Infertility/Male Sexual Dysfunction

MP–07.19Our Experience with Penile Girth Augmentation Through Acellular Porcine Dermal Grafts: A 69–Patient SeriesGiovanni Alei, Italy

MP–07.20Reconstruction of Iatrogenic Trapped Penis by Genital Skin FlapsVladimir Kojovic, Serbia

MP–07.21Prospective Long-Term Follow-Up of Patients with Chronic Orchialgia After Double-Blind, Placebo-Controlled Blockades of the Spermatic Cord Followed By Microsurgical DenervationRobert Oomen, The Netherlands

1515–1630

VIDEO SESSION 3: Trauma & ReconstructionChairs: Richard Santucci, USA

Joachim Steffens, Germany

Room: Hall 101515–1525VID–03.01Robotic Repair of Vesico-Vaginal Fistula Using a Pedicled Peritoneal FlapGianluca D’Elia, Italy

1525–1535VID–03.02Vesico-Vaginal Fistula Repair: Our Robotic TechniqueRené Sotelo, Venezuela

1535–1545VID–03.03Robotic Repair of Complex Vesicovaginal FistulaeRené Sotelo, Venezuela

1545–1555VID–03.04Surgical Treatment of Iatrogenic Recto-Urinary Fistula: York-Mason TechniquePedro Bargão, Portugal

1555–1605VID–03.05The Reconstruction of a Completely Destroyed Urethra from the Sphincter up to the Meatus by the Use of Buccal Mucosa GraftJörn Beier, Germany


BERLIN SIU 2011 75

MONDAYOctober 17

1605–1615VID–03.06Treatment of Recto-Urethral Fistula After Radical Prostatectomy with Gracilis Muscle FlapJose María Caballero Gine, Spain

1615–1625VID–03.07Hybrid Minimally Invasive Oral Mucosal Graft Urethroplasty for Pan Anterior Urethral StricturesAmlesh Seth, India

1645–1800

SPONSORED SYMPOSIA

1645-1730

Recordati

LUTS/BPH: The Clinical Advantages of the Novel Alpha Blocker Silodosin

Room: Oslo1645–1650

Introduction Francesco Montorsi, Italy

1650–1705Clinical Case 1Francesco Montorsi

1705–1720Clinical Case 2Matthias Oelke, Germany

1720–1730Discussion and ConclusionsFrancesco MontorsiMatthias Oelke

1645-1800

prIME Oncology

Evaluating the Current Therapeutic Landscape for Advanced Prostate Cancer

A prIME Oncology Symposium supported by Dendreon Corporation

Chair: Cora Sternberg, Italy

Room: Stockholm1645–1650Welcome and IntroductionCora Sternberg

1650–1705Examining the Issues and Unmet Needs in the Treatment of Advanced Prostate CancerCora Sternberg

1705–1725Integration of Newly Approved Therapies into the Continuum of Care for Advanced Prostate CancerThomas Powles, UK

1725–1745What Are the Promising Novel Strategies on the Horizon in Advanced Prostate Cancer?Karim Fizazi, France

1745–1800Importance of the Multidisciplinary Team in Prostate Cancer: The Urologist’s PerspectivePeter Mulders, The Netherlands

1800Concluding Remarks and AdjournCora Sternberg



MONDAYOctober 17

1800–2000

SIU WORLD FORUM FOR PATIENTS: BENIGN PROSTATIC HYPERPLASIA (BPH)Chair: Rainer Kuntz

Room: ICC Lounge

This session will be conducted in German.

1900–2300

SIU OKTOBERFEST NIGHT

Berlin Station


BERLIN SIU 2011 77

MONDAYOctober 17

UNMODERATED POSTER SESSION 1

Room: Exhibit Hall

Adrenal, Kidney & Ureter; Assessment of LUT/LUTD Incl. Urodynamics; Basic Science; Bladder Cancer; Female Urology; History; Imaging/Radiology; Infections & Inflammatory Diseases; Infertility; Kidney & Ureteral Cancer

UP–01.001Effect of Haemodyalisis on Serum Concentration of Nitric Oxide in Patients with End-Stage Renal DiseaseHajrudin Spahovic, Bosnia and Herzegovina

UP–01.002The Tip-of-12th Rib Flank Incision for Nephron-Sparing Renal Tumor ResectionMatei Andreoiu, USA

UP–01.003The Indication and Limit of Laparoscopic Adrenalectomy for PheochromocytomaHirofumi Izaki, Japan

UP–01.004Utilization of Allium Ureteral Stent in the Endoscopic Treatment of Ureteral Stenosis: Our Experience and Preliminary ResultsMariarita Salvitti, Italy

UP–01.005Endovascular Management of Hemorrhagic Complications After Percutaneous NephrolithotomyGeorge Daniel Radavoi, Romania

UP–01.006Clinical and Pathological Analyses of Adrenal Lipomatous Tumors: Experience with 51 Cases in ChinaFu-Kang Sun, China

UP–01.007Is the Short-Term Outcome of Transurethral Resection of the Prostate Affected by Preoperative Degree of Bladder Outlet Obstruction by Urodynamic Study?Jeong Man Cho, South Korea

UP–01.008Application of the SHEFFPAT Questionnaire to Assess Patient Feedback in a One-Stop Haematuria ClinicEdmund Chedgy, UK

UP–01.009Analysis of the Pressure-Flow Study in Weak Detrusor Patients with Benign Prostatic Hypertrophy: How Do We Manage?Osamu Ishizuka, Japan

UP–01.010Chronic Urinary Retention in Men: Can We Define It?Carlo Luigi Augusto Negro, UK

UP–01.011The Value of MELD Score in Predicting the Outcome of Patients with Liver Cirrhosis Undergoing a Urological ProcedureCristian Surcel, Romania

UP–01.012Sonication of Suprapubic Catheters: Frequency and Characteristics of Colonizing Bacterial BiofilmsGernot Bonkat, Switzerland



MONDAYOctober 17

UP–01.013On Functional Vesical Disturbances After ToxicantsUlrich Haerlin, Germany

UP–01.014Effect of Testosterone Ablation on Cardiac Muscle Electrophysiology: A New Insight to Side Effects Caused by CastrationHaluk Kulaksizoglu, Turkey

UP–01.015Smooth Muscle Differentiation of Purified Human Skeletal Muscle Derived Cells for Urological RegenerationShing-Hwa Lu, Taiwan

UP–01.016Changes in Intracorporeal Temperature of Tissue Pad After Using Ultrasonically Activated DevicesTeruyuki Ogawa, Japan

UP–01.017Damage to the Urinary Tract Induced by Oral Illegal Ketamine in a Rat ModelAzad Hassan Abdul Razack, Malaysia

UP–01.018Linear Correlations in Chromosomal-Based Gene Expression in Urinary Bladder CancerIoannis Boulalas, Greece

UP–01.019Identification of Cisplatin Resistance-Associated Proteins in Bladder Cancer by Two-Dimensional Gel Electrophoresis and Mass SpectrometryTadahiko Kikugawa, Japan

UP–01.020Superoxide Dependant Differential Regulation of ERK Signaling Controls the Metastatic Potential of Human Bladder Cancer CellsBadar Mian, USA

UP–01.021The Role of Actinin–4 in Bladder Cancer MetastasisHiroyoshi Nakatsuji, Japan

UP–01.022Increased Expression of the Oncogenic KLF6–SV1 in Bladder CancerNishihara Chikako, Japan

UP–01.023Stabilization of Urothelial Primary Culture and Chemosensitivity Assay in Transitional Cell CarcinomaAntonio Luigi Pastore, Italy

UP–01.026The Histone Deacetylase Inhibitor Valproic Acid Delays Cell Cycle Progression of Human Bladder Cancer Cells in vitroStefan Vallo, Germany

UP–01.027Expression and Function Role of DNA Methyltransferase 1 in Human Bladder CancerChun-Te Wu, Taiwan

UP–01.028Narrow Band Imaging (NBI) Assisted TURBt: Does It Improve Detection and Treatment Rates?Paulo Azinhais, Portugal


BERLIN SIU 2011 79

MONDAYOctober 17

UP–01.029Can Transrectal Ultrasound Be as Useful in Bladder Cancer as in Prostate Cancer?Erkan Erkan, Turkey

UP–01.030A Prospective Multi-Center Study of a Novel Urinary Diagnostic Test for the Detection of Transitional Cell Carcinoma in Patients with Gross HematuriaPeter Gilling, New Zealand

UP–01.031Does Atypia in Urine Cytology Predict Malignancy?Cheong Yu, China

UP–01.032NMP22 Bladder Check Tests Urine Cytology for Detecting NMIBCMariarita Salvitti, Italy

UP–01.033Diagnostic Value of a Urine Based Tumor Marker for Screening Lower Urinary Tract in Low-Risk Patients with Asymptomatic Microscopic HematuriaHakki Ugur Ozok, Turkey

UP–01.034Expression of CD147 in Patients with Non-Muscle Invasive Transitional Cell Carcinoma of Urinary Bladder: Utility as a Marker of Presence of TumourAmlesh Seth, India

UP–01.035Virtual Cystoscopy (Pneumo-Cystoscopy): Its Utility in the Prospective Evaluation of Bladder TumorIqbal Singh, India

UP–01.036Urinary Protein Patterns Discriminate Bladder Cancer Patients from Healthy SubjectsDerya Tilki, Germany

UP–01.037The Value of Asymptomatic Microscopic Hamaturia for Diagnosis of Urologic MalignanciesByung Hoon Kim, South Korea

UP–01.038Urothelial Tumoral Disease: “En Bloc” Nephroureterectomy, Cystoprostatectomy and UrethrectomyCristian Surcel, Romania

UP–01.039Chemoradiotherapy as a Bladder Sparing Treatment in Muscle Invasive Bladder Cancer (MIBC), Long-Term 16 Years Follow-Up: Experience of a Single InstitutionGiuseppe Morgia, Italy

UP–01.040Quality of Life in Patients with Bladder Cancer After Radical Cystectomy: Are There Changes?Cristian Vasile Casu, Spain

UP–01.041Justification for Radical Cystectomy in OctogenariansHector Garde, Spain

UP–01.042A Retrospective Evaluation of Radical Cystectomy Versus Bladder Preservation Therapy in Patients 80 Years Old and Older with Muscle-Invasive Bladder CancerRoman Mayr, Italy



MONDAYOctober 17

UP–01.043Postoperative Recovery of Bowel Function After Extraperitoneal Retrograde Total Cystectomy for Patients with Invasive Bladder CancerTakehiko Segawa, Japan

UP–01.044Ileal Orthotopic Bladder Replacement Without Stenting of Ureterointestinal Anastomosis: 10 Years’ ObservationPavo Wozniak, UK

UP–01.045Experience of Gemcitabine and Nedaplatin for Unfit Patients with Advanced Urothelial CancerKazuya Mikami, Japan

UP–01.046Intravesical Bacillus Calmette-Guérin Immunotherapy: The Experience of the Centro Hospitalar De Coimbra Urology DepartmentPaulo Azinhais, Portugal

UP–01.047Cathepsin B in the Diagnosis of Transitional Cell Carcinoma of the BladderPavel Dusek, Czech Republic

UP–01.048Fast Track in Urology: Cystectomy Results from a General Hospital ProviderAnne Kiel, Germany

UP–01.049pT0 After Radical Cystectomy: A Sign of Improved Outcome?Peter Kronenberg, Portugal

UP–01.050Analysis of Perioperative and 5–Year Oncological Outcome of 200 Cases of Open Radical Cystectomy: A Single Centre ExperienceNayan Mohanty, India

UP–01.051Symptom Analysis for Patients Undergoing Mitomycin Hyperthermia TreatmentSaheel Mukhtar, UK

UP–01.052Outcome of Treatment of High-Risk Non Muscle-Invasive Bladder Cancer with Mitomycin Hyperthermia with a Minimum Follow-Up of Two YearsSaheel Mukhtar, UK

UP–01.053Is the Presence or Absence of Tumour Necrosis a Significant Predictor of Survival in Bladder Cancer?Tahir Qayyum, UK

UP–01.054Implementation of a Standardized Uro-Oncology Perioperative ProtocolAlexander Rawlinson, UK

UP–01.055The Effect of Laparoscopic Radical Cystectomy on Postoperative CRP Level: Comparison with Open Radical CystectomyFuminori Sato, Japan

UP–01.056Improving Recovery After Cystectomy: Can Length of Stay Be Shortened?Karan Wadhwa, UK


BERLIN SIU 2011 81

MONDAYOctober 17

UP–01.057Sub Staging of T1 Bladder Cancer: Relationship of Progression and Recurrence to Depth of InvasionIrfan Ahmed, Pakistan

UP–01.058Risk Stratification in High Risk Superficial Bladder Cancer: Does Imaging Have a Role?Muhammad Rafiq, UK

UP–01.059Evaluation of the Need for Transuretheral Biopsy at First Follow-Up After Intravesical BCG Therapy for Superficial Bladder CancerKhaled Mursi Hammoud, Egypt

UP–01.060Clinical Significance of Immediate Urine Cytology After Transurethral Resection of Bladder Tumor in Patients with Non-Muscle Invasive Bladder CancerSang Deuk Kim, South Korea

UP–01.061Ablative Efficacy of Sequential Intravesical Chemotherapy Using Gemcitabine and Mitomycin C for Superficial Bladder CarcinomaSantosh Kumar, India

UP–01.062Validation of EAU Guideline Risk Classification for Japanese Non-Muscle Invasive Bladder CancerHideyasu Matsuyama, Japan

UP–01.063Outcome of Patients Affected by Papillary Urothelial Neoplasm of Low Malignant Potential: Single Centre CohortFrancesco Pisanti, Italy

UP–01.064GreenLight 30 W and Bladder Cancer: Is It a Good Option in Elderly High Risk Patients? Preliminary Results of a Monocentric Prospective StudyCarlo Luigi Augusto Negro, UK

UP–01.065Randomized Biopsy in the Diagnosis and Treatment of Superficial Bladder CancerKairat Nitkaliyev, Kazakhstan

UP–01.066Prognostic Factors in a Prospective Series of Non-Muscle-Invasive Bladder Cancer Treated with BCGPaolo Gontero, Italy

UP–01.067How Do Tumour Characteristics Influence Outcome Regarding Different Conservative Treatment Options for Non-Muscle Invasive Bladder Cancer T1G3?Joan Palou, Spain

UP–01.068Intravesical Non-alkalinized Lidocaine Instillation for Interstitial Cystitis/Bladder Pain Syndrome PatientsTeiichiro Aoyagi, Japan

UP–01.069Does Transobturator Tape Procedure Affect Walking? A Prospective Study with 3D Computerized Gait AnalysisEmin Aydur, Turkey

UP–01.070Assessment of Structural Changes and Complications in Obturator Fossa Due to Outside-In Transobturator Tape Procedure Using MRIEmin Aydur, Turkey



MONDAYOctober 17

UP–01.071Surgical Management of the Complications Associated with Transobturator Sling ProceduresGheorghe Bumbu, Romania

UP–01.072Clinical Impact of Body Mass Index on the Outcome of the SPARC-Sling System for the Treatment of Female Stress Urinary IncontinenceKatja Fischereder, Austria

UP–01.073Bladder Endometriosis: Clinical, Diagnostic and Therapeutic AspectsDario Garcia-Rojo, Spain

UP–01.074Recurrent Bacterial Cystitis, Bladder Instillation with a Combined Solution of Sodium Halurate and Chondroitin Sulfate (IALURIL): One Year of Follow-UpBarbara Cristina Gentile, Italy

UP–01.075Tension-Free Vaginal Tape Versus Transobturator Vaginal Tape in Management of Female Stress Urinary Incontinence Long-Term Follow-Up: Which to Choose?Khaled Mursi Hammoud, Egypt

UP–01.076Use of Vaginal Flap Neighbourhood for Improving Continence in Cervical Fistula, Cervico-Urethral and Urethral-Vaginal Obstetrical OriginMekeme Mekeme Junior Barthelemy, Cameroon

UP–01.077Impact of Intravesical Hyaluronic Acid and Chondroitin Sulphate on Bladder Pain Syndrome/Interstitial CystitisDaniele Porru, Italy

UP–01.078Randomized Trial Comparing a Conventional Mid-Urethral Sling and Two Single-Incision Slings: Mid-Term EvaluationAlexandre Resende, Portugal

UP–01.080Comparing Results of Two Types of Transobturator Tape (TOT), In-Out Technique, Used in Women with Stress Urinary IncontinenceCristian Surcel, Romania

UP–01.081Pelvic Organ Prolapse on the Internet: Similarities and Differences Between English-Speaking Countries and JapanTakeya Kitta, Japan

UP–01.082Single Incision Technique Using RSD-Ney for Insertion of Titanium Coated Extra-Light Mesh Yields More Favourable Clinical Outcomes in Patients Suffering from Vaginal Vault Prolapse Resulting from Previous Pelvic Tumor SurgeryJoerg Neymeyer, Germany

UP–01.083Application of Small Intestinal Submucosa Graft in Repair of Complicated Vesico-vaginal Fistula: Pilot StudyMohamed Rasheed Taha, Egypt


BERLIN SIU 2011 83

MONDAYOctober 17

UP–01.085Urethral Catheterization: An Ancient ArtRajendar Marri, UK

UP–01.086High-Intensity Focused Ultrasound in Urology: An Amazing Journey of 15 Years of Clinical UseHemant Nemade, UK

UP–01.087From Bats and Ships to Prostate and Kidneys: A Brief History of Ultrasound in UrologyHemant Nemade, UK

UP–01.088History of Aphrodisiacs: From Venus to ViagraSanjay Rajpal, UK

UP–01.089Mitomycin-C: Historical Aspects of the Discovery of Most Commonly Used Chemotherapy Agent in UrologyHemant Nemade, UK

UP–01.090A Historical Approach to the Causes of CancerApostolos Rempelakos, Greece

UP–01.091Byzantine Surgical Techniques for Penile Diseases: Descriptions of the Eminent Surgeon Oribasius (4th C. AD)Apostolos Rempelakos, Greece

UP–01.092Practice of Paedo-Urology in Byzantine ConstantinopleApostolos Rempelakos, Greece

UP–01.093Satyriasis and Priapism in Hellenistic Medical LiteratureApostolos Rempelakos, Greece

UP–01.094Ithyphallism in Ancient Greek ArtApostolos Rempelakos, Greece

UP–01.095The Second Oldest Urological Department in Europe Is Over 90 Years Old: An Historical ReviewImre Romics, Hungary

UP–01.096The Reformator Martin Luther’s Stone Disease During His Time at Wartburg CastleH. Matthias Weber, Germany

UP–01.097The Impact of the Degree of Spongiofibrosis on Surgical Decision Making in Male Short Anterior Urethral StrictureAlaa Elrifai, Egypt

UP–01.098Is Routine Diuresis Renography Indicated After Pyeloplasty ?Rami Issa, UK

UP–01.099Contrast-Enhanced Ultrasound (CEUS) in Imaging of Renal Space Occupying Lesion: What Is its Role?Vikas Agarwal, India



MONDAYOctober 17

UP–01.100Transrectal Doppler Ultrasound Imaging of Cowper’s Bulbourethral Glands: A Preliminary ReportAdam Golab, Poland

UP–01.101Clinical Value of Diffusion-Weighted Magnetic Resonance Imaging for the Detection of Prostate CancerYoshio Maki, Japan

UP–01.102Improved Image Assessment for Intravenous Excretion Urography by Different Speed Injections of Contrast MediumNobuyuki Nakamura, Japan

UP–01.103Urologists’ Best Friend, “Mobile Urological Bag” (MUB): A Lot of Technology in Little SpaceJoerg Neymeyer, Germany

UP–01.104Emergency Percutaneous Nephrostomy in Supine Position by Urologist Under Local AnesthesiaAda Ng, China

UP–01.105Imaging for Acute Loin Pain Suggestive of Renal Colic: Are We Detecting More Clinically Significant Extra-Renal Findings Since the Emergence of CT KUB?Rebecca Nicholas, UK

UP–01.106Clinical Value of Fluorodeoxyglucose Positron Emission Tomography/Computed Tomography (PET/CT) in Urologic CancersToru Nishiyama, Japan

UP–01.107Retroperitoneal Dedifferentiated Liposarcoma with Production of Granulocyte Colony-Stimulating Factor (G-CSF) Accompanied by Spontaneous Rupture: PET/CT Imaging of a G-CSF-Producing TumorShin Ohira, Japan

UP–01.108Transrectal Ultrasonography in Assessing Vesico-urethral Anastomosis After Radical Prostatectomy. Can Cystography Be Avoided?Giacomo Perugia, Italy

UP–01.111A Series of Colo-Vesical Fistula Presenting as Recurrent Urinary Tract InfectionShivadeo Bapat, India

UP–01.112Short-Term Success Rates of Ureteral De-obstruction in Patients with Primary Retroperitoneal Fibrosis Undergoing Medical or Surgical TreatmentHannes Cash, Germany

UP–01.113A Randomized Single-Blind Comparison of the Cost-Effectiveness of the High-Level Disinfectants Tristel Fuse (Chlorine Dioxide) and Cidex Opa (Ortho-Phthaldehyde) for Use with Flexible CystoscopesPeter Gilling, New Zealand

UP–01.114Wunderlich Syndrome: A Rare Complication of Renal AngiomyolipomaJan Breza, Slovak Republic


BERLIN SIU 2011 85

MONDAYOctober 17

UP–01.115Effect of Urethral Catheter in Infection Rates After Prostate BiopsyGokhan Koc, Turkey

UP–01.116Does Diabetes Mellitus Affect the Infection Rates after Prostate Biopsy?Gokhan Koc, Turkey

UP–01.117Masks of Kidney TuberculosisEkaterina Kulchavenya, Russia

UP–01.118Urogenital Tuberculosis in SiberiaEkaterina Kulchavenya, Russia

UP–01.119Laser Surgery in Complex Therapy of Urogenital TuberculosisEkaterina Kulchavenya, Russia

UP–01.120Chronological Age Is Not an Independent Predictor of Clinical Outcomes after Radical NephroureterectomyShahrokh F. Shariat, USA

UP–01.121Unexpected Multidrug Resistance of Methicillin-Resistant Staphylococcus Aureus (MRSA) in Urine Samples: A Single Center StudyMartin Schmudermaier, Austria

UP–01.122Trends of Increasing Resistance of E.Coli and Non Significant Changes in Extended Spectrum Beta-Lactamase (ESBL) E.Coli in Urinary Tract InfectionsMartin Schmudermaier, Austria

UP–01.123Risk Factor for Severe Infection in Patients with UrosepsisYuzo Nakano, Japan

UP–01.124About Isolation Sites, and Antimicrobial Agents Susceptibility of Extended-Spectrum Beta Lactamase-Producing E. Coli in My HospitalHitoshi Oh-Oka, Japan

UP–01.125The Scroto-Perineal Necrotizing Fasciitis: 30 Cases, 10 Years’ ExperienceGiandomenico Passavanti, Italy

UP–01.126Impact of Urinalysis Results on Flexible Cystoscopy ListsNiyukta Thakare, UK

UP–01.127Management of Fournier’s Gangrene: A Case-Series of 20 PatientsMee-Na Nina Wischnack, Germany

UP–01.128The Role of Nitric Oxide Synthase Expression in the Pathogenesis of VaricoceleErkan Erkan, Turkey



MONDAYOctober 17

UP–01.129Do Varicocele and Varicose Veins Have Any Relation? A Prospective Work-UpHasan Soydan, Turkey

UP–01.130Risk Factors for Developing Pain in Normospermia Varicocele PatientsShiou-Sheng Chen, Taiwan

UP–01.131Testicular Azoospermia: FSH Impact Factors on Testicular Biopsy Score for MESA, TESE and ICSIShalva Chovelidze, Georgia

UP–01.132Ligation of the Dilated External Spermatic Veins Improves the Outcome of Microscopic Subinguinal VaricocelectomyTarek Abdelbaky, Egypt

UP–01.133Surgery or Embolization for Varicoceles in Subfertile Men?Pedro Moreira, Portugal

UP–01.135Treatment of Post-Varicocelectomy Persistent Oligozoospermia with Oral Tamoxifen Citrate: A Randomized, Placebo-Controlled StudyMohamed Abdel Aziz, Saudi Arabia

UP–01.136Which Men Have More Likelihood of Success with a Testicular Biopsy?Luis Figueiredo, Portugal

UP–01.137IVF Using Surgically Obtained Spermatozoa May Be Preferred as the Primary Treatment Modality in Cases of Obstructive AzoospermiaM.A. Fischer, Canada

UP–01.139The Role of Surgical Ligation of the Left Internal Spermatic Vein for the Management of Infertile Men with Subclinical Left VaricoceleAlexandros Theodosiou, Greece

UP–01.140The Prognostic Value of C-Reactive Protein in Regard to Cancer-Specific and Overall Survival in Clear Cell Renal Cell Cancer Patients May in Part Be Explained by Vascular Endothelial Growth FactorGigja Gudbrandsdottir, Norway

UP–01.141Elevated Preoperative Serum Levels of MCP-1 (CCL2) is a Prognostic Marker for Cancer-Specificand Overall Survival in Renal Cell Cancer PatientsGigja Gudbrandsdottir, Norway

UP–01.142Impact of CD133 Expression in Renal Cell CarcinomaWalter Da Costa, Brazil

UP–01.143Loss of the Tight Junction Protein Claudin-7 Correlates with Carcinogenesis and Grading of the Clear Cell Renal Cell CarcinomaMohamed Gadelmoula, Saudi Arabia


BERLIN SIU 2011 87

MONDAYOctober 17

UP–01.144Prognostic Value of MAGE A9 in Renal Cell CarcinomaGencay Hatiboglu, Germany

UP–01.145Coexpression of Neural Cell Adhesion Molecule and Fibroblast Growth Factor Receptor 1 in Renal Cell CarcinomaCane Tulic, Serbia

UP–01.146Identification of Potential Prognostic Markers with Gene Expression Analysis in Clear Cell Renal Cell CarcinomaMatthias Maruschke, Germany

UP–01.147Accuracy of Conventional Pathologic Predictive Factors in Histological Subtype Chromophobe Renal Cell CarcinomaJoan Palou, Spain

UP–01.148E2EPF as an Ubiquitin Carrier Protein Plays a Role in the Cancer Genesis of Papillary Renal Cell CarcinomaFrederik Roos, Germany

UP–01.149Immunophenotype, Differentiation Capacity and Tumor Promoting Potential of Renal Cell Carcinoma-Derived Mesenchymal Stem Cell-Like Stromal CellsRüdiger Sorg, Germany

UP–01.150Impact of Body Mass Index and Weight Loss on Cancer-Specific and Overall Survival in Patients with Surgically Resected Renal Cell CarcinomaSabine Brookman-May, Germany

UP–01.151Analysis of the Characteristics of Renal Masses Diagnosed in Our Medium: 2008–2010María Del Carmen Cano García, Spain

UP–01.152Renorrhaphy in Partial Nephrectomy: What Should We Use?Somita Sarkar, UK

UP–01.153Accuracy of Multi-Detector Computed Tomography (MDCT) in Staging of Renal Cell Carcinoma (RCC): Analysis of Risk Factors for Mis-staging and its Impact on Surgical InterventionMohammed Hassan, Egypt

UP–01.154Bosniak IIF and III Complex Renal Cysts: Radiological and Clinical OutcomesMuhammad Elmussareh, UK

UP–01.155Correlation Between B7-H1/H3 Expression, Survival and Pathologic Parameters in Renal Cell Carcinoma PatientsThomas Gutschi, Austria

UP–01.156Reassessing the 2009 AJCC TNM Staging System for Renal Cell Carcinoma with Regard to Lymph Node MetastasisJumpei Iizuka, Japan

UP–01.157Metastatic Renal Cancer in the Targeted Therapy Era: The Sherbrooke ExperienceMichel Carmel, Canada



MONDAYOctober 17

UP–01.158Metanephric Adenoma: Unusual Renal Neoplasm, 2 Case ReportsPaulo Azinhais, Portugal

UP–01.159Prognostic Factors and Survival of Renal Cell Carcinoma in Japanese PatientsYoshiyuki Miyaji, Japan

UP–01.160Long-Term Follow-Up Is Necessary for Patients Presenting with pT1 and pT2 Renal Cell CarcinomaSebastian Nestler, Germany

UP–01.161Laparo-Endoscopic Single-Site Partial Nephrectomy: Report of Two Initial CasesHoang Nguyen Phuc Cam, Vietnam

UP–01.162Recurrence Pattern in Patients with Locally Advanced Renal Cell Carcinoma (LARCC): Implications of Clinico-Pathologic VariablesWael Sameh, Egypt

UP–01.163T3 Renal Cell Carcinoma: Has the TNM Classification (7th Version) Got It Right?Somita Sarkar, UK

UP–01.164Serum Cystatin C: A Marker of Early Kidney Function Damage After Tumor Nephrectomy?Marianne Schmid, Germany

UP–01.165Examination for Hyperuricemia after Operations of Renal Cancer and Renal Pelvic CancerMorito Sugimoto, Japan

UP–01.166Risk Factor of Hyperuricemia After NephrectomyMorito Sugimoto, Japan

UP–01.167Successful Improvement of Ambulatory Function by Direct Decompressive Surgery in Non-Ambulant Patients with Extradural Spinal Cord Compression Due to Spinal Metastasis of Renal Cell CarcinomaToshio Takagi, Japan

UP–01.168Incidence of Lymph Node Involvement According to Pathological T Stage or Tumor Grade in the Urothelial Carcinoma of the Upper Urinary TractToshio Takagi, Japan

UP–01.169Impact of the Tumor Enhancement Pattern in Computed Tomography in Detecting Renal Cell Carcinoma from Small Renal Masses: Who Really Requires Biopsy?Toshio Takagi, Japan

UP–01.171Age and Gender, Independent Prognostic Factors of Renal Cell Carcinomas: A Multicenter StudyIn Rae Cho, Korea, South

UP–01.172Metastasis in Renal Cell Carcinoma is Characterized by a Specific miRNA SignatureKerstin Junker, Germany


BERLIN SIU 2011 89

MONDAYOctober 17

UP–01.173Impact of Diabetes Mellitus on the Prognosis of Renal Cell CarcinomaSascha Pahernik, Germany

UP–01.174Methylenetetrahydrofolate Reductase Genotype and Haplotype May Be Associated with the Aggressiveness and Prognosis of Clear Cell Renal Cell CarcinomaShigeru Sakano, Japan

UP–01.175The Demography of Renal Cell Carcinoma in Bloemfontein, South Africa: Has it Changed Over the Past 15 Years?Frederik Claassen, South Africa

UP–01.176Accuracy of Biopsy in Tumors of Renal Parenchyma Smaller than 4 CentimetersDario Garcia-Rojo, Spain

UP–01.177Renal Mass Qualitative Enhancement Using Cadence Contrast Pulse Sequencing TechnologyGeorge Daniel Radavoi, Romania

UP–01.178Does Multidetector Row Computed Tomography Improve Accuracy in T Staging of Upper Urinary Tract Urothelial Carcinoma?Toshiaki Tanaka, Japan

UP–01.179Use of Quantitative Shotgun Proteomics to Identify Fibronectin 1 as a Novel Plasma Biomarker for Clear Cell Renal Cell CarcinomaAkira Yokomizo, Japan

UP–01.180Expression of Claudin-1 and 7 in Clear Cell Renal Cell Carcinoma and Its Clinical SignificanceByung Hoon Kim, South Korea

UP–01.181Laparoscopic Partial Nephrectomy for ≥ cT1b Renal Masses: A New Surgical ParadigmRicardo Rendon, Canada

UP–01.182Tuberous Sclerosis with Cutaneous Phenotype: Clinical ParticularitiesCristian Surcel, Romania

UP–01.183Box Counting Fractal Analysis in the Management of Small Renal MassesCristian Surcel, Romania

UP–01.184Mathematical Models for Estimating the Severity of Postoperative Acute Kidney Injury After Radical NephrectomyCristian Surcel, Romania

UP–01.185Intermediate Term Follow-Up of a Cohort of 63 Old and Comorbid Patients with Renal Masses Primarily Treated with ObservationChristian Beisland, Norway

UP–01.187Partial Nephrectomy for Kidney Cancer: Functional Results after First 43 CasesTommaso Brancato, Italy



MONDAYOctober 17

UP–01.188Laparoscopic Radical Nephrectomy: Initial Experience and Comparison with Experienced Surgeon Perioperative OutcomesFernando Cabrera Meiras, Spain

UP–01.189Impact of Renal Vein Invasion and Fat Invasion in PT3a Renal Cell CarcinomaWalter Da Costa, Brazil

UP–01.190The Fuhrman Grading System and CD44: Revisited ThemesWalter Da Costa, Brazil

UP–01.191Nephron-Sparing Surgery: Treatment of Choice for Localized Renal Cell Cancer?Jasenko Djozic, Serbia

UP–01.192Nephroureterectomy for Upper Tract TCC: Can We Predict Outcome?Somita Sarkar, UK

UP–01.193Oncological Outcomes of Partial Nephrectomy for Tumors Greater than 4 cm: A 10–Year Systematic ReviewRicardo Rendon, Canada

UP–01.194Laproendoscopic Single Site (LESS) Radical Nephrectomy and Radical NephroureterectomyArvind Ganpule, India

UP–01.195Treatment of Metastatic Renal Cell Carcinoma with Sunitinib: 4-Year Experience in Our DepartmentTiago Gorgal-Carvalho, Portugal

UP–01.196Radiofrequency Ablation of Small Renal Cell Carcinoma: Embolization before RFAAlexey Kalpinskiy, Russia

UP–01.197Invasive Bladder Tumor Recurrence After Nephroureterectomy for Upper Urinary Tract Urothelial CarcinomaMasashi Kato, Japan

UP–01.198Partial Nephrectomy vs Laparoscopic Radical Nephrectomy Renal Function OutcomesPaulo Azinhais, Portugal

UP–01.199Nephron-Sparing Surgery in The Treatment of T1b RCC: Our Experience and Review of the LiteratureMariarita Salvitti, Italy

UP–01.200Oncological Long-Term Results of Elective Nephron-Sparing Surgery versus Radical Nephrectomy for Renal Tumours Larger Than 4 cmSherif Mehrallivand, Germany

UP–01.201Impact of the Primary Tumor in situ on the Response of Metastatic Lesions to Targeted Therapy in Patients with Metastatic Renal Cell CarcinomaMasahiro Nozawa, Japan


BERLIN SIU 2011 91

MONDAYOctober 17

UP–01.202Endoscopic Management of Upper Tract TCC: Long Term Follow-UpGheorghe Nita, Romania

UP–01.203Experience in Cryoablation of Small Renal Masses from a Single UK CentreHemant Nemade, UK

UP–01.204Surgery + Intraoperative Radiotherapy + Additive External Beam Radiation: A Promising Option for Treatment of Locally Recurrent Renal Cell CarcinomaMarkus Riedl, Germany

UP–01.205Is Obesity an Important Predictor of Outcome in Patients Undergoing Radical Nephrectomy with Concomitant IVC Thrombectomy for Renal Cell CarcinomaPhilippe E. Spiess, USA

UP–01.206Prognosis and Characteristics of Renal Cell Carcinoma in Hemodyalisis Patients: Comparison Between Unilateral and Bilateral OccurrenceToshio Takagi, Japan

UP–01.207Thermal Damage of the Soft Coagulation in Pig’s KidneyOta Tomonori, Japan

UP–01.208Survival Following Nephrectomy for Advanced Renal Cell Tumors with Renal Vein InvolvementHemant Nemade, UK

UP–01.209Integrating Robot-Assisted Laparoscopic Partial Nephrectomy to the Robotic Surgery Program: The City of Hope ExperienceBertram Yuh, USA

UP–01.210Benefits of Embarking on a Robotic Nephro-Ureterectomy Programme for Surgeon and PatientRhana Zakri, UK

UP–01.211Comparison Between the Group Who Showed Pain Relief by Alpha Blocker Agent and the Group Who Did Not in Patients with CP/CPPSJung Ki Jo, South Korea



BERLIN SIU 2011 93

TUESDAYOctober 18

0630–0745

SPONSORED SYMPOSIUM

American Medical Systems

Panel Discussion: Male Urinary Incontinence

Room: ICC Lounge0630–0642Introduction and Overview of Male Stress Urinary IncontinenceKurt McCammon

0642–0655Patient Selection for Anti-Incontinence ProceduresWilliam Lynch, Australia

0655–0710AdVance and AdVance XPRicarda Bauer, Germay

0710–0725AUS Tips and TricksMichael Metro, USA

0725–0745Patient Presentations and Question and Answer

0800–1600

LIVE SURGERY FROM CHARITÉ HOSPITAL, BERLINThis presentation was supported by an unrestricted educational grant from the following: American Medical Systems, Inc., Karl Storz GmbH & Co. Kg.*.

Room: Hall 30815-0930Urethral Reconstruction0930-1000Break1000-1130Urolithiasis1130-1230Break1230-1400Renal Surgery1400-1415 Break1415-1545BPH Laser Therapy

*At press time.



TUESDAYOctober 18

0630–0800


IC05: Robotic Partial NephrectomyChair: Craig Rogers, USA

Room: Salon 11/120630–0655Robotic Partial NephrectomyCraig Rogers, USA

0655–0720Robotic Nephroureterectomy and Upper Urinary Tract ReconstructionAshok K. Hemal, USA

0720–0740Establishing a Multiservice Surgical Robotic Program: Essential Elements of Clinical Safety and Financial SuccessSurena Matin, USA

0740–0800Robotic Nephrectomy and Donor NephrectomyJacques Hubert, France

IC06: Urethral Strictures: Three Ways to Solve Every Stricture (Penile, Panurethral, Bulbar, Traumatic)

Chair: Miroslav Djordjevic, Serbia

Room: Hall 90630–0700Graft Urethroplasty: Is It Always Possible?Francisco Martins, Portugal

0700–0730Flap Urethroplasty: Tricks and TrapsMiroslav Djordjevic

0730–0800Anastomotic Urethroplasty: Challenges and LimitsAllen Morey, USA

IC07: Laparoscopic Donor NephrectomyChair: Alexander Bachmann, Switzerland

Room: Salon 15/160630–0645LESS and Donor Nephrectomy: Is There Still a Market?Andre Van der Merwe, South Africa

0645–0700Laparoscopic Donor Nephrectomy: Better than Open?Serdar Deger, Germany

0700–0715Cosmetic Aspects of Live Kidney Donors: Are They Really Important?Nicole Ebinger Mundorff, Germany

0715–0730The Advantages of the Transperitoneal RouteNasser Simforoosh, Iran


BERLIN SIU 2011 95

TUESDAYOctober 18

0730–0745Retroperitoneoscopic Donor Nephrectomy: Our Technique and ResultsKazunari Tanabe, Japan

IC08: Premature EjaculationChair: Ira Sharlip, USA

Room: Salon 17/180630–0635IntroductionIra Sharlip

0635–0655Epidemiology of Premature EjaculationIra Sharlip

0655–0715Genetics of Premature EjaculationMarcel Waldinger, The Netherlands

0715–0735Oral Therapy for Premature EjaculationCraig Donatucci, USA

0735–0755Non-Oral Therapy for Premature EjaculationHossein Sadeghi, USA

0755–0800Questions and Wrap-upAll

IC09: Focal Ablative Prostate TherapyChair: John F. Ward, USA

Room: Hall 100630–0635Introductory RemarksJohn F. Ward

0635–0655Prostate Biopsy for Patient SelectionJohn F. Ward

0655–0700Q&A0700–0720Prostate Cancer Imaging (MRI and Histoscanning)Mark Emberton, UK

0720–0725Q&A0725–0745Targeted Prostate Cancer Ablation: Techniques and OutcomesThomas Polascik, USA

0745–0750Q&A

0750–0800Panel Discussion with Audience and Closing Remarks



TUESDAYOctober 18

0745–1000

PLENARY 2Bladder CancerChairs: Patrick Coloby, France

Joachim W. Thüroff, Germany

Room: Hall 10745–0755Clinical Pearls: The Past Year in Review: OncologyVijay Sangar, UK

0755–0810The 2004 WHO Classification of Urothelial Neoplasms RevisitedRuth Knüchel-Clarke, Germany

0810–0825Re-TURB: Why, When and How?Harry Herr, USA

0825–0840BCG for CIS: What Is Proven After 30 Years?Maurizio Brausi, Italy

0840–0925High Grade pT1 BCA: How Early Cystectomy?Moderator: Mark Soloway, USA

Panelists: Hassan Abol-Enein, EgyptRichard Hautmann, GermanyWiking Månsson, SwedenJuan Palou, SpainVito Pansadoro, Italy

0925–0940Neoadjuvant ChemotherapyCora Sternberg, Italy

0940–1000Pro-Con Debate: Lymph Node Dissection Is Curative in Urological Cancers vs. Staging OnlyModerator: Arturo Mendoza Valdés, Mexico

CurativeUrs E. Studer, Switzerland

Staging OnlyJoachim W. Thüroff, Germany

1000–1130

SIU CONGRESS 1914 IN BERLIN: UROLOGY A CENTURY AGOChairs: Alain Jardin, France

Dirk Schultheiss, Germany

Room: Hall 8Cells, Microbes and Salvarsan in Berlin: A Medical Metropolis in the Long 19th CenturyThomas Schnalke, GermanyHistory of the Early Years of the SIUHeinrich Moll, GermanyJames Israel (1848–1926): Founding Member of the SIU and Leading Kidney Surgeon of His TimeDirk Schultheiss, GermanyUrology in Germany Between 1933 and 1945Heiner Fangerau, Germany


BERLIN SIU 2011 97

TUESDAYOctober 18

1000–1200


PARALLEL PLENARY 6Urinary DiversionChairs: Hassan Abol-Enein, Egypt

Richard Hautmann, Germany

Room: Hall 61000–1020CAU Lecture: Urinary Diversion: The Latin American PerspectiveAntonio Carlos Pompeo, Brazil

1020–1100Laparoscopic/Robotic vs. Open Urinary Diversion After Laparoscopic Cystectomy?Moderator: Arnulf Stenzl, GermanyPanelists: Hassan Abol-Enein, Egypt

Octavio Castillo, ChileRichard Gaston, FranceRaj S. Pruthi, USAStefan Siemer, GermanyPeter Wiklund, Sweden

1100–1120SIU-Albert Schweitzer LectureIsmail Khalaf, Egypt

1120–1135Is There Still a Role for Continent and Urinary Diversion?Urs E. Studer, Switzerland

1135–1150The Long-Term Metabolic and Neoplastic Consequences of Urinary DiversionRandall Rowland, USA

PARALLEL PLENARY 7Trauma From MISChairs: René Sotelo, Venezuela

Ingolf Tuerk, USA

Room: ICC Lounge1000–1015Bleeding and Extravasation in Percutaneous NephrolithotripsyMahesh Desai, India

1015–1030Ureteral Damage in UreteroscopyChristoph Klinger, Germany

1030–1045Bleeding, Bowel Injury, Conversion in Laparoscopic/Robotic SurgeryIngolf Tuerk, USA

1045–1055Septic ComplicationsPilar Laguna, The Netherlands

1055–1105Urinary ExtravasationJens Rassweiler, Germany

1105–1115The Forgotten StentGunter Janetschek, Austria

1115–1155Round Table Discussion Based on Case Presentations:

“Nihil Nocere”Moderator: René SoteloPanelists: All



TUESDAYOctober 18

PARALLEL PLENARY 8Prostate CancerChairs: Christopher Cheng, Singapore

Arnauld Villers, France

Room: Hall 71000–1015Quality of Life and Satisfaction with Therapy Amongst PCA SurvivorsMartin Sanda, USA

1015–1105Panel Presentations and Discussion: Cost/Benefit Ratio of ChemopreventionChair: Peter Albertsen, USA

1015–1025Dietary MeasuresHideyuki Akaza, Japan

1025–1035Lifestyle ChangesArturo Mendoza-Valdés, Mexico

1035–1045Antioxidants/Anti-Inflammatory AgentsAhmad Shabsigh, USA

1045–10555–α Reductase InhibitorsGerald Andriole, USA

1055–1105DiscussionAll

1105–1155Panel Discussion Based on Case Presentations: Management of High-Risk Locally-Confined PCAModerator: Peter Scardino, USA

Panelists: Arturo Mendoza-Valdés, MexicoMichael Stöckle, GermanyHendrik van Poppel, BelgiumThomas Wiegel, Germany

1200–1315

BREAK

SPONSORED SYMPOSIAAstellas Pharma Inc.

The Male LUTS Debate

Chair: Paul Abrams, UK

Room: Stockholm1200–1205Introduction and Audience PollingPaul Abrams

1205–1310The Motion: α1-Adrenoceptor Antagonist Monotherapy Is the Right First-Line Treatment for All Men with Bothersome LUTSPresentations, Panel Debate, Audience PollingFor the Motion: François Desgrandchamps, France

Mark Speakman, UK

Against the Motion: Marcus Drake, UKMatthias Oelke, Germany

1310–1315Take-Home MessagesPaul Abrams


BERLIN SIU 2011 99

TUESDAYOctober 18

CME-certified Symposium – International State of the Science of Immunotherapy in Prostate Cancer

This activity is supported by an independent educational grant from Dendreon Corporation.

Jointly sponsored by the Postgraduate Institute for Medicine and the Institute for Medical Education and Research, Inc.

Room: OsloChairs: Charles G. Drake, USA

Adam S. Kibel, USA

1200–1205Activity OverviewCharles G. Drake

1205–1225International Comparison of the Changing Landscape of Advanced Prostate Cancer ManagementKurt Miller, Germany

1225–1240Optimal Incorporation of Immunotherapy in Early-Stage CRPCCharles G. Drake

1240–1255Practical Application Case SeriesAdam S. Kibel

1255–1315Panel Discussion and Q&ACharles G. DrakeAdam S. KibelNoel W. Clarke, UKKurt MillerFrancesco Montorsi, Italy

1315–1600

NEW FINDINGS/RECOMMENDATIONS FROM THE 2011 INTERNATIONAL CONSULTATION ON UROLOGIC DISEASES (ICUD) ON PROSTATE CANCER, PART IChairs: Gerald Andriole, USA

Manfred P. Wirth, Germany

Room: ICC Lounge1315–1335A Brief History of Prostatic DiseasesPeter Thompson, UK

1335–1355Issues Related to Early DetectionMonique Roobol, The Netherlands

1355-1415Advances in Biomarkers for Prostate DiseasesSamir Taneja, USA

1415-1435New Developments in the Anatomical and Metabolic Imagery of the Prostate and Metastatic SitesJohn Coleman, USA

1435-1455Patients’ Perspectives on Prostate DiseasesPaul Lange, USA

1455-1515Metastatic PCA and Systemic TherapiesMario Eisenberger, USA

1515–1600Questions/Answers/Case Discussions



TUESDAYOctober 18

1315–1445


PARALLEL PLENARY 9Female IncontinenceChair: E. Ann Gormley, USA

Ajay Singla, USA

Room: Hall 71315–1330Urge or Stress: How Much Urodynamics Is Necessary?Marcus Drake, UK

1330–1345Severity of Incontinence Is Definition-Dependent: Results of a Prospective Randomized Study (TVT vs. Burch)Paul Hilton, UK

1345–1400Pharmacotherapy of OABKarl-Erik Andersson, USA

1400–1430Pro-Con Debate: Vaginal Sacrospinous Fixation vs. Abdominal SacrocolpopexyModerator: Eckhard Petri, GermanyVaginal Surgery: Heinz Kölbl, GermanyAbdominal Surgery: Christian Hampel, Germany

1430–1445Complications of Alloplastic Slings/MeshesEckhard Petri, Germany

PARALLEL PLENARY 10 Urethral Reconstruction: Global

PerspectivesChair: Sanjay Kulkarni, India

Richard Santucci, USA

Room: Hall 61315–1325Anastomotic Repair of Long Bulbar StrictureAllen Morey, USA

1325–1335Non-Transecting Anastomotic Bulbar UrethroplastyDaniela Andrich, UK

1335–1345Pan-Urethral Stricture Repair with Combined Penile and Scrotum Skin FlapQiang Fu, China

1345–1355Pan-Urethral Stricture Repair with One Side Dissection: Dorsal Onlay BMG UrethroplastySanjay Kulkarni, India

1355–1405Reconstruction of a Posterior Stricture Associated with a Rectourethral Fistula after Prostate Cancer Brachytherapy Using Gracilis Flap InterpositionReynaldo Gómez, Chile

1405–1415Perineal UrethrostomyGuido Barbagli, Italy

1415–1425Female Urethral ReconstructionIgor Vaz, Mozambique



BERLIN SIU 2011 101

TUESDAYOctober 18

1315–1445

ABSTRACT SESSIONS

PODIUM SESSION 3 Prostate Cancer, AdvancedChairs: Christopher Cheng, Singapore

Fred Saad, Canada

Room: Hall 81315–1325POD–03.01Risk Assessment for Prostate Cancer Metastases by Using the Capra Score: Results from 3239 European PatientsLars Budäus, Germany

1325–1335POD–03.02Prognostic Factors for Locally Advanced Prostate Cancer: A Multi-Center ExperienceSteven Joniau, Belgium

1335–1345POD–03.03Increased Cardiac Admission Rates in Prostate Cancer Patients Treated with Androgen Deprivation Therapy in EnglandEdward Jefferies, UK

1345–1355POD–03.04A Phase III Randomized Trial of Intermittent vs. Continuous Androgen Suppression for PSA Progression After Radical Therapy (NCIC CTG PR.7/SWOG JPR.7/CTSU JPR.7/ UK Intercontinental Trial CRUKE/01/013)Laurence Klotz, Canada

1355–1405POD–03.05Significance of Cyr61 Overproduction Induced by N-Acetylcysteine in Human Prostate Cancer PC-3 CellsChangho Lee, South Korea

1405–1415POD–03.06GTx-758, an Oral ERα Agonist Being Developed for ADT, Lowers Serum TestosteroneRonald Morton, USA

1315–1445

MODERATED POSTER SESSION 8 InfectionsChairs: Florian Wagenlehner, Germany

Chris F. Heyns, South Africa

Room: Salon 13/14

MP–08.01Does Intestinal Preparation Before Prostate Biopsy Guided by Transrectal Ultrasonography Affect Infection Rates?Gokhan Koc, TurkeyMP–08.02Xanthogranulomatous Pyelonephritis in ChildrenNabil Mhiri, TunisiaMP–08.03Effects of DM on Treatment Prognosis in Acute PyelonephritisKyung Seo Park, South Korea



TUESDAYOctober 18

MP–08.04Effects of Thermotherapy and Medical Therapy for Chronic Prostatitis/Chronic Pelvic Pain Syndrome: A Prospective StudyHong Sup Kim, South Korea

MP–08.05Disintegrating Perineum Disease in Patients Who Present with Urethral Strictures: A Review of 21 CasesFrederik Claassen, South Africa

MP–08.06Ultrasound and Morphological Conformity with Chronic ProstatitisAkhmed Pshikhachev, Russia

MP–08.07Randomized Clinical Trials on Antibiotic Prophylaxis in Flexible UrethrocystoscopyClara Lahoz Garcia, Spain

MP–08.08New Mutation in parE. Contribution to Quinolone Resistance in Extended-Spectrum-Lactamase-Producing Escherichia coli IsolatesClara Lahoz Garcia, Spain

MP–08.09Minimally-Invasive Management of Prostatic Abscess: Transrectal Ultrasound Guided Aspiration of Prostatic Abscess Under Local Anesthesia: Ganga Ram NeedleSudhir Khanna, India

MP–08.10Role of DNA PCR in Early Diagnosis of Genitourinary TuberculosisSudhir Khanna, India

MP–08.11Clinical Features of Mumps Orchitis in Vaccinated Postpubertal Males: A Single-Center Series of 62 PatientsJong Hyun Yoon, South Korea

MP–08.12Bacterial Growth in the Rectum and Urine Before and After Trans-Rectal Ultrasound-Guided Prostate BiopsyPeter Black, Canada

MP–08.13Diagnosis and Treatment for Male Genital TuberculosisEkaterina Kulchavenya, Russia

MP–08.14Multiple Resistant Enterobacteriaceae Implied in Urinary Tract Infections in an Ambulatory Urological WardMartha Orsolya, Romania

MP–08.15Significance of Pyospermia in Patients with VaricoceleSeung Ki Min, South Korea

MP–08.16Extended-Spectrum Beta-Lactamase (ESBL) Producing Enterobacteriacea in the Urinary Tract: Emerging Epidemiological Situation in University Hospital BaselGeorg Müller, Switzerland

1315–1445

MODERATED POSTER SESSION 8Infections


BERLIN SIU 2011 103

TUESDAYOctober 18

MP–08.17Is the Adjuvant Amikacin Effective as Antibiotic Prophylaxis for Transrectal Prostate Biopsy in Patients with Fluoroquinolone-Resistance in the Rectal Flora?Yoshitsugu Nasu, Japan

MP–08.18Alpha-Blockers, Antibiotics and Anti-Inflammatories Have a Role in Management of Chronic Prostatitis/Chronic Pelvic Pain Syndrome (CP/CPPS)J. Curtis Nickel, Canada

MP–08.19Prevalence of Antimicrobial Resistance in Rectal Normal Flora of Patients Undergoing Transrectal Ultrasonography-guided Prostate Biopsy in KoreaSeung Chol Park, South Korea

MP–08.20The “Ketamine Bladder”: An Emerging Public Health Problem?Sanjay Rajpal, UK

MP–08.21Correlation with Urinary Epithelium and Primary Symptoms in Interstitial Cystitis: Investigation of Scanning Electron MicroscopyTeruhiko Yokoyama, Japan

MP–08.22Predictive Factors of Bacteriuria in Emergency Patients of Ureteral Calculi Without FeverChoong-Hee Noh, South Korea

1315–1445

MODERATED POSTER SESSION 9BPO/LUTSChairs: Karl-Erik Andersson, USA

Luc Valiquette, Canada

Room: Salon 15/16

MP–09.01Hydrodynamic Aspects of Intravesical Protrusion of the Prostate in Patients with Voiding DysfunctionGaku Sakuyama, Japan

MP–09.02Role of Resistive Index as Prognostic Indicator in Treatment of BPHHarvinder Singh, India

MP–09.03Operative Impacts on Lower Urinary Tract Symptoms of Patients with BPH and Prostatitis: Comparison of Post Transurethral Resection StateChoong-Hee Noh, South Korea

MP–09.04The Long-Term Benefits of Combined Therapy of Chronic Non-Bacterial ProstatitisRazvan Bardan, Romania

MP–09.05Treatment with Once-Daily Tadalafil: Improvement in Symptoms of Benign Prostate Hyperplasia and Related Quality of Life for Men with or Without Erectile DysfunctionKim Drasa, Albania



TUESDAYOctober 18

MP–09.06Role of Combined Use of Ketoconazole and Tamsulosin in the Management of Acute Urinary Retention Due to Benign Prostatic ObstructionMohamed Elbendary Elnady, Egypt

MP–09.07New Direction in the Treatment of Benign Prostate Hyperplasia Using Adenoprosin: Biologically Active Entomological MedicineVitalii Ghicavii, Moldova

MP–09.08Serum Prostate Specific Antigen Level Predicts the Effectiveness of Silodosin in Patients with Benign Prostate HyperplasiaFumio Nakajima, Japan

MP–09.09Efficacy and Safety of Combination of Alfuzosin and Low Dose Udenafil Once Daily versus Monotherapy in Patients with Comorbid Lower Urinary Tract Symptoms and Erectile Dysfunction: Randomized Prospective Open-Label StudyDeok Hyun Cho, South Korea

MP–09.10Rapid Increases in Healthcare Utilization and Cost Due to Benign Prostatic Hyperplasia in South Korean Males: Retrospective Population-Based AnalysisWoo Suk Choi, South Korea

MP–09.11Prevalence of Benign Prostatic Hyperplasia and Lower Urinary Tract Symptoms in GhanaiansEdward Donkor Yeboah, Ghana

MP–09.12Prostatic Urethral Angulation Can Predict Urinary Flow Rate and Urinary Symptom Score in Men with Lower Urinary Tract SymptomsWon Sik Ham, South Korea

MP–09.13Contribution of Common Medications to Lower Urinary Tract Symptoms Among Community Dwelling MenMelanie Wuerstle, USA

MP–09.14Comparison Between 70w-12w-150w in the Vaporesection of BPH with Thulium LaserStefano Mattioli, Italy

MP–09.15Photoselective Vaporization of Prostate vs TURP: A Prospective, Randomized Study with One-Year Follow-Up Nayan Mohanty, India

MP–09.16Does a Patient with Parkinson’s Disease and Benign Prostatic Obstruction or Hypocontractility of the Detrusor Benefit from a Transurethral Resection of the Prostate?Andreas Neisius, Germany

MP–09.17Medication Adherence and Strategies for Improvement of Tamsulosin in Elderly Benign Prostatic Hyperplasia PatientsHitoshi Oh-Oka, Japan

1315–1445

MODERATED POSTER SESSION 9BPO/LUTS


BERLIN SIU 2011 105

TUESDAYOctober 18

1315–1445

MODERATED POSTER SESSION 10StonesChair: Shiv Bhanot, UK

Room: Salon 11/12

MP–10.02Increased Risk of Diabetes on Patients with Urinary Calculi: A Population-Based Follow-Up StudyWei-Che Wu, Taiwan

MP–10.03Evaluation of Risk Factors for Prognosis of Temporary Renal Impairment After Secondary Extracorporeal Shock Wave Lithotripsy (ESWL) in Renal Stone TreatmentManfred P. Wirth, Germany

MP–10.05Complications of Semirigid Ureteroscopy: The Experience of a Single Academic Tertiary Center with More Than 2500 CasesMircea Radu Botoca, Romania

MP–10.06Retrograde Intrarenal Surgery: Experience of 76 Cases with Recurrent Renal CalculiMohamed Gadelmoula, Saudi Arabia

MP–10.07PCNL Monotherapy for Complex Renal CalculiRajesh Kukreja, India

MP–10.08Chest Complications Following Supracostal PCNL May Be Delayed and Are More Common on the Right SideAmlesh Seth, India

MP–10.09Early Ureterolithotripsy for Obstructive Stones in Single Kidney PatientsBarbara Cristina Gentile, Italy

MP–10.10Ureteroscopy Complications: Our Long-Term ExperienceBarbara Cristina Gentile, Italy

MP–10.11Ureteroscopy: Role of Post-Operative Renal UltrasonographyBarbara Cristina Gentile, Italy

MP–10.13Particularities of Retrograde Ureteroscopy for Impacted Proximal Ureteral Stones: Experience of 200 CasesRazvan Multescu, Romania

MP–10.14Simultaneous Antegrade and Retrograde Approach for Complex Upper Tract Stones in Modified Supine Valdivia Position: Early ExperienceAda Ng, China

MP–10.15The Dilemma of Infected Hydronephrosis Treatment Due To Ureteric Calculi: To Stent or To Perc?Michael Nomikos, Greece



TUESDAYOctober 18

MP–10.16Cystatin-C, Interleukin-18 and N-GAL Levels as Biomarkers of Inflammatory Response After Extracorporeal Shock Wave LithotripsyMichael Nomikos, Greece

MP–10.18One Shot Versus Amplatz Sequential Fascial Dilatation Technique for Tract Creation in PCNLSanjeev Tonshal, India

MP–10.19Effect of Dilatation Type Used During Percutaneous Nephrolitotomy Operations on Operation and Fluoroscopy Times, Preoperative and Postoperative Hematocrit and Creatinine LevelsGokhan Koc, Turkey

MP–10.20The Effect of Body Mass Index on Operative and Fluoroscopy Time, Postoperative Hematocrite and Creatinin Values in Percutaneous NephrolitotomyGokhan Koc, Turkey

1315–1445

MODERATED POSTER SESSION 11 Pediatric UrologyChairs: Catherine deVries, USA

Margit Fisch, Germany

Room: 44

MP–11.01Laparoendoscopic Single-Site Surgery (LESS) In Paediatric Patients Less Than 5 Years of AgeArvind Ganpule, India

MP–11.02The Role of Urodynamical Findings in the Management of Children’s Overactive BladderMartha Orsolya, Romania

MP–11.03Screening for Mutations in Id2 Gene in Familial HydronephrosisYoshitaka Aoki, Japan

MP–11.04The Assessment of Electromyography Study Tracing in Children with Lower Urinary Tract SymptomsFrederik Claassen, South Africa

MP–11.05Epididymitis in Children: New Insights on an Old ProblemCatherine deVries, USA

1315–1445

MODERATED POSTER SESSION 10Stones


BERLIN SIU 2011 107

TUESDAYOctober 18

MP–11.06Ileal Neobladder in Pediatric Population: Objective Assessment of the Long-Term SequelaeAli Ahmed Abdelhalim, Egypt

MP–11.07A Third of Patients With a Unilateral Palpable Undescended Testes Have a Contralateral Patent ProcessusBarry A. Kogan, USA

MP–11.08Hypospadias Management in High Familial Incidence Area of Jizan, Saudi Arabia: A Prospective StudyAkhileshwar Jha, Saudi Arabia

MP–11.09Tubularized Preputial Double Faced Flap Urethroplasty Is a Good Alternative Surgery in Management of Proximal Hypospadias with Chordee, or Unhealthy Urethral Plate Requires OrthoplastyTarek Abdelbaky, Egypt

MP–11.10Free Tube Graft Urethroplasty for Repair of Hypospadias with ChordeeKenji Obara, Japan

MP–11.11Primary Vesico-ureteral Reflux: Comparison of Factors Between Infants and ChildrenJae Shin Park, South Korea

MP–11.12Role of Laparoscopy in Diagnosis and Management of Non-Palpable Undescended TestisKhaled Mursi Hammoud, Egypt

MP–11.15Application of Deflux® Gel Injection Into the Bladder Neck Area in Patients with Neuropathic Sphincter FailureLidia Skobejko-Wlodarska, Poland

MP–11.16Uretero-Pelvic Junction Obstruction in Double KidneysChristopher Ziesel, Germany

1315–1445

VIDEO SESSION 4 Minimally Invasive Surgery IIChairs: Petrisor Geavlete, Romania

Jens Rassweiler, Germany

Room: Hall 101315–1325VID–04.01Laparoendoscopic Single-Site Surgery Approach for Simultaneous Bilateral NephrectomyAmit Bhattu, India

1325–1335VID–04.02Bilateral Simultaneous Laproendoscopic Single Site Surgery (LESS) Pyeloplasty in a 4-Month-Old ChildArvind Ganpule, India

1335–1345VID–04.03Percutaneous Nephrolithotomy (PCNL) in Patient with Severe Spinal DeformityRavindra Sabnis, India



TUESDAYOctober 18

1345–1355VID–04.04Hybrid Laparoendoscopic Single Site Radical ProstatectomyPaul Rouse, UK

1355–1405VID–04.05A Novel Intracorporeal Knotting Technique for Laparoendoscopic SurgeryPaul Rouse, UK

1405–1415VID–04.06NOTES Hybrid Transvaginal Upper Pole HeminephrectomyRené Sotelo, Venezuela

1415–1425VID–04.07Laparoscopic Management of Incisional Hernias at the Site of Extraction after Robotic ProstatectomyRené Sotelo, Venezuela

1425–1435VID–04.08Laparoscopic Resection of a Large Functional Paraganglioma in the Organ of Zuckerkandl (PZ)Domenico Veneziano, Italy

1315–1445

VIDEO SESSION 5 Kidney & Ureteral CancerChairs: Markus Hohenfellner, Germany

Osamu Ogawa, Japan

Room: Salon 17/181315–1325VID–05.01Laparoscopic Partial Nephrectomy: “Zero-Ischemia” Technique with Controlled HypotensionRené Sotelo, Venezuela

1325–1335VID–05.02Laparoscopic Partial Nephrectomy in Polycystic KidneyJuan Peña, Spain

1335–1345VID–05.03Partial Nephrectomy by Retroperitoneoscopy Without Hilar ClampingJuan Peña, Spain

1345–1355VID–05.04Simultaneous Double Partial Nephrectomy for a Double Ipsilateral TumorJuan Peña, Spain

1355–1405VID–05.05Endoscopic Treatment of Multiple Ureteral Tumors in an Eighty-Year-Old PatientTomislav Pejcic, Serbia

1315–1445

VIDEO SESSION 4:Minimally Invasive Surgery II


BERLIN SIU 2011 109

TUESDAYOctober 18

1405–1415VID–05.06Laparo-Endoscopic Single Site Transvesical Bladder Cuff ExcisionRené Sotelo, Venezuela

1415–1425VID–05.07Pluck Detachment of the Intramural Ureter Using Bipolar Plasma Vaporization: An Innovative Endoscopic Method During NephroureterectomyRazvan Multescu, Romania

1425–1435VID–05.08Investigation of an Extended Set of Specialized Fiber Probes During the Application of Thermal Energy at Parenchymal TissueJoerg Neymeyer, Germany

1435–1445VID–05.09Improved Precision and Therapy Outcome During the Use of Laser Energy with a New Fiber Design and NBI (Narrow Band Imaging) Technology for the Treatment of Tumor Tissue at the Renal PelvisJoerg Neymeyer, Germany

1445–1515

BREAK

1515–1645

SURGICAL TIPS SESSIONS 3–4

SURGICAL TIPS 3Female Incontinence SurgeryChair: Marcus Drake, UKFaculty: Heinz Kölbl, Germany

Eckhard Petri, GermanyChristian Hampel, Germany

Room: Hall 7

SURGICAL TIPS 4Hypospadias RepairChair: Dragana Filipas, GermanyFaculty: Raimund Stein, Germany

Antoine E. Khoury, USAPaolo Caione, Italy

Room: Hall 6

1515–1645

ABSTRACT SESSIONS

PODIUM SESSION 4 BPO/LUTSChair: Reynaldo Gómez, Chile

Rainer Kuntz, Germany

Room: Hall 81515–1525POD–04.01Comparing Holmium Laser Enucleation of Prostate (HoLEP) with Bipolar Transurethral Resection of Prostate: A Prospective Randomized Controlled TrialAjay Bhandarkar, India



TUESDAYOctober 18

1525–1535POD–04.02A Prospective Randomized Study Between Transurethral Vaporisation Using Plasmakinetic Energy and Transurethral Resection of Prostate: 8 Years’ Follow-UpPonnambalam Chandrasekar, UK

1535–1545POD–04.03Holmium Laser Enucleation of the Prostate (HoLEP) and Incidential Prostate Cancer: Clinical Significance of Histology in Laser Prostatectomy in Men <70 YearsLuis Alex Kluth, Germany

1545–1555POD–04.04Bipolar Plasma Vaporization Versus Monopolar and Bipolar TURP: Results of a Prospective, Randomized, Long-Term ComparisonBogdan Florin Geavlete, Romania

1555–1605POD–04.05Comparison Between Plasmakinetic Resection of Prostate and Monopolar TURP: A Prospective Randomized Trial with 5–Year Follow-upSuresh Patankar, India

1605–1615POD–04.06The Effect of Increasing Doses of a Saw Palmetto Fruit Extract on Lower Urinary Tract Symptoms Attributed to Benign Prostatic Hyperplasia: A Randomized TrialClaus G. Roehrborn, USA

1615–1625POD–04.07Intravesical Prostatic Protrusion in Benign Prostatic Hyperplasia: Does It Make Any Difference in Results After Transurethral Resection of the Prostate?Jae Shin Park, South Korea

1625–1635POD–04.08Management Algorithm for Bladder Outlet Obstruction in WomenManu Gupta, India

1515–1645

PODIUM SESSION 5 Bladder CancerChairs: Peter Black, Canada

Hubertus Riedmiller, Germany

Room: Hall 91515–1525POD–05.01Narrow Band Imaging Cystoscopy Improves the Detection of Bladder CancerRami Issa, UK

1525–1535POD–05.025–Aminolevulinic Acid-Based Photodynamic Detection for Diagnosing Urothelial Cancer Cells in Urine SedimentsKiyohide Fujimoto, Japan

1515–1645

PODIUM SESSION 4BPO/LUTS


BERLIN SIU 2011 111

TUESDAYOctober 18

1535–1545POD–05.03Treatment Changes and Long-Term Recurrence Rates After HAL Fluorescence Cystoscopy: Does Blue Light Really Make a Difference in the Long Run?Bogdan Florin Geavlete, Romania

1545–1555POD–05.04Stage pT0 After Radical Cystectomy: Are All Patients Equal?Shahrokh F. Shariat, USA

1555–1605POD–05.05Risk Stratification of Patients Who Are pT0N0 After Radical CystectomyShahrokh F. Shariat, USA

1605–1615POD–05.06Optical Coherence Tomography (OCT) as an Adjunct to Conventional Cystoscopy and Pathology for Non-Invasive Endoscopic Staging of Bladder TumorsSeth P. Lerner, USA

1615–1625POD–05.07Smoking Behaviour Is a Risk Factor for Recurrence After Transurethral Resection of Non-Muscle-Invasive Bladder CancerRianne Janna Marie Lammers, The Netherlands

1625–1635POD–05.08Bipolar Plasma Vaporization and NBI for Large Non-Muscle Invasive Bladder Tumors: Results of a Prospective, Randomized, Long-Term Comparison to the Standard ApproachBogdan Florin Geavlete, Romania

1515–1645

PODIUM SESSION 6 Minimally Invasive SurgeryChair: Mihir Desai, USA

Room: Hall 101515–1525POD–06.01Mininvasive Open Tumor Enucleation vs. Percutaneous Radiofrequency Ablation vs. Active Surveillance of Small Renal Masses <3 cm in Old Patients: Long-Term Results of a Prospective Follow-Up StudyMaurizio Brausi, Italy

1525–1535POD–06.02Establishing a Viable Robotic Service: A Twelve-Month Experience of the ChallengesRami Issa, UK

1535–1545POD–06.03Prostate Tumour Identification Using a Force-Sensitive Rolling Indentation ProbePardeep Kumar, UK

1545–1555POD–06.04Laparoscopic Versus Open Radical Cystectomy: Prospective Nonrandomized Comparison of Morbidity and Pathological Measures of Early Oncological EfficacySaid Mohammed Moudouni, Morocco



TUESDAYOctober 18

1555–1605POD–06.05Unusual Complications of Laparoscopic Surgery and Lessons LearntSuresh Patankar, India

1605–1615POD–06.06Multi-Institutional Analysis of Robotic Assisted Partial Nephrectomy for Clinical Stage T1b Renal Tumors: Perioperative Outcomes in 445 PatientsCraig Rogers, USA

1615–1625POD–06.07Laparoscopic Transvesical Urological Procedure Is Safe and Feasible: Report of the First UK ExperienceHemant Nemade, UK

1515–1645

MODERATED POSTER SESSION 12Trauma & ReconstructionChairs: Guido Fechner, Germany

Allen Morey, USA

Room: Salon 11/12

MP–12.02The Electronic Modular Artificial Sphincter ARTUS: Results of the Cadaver StudyRoland Dahlem, Germany

MP–12.03Management of Iatrogenic Rectourinary Fistulas: A Six-Year ExperienceKaren De Baets, Belgium

MP–12.04Tissue-Engineered Buccal Mucosa Urethroplasty: Outcome of Our First PatientsOliver Engel, Germany

MP–12.05Transvaginal Repair of Genital Prolapse with Prolift System: Morbidity and Anatomic Outcomes After 6 Years of Use: A Multicentric StudySebastien Kozal, France

MP–12.06Reconstruction of Extended Urethral Strictures with a Buccal Mucosal Graft: Success Rates After 60 Months of Follow-up: Analysis of 184 PatientsAbhishek Pandey, Germany

1515–1645

PODIUM SESSION 6 Minimally Invasive Surgery


BERLIN SIU 2011 113

TUESDAYOctober 18

MP–12.07Dynamic and Radiologic Evidence for Improved Function of Detubularized Isolated Ureterosigmoidostomy (Atta Pouch)Wael Sameh, Egypt

MP–12.08Management of Bladder Exstrophy Epispadias Complex in Patients Presenting in AdulthoodAmlesh Seth, India

MP–12.09Late Oral Morbidity of Oral Mucosal Graft Harvest Site for Substitution UrethroplastyJoachim Steffens, Germany

MP–12.10Vascularization of Free Preputial Grafts: Does Dorsal vs Ventral Graft Placement Make a Difference? An Experimental StudyAnastasios Tahmatzopoulos, Greece

MP–12.11The Buccal Mucosa “Snodgraft” Hypospadias Repair: Our ExperienceSorin Patrascoiu, Romania

MP–12.12Practice Patterns of US Urologists Treating Urethral Stricture: A Quality of Care IssueFrank Burks, USA

MP–12.13Does Previous Endoscopic Urethrotomy Affect Results of Anastomotic Urethroplasty? Hong Kong ExperienceCheung Hing Cheng, China

MP–12.14Treatment of Male Urethral Strictures: Repeated Dilation and Internal Urethrotomy Re-EvaluatedJo Van der Merwe, South Africa

MP–12.15Repeated Endoscopic Treatment of Bulbar Urethral Strictures Is Associated With Increased Stricture Complexity and Duration of SymptomsSteven Hudak, USA

MP–12.16Short-Term Outcome of Contemporary Urethroplasty at a Tertiary Care CenterLuis Alex Kluth, Germany

MP–12.17Extended Long-Term Results of Surgery for Urethral StrictureLuis Alex Kluth, Germany

MP–12.18Transpubic Repair of Urethral Pathology in WomenDurwood Neal, USA

MP–12.19The Mesh-Graft-Urethroplasty: Is There Still an Indication?Philip Reiss, Germany



TUESDAYOctober 18

1515–1645

MODERATED POSTER SESSION 13Prostate Cancer, LocalizedChairs: Paul Lange, USA

Kurt Miller, Germany

Room: Salon 13/14

MP–13.01Radical Prostatectomy in Men with Continued Oral Aspirin Medication: Revisiting an Old Paradigm?Lars Budäus, Germany

MP–13.02First Experience Worldwide with a New Radioactive Fiducial Marker for External Beam Radiation Therapy for Localized Prostate Cancer: The Urological AspectsRobert Davits, The Netherlands

MP–13.03Does Repeat Focal Ablation Using High Intensity Focused Ultrasound (Sonablate 500) Compromise Morbidity or Genito-Urinary Functional Outcome in Men with Localized Prostate Cancer?Louise Dickinson, UK

MP–13.04Clinical Significance of Surgical Margins Status in Patients Subjected to Radical ProstatectomyJakub Dobruch, Poland

MP–13.05Five Years’ Experience with High-Intensity Focused Ultrasonography for Prostate Cancer Treatment: A Mid-Term Follow UpElmar Heinrich, Germany

MP–13.06Complications of Open Radical Prostatectomy: More Than 18 Years' Experience at One CenterMark S. Soloway, USA

MP–13.07Surgical Margin Status Is Not Associated with Overall Survival After Radical ProstatectomyMark S. Soloway, USA

MP–13.08The Hybrid Interactive Method in Permanent Prostate Brachytherapy Reduces Excess SeedsTsuyoshi Iwata, Japan

MP–13.09Outcome Analysis of Positive Surgical Margins in Consecutive 428 Retropubic Radical ProstatectomiesJagdeesh Kulkarni, India

MP–13.10Prostate Cancer Focality and Selection of Patients for Focal TherapyBarbara Cristina Gentile, Italy

MP–13.11Prediction of Prostate Cancer Tumour Volume from Biopsy Cores: A Simple Guide by Gland VolumeSimon Robinson, UK


BERLIN SIU 2011 115

TUESDAYOctober 18

MP–13.12Robotic Assisted Laparoscopic Prostatectomy: Perioperative Complications and Oncological OutcomesClaus G. Roehrborn, USA

MP–13.13Robotic Assisted Laparoscopic Prostatectomy: Functional Outcomes and Learning CurveClaus G. Roehrborn, USA

MP–13.14High-Intensity Focused Ultrasound for the Treatment of Localized Prostate Cancer: Ten-Year Follow-UpToyoaki Uchida, Japan

MP–13.15Low Dose Rate Brachytherapy: Oncological Outcomes in Prostate Cancer PatientsLuis Busto Martin, Spain

MP–13.16Multiple (12-Cores) Vesico-Urethral Anastomosis Biopsy After Radical Prostatectomy: Outcomes of 43 Patients with Biochemical FailureRenat Guspanov, Russia

MP–13.17Evaluation of Non-Invasive MRI Technique in the Diagnosis of Prostate CancerIhab Hekal, Saudi Arabia

MP–13.18Presence of Neutrophilic Infiltration in the Prostate and Its Relationship with Serum PSA Levels in Asymptomatic PatientsOmer Onur Cakir, Turkey

MP–13.19Clinically Significant Prostate Cancer Is Present Anteriorly in Nearly Fifty Percent of Men Classified as Presumed Low-Risk on Diagnostic TRUS BiopsiesParas Singh, UK

MP–13.20Diminished Expression of Selected Micrornas Correlates with Upregulation of Prostate Cancer Associated GenesManfred P. Wirth, Germany

MP–13.21Concomitant Incubation of Prostate Cancer Cells with the Platinum-Based Chemotherapeutic Carboplatin and Carbon Nanoparticles Enhances CytotoxicityManfred P. Wirth, Germany



TUESDAYOctober 18

1515–1645

VIDEO SESSION 6StonesChairs: Tarik Esen, Turkey

Anup Patel, UK

Room: Salon 15/161515–1525VID–06.01Micro PCNL: The New Cutting Edge Technology in Renal StoneVikas Agarwal, India

1525–1535VID–06.02AH-1 Stone Removal System to Treat Bladder StonesAihua Li, China

1535–1545VID–06.03Nephroscopy with Carbon Dioxide in Combination with Laparoscopy in the Treatment of Urinary StonesAlejandro Garcia-Segui, Spain

1545–1555VID–06.04Tubeless PCNL with Patients in Supine Position Under Epidural AnesthesiaHosein Karami, Iran

1555–1605VID–06.05Is Ureteral Stenting Necessary During Laparoscopic Ureterolithotomy for Management of Large Ureteric Calculi?Hosein Karami, Iran

1605–1615VID–06.06Retrograde Ureteroscopy for Large Stones: Why Use a Small Caliber Ureteroscope When a Nephroscope Can Be Used?Mohammed Lezrek, Morocco

1615–1625VID–06.07Tricks of Percutaneous Surgery with the Split-Leg Modified Lateral PositionMohammed Lezrek, Morocco

1625–1635VID–06.08Techniques to Overcome Renal Mobility During Percutaneous Tract CreationMohammed Lezrek, Morocco

1635–1645VID–06.09Laparoscopic Anatrophic Nephrolithotomy Technical Modifications with Reduced Ischemia TimeRené Sotelo, Venezuela


BERLIN SIU 2011 117

TUESDAYOctober 18

1515–1645

VIDEO SESSION 7 Prostate CancerChairs: Martin Schostak, Germany

John Ward, USA

Room: Salon 17/181515–1525VID–07.01The Intrafascial Nerve Sparing Radical Perineal ProstatectomyJörn Beier, Germany

1525–1535VID–07.02Advantages of Extraperitoneal Robotic Prostatectomy: Description of Technique and Comparison to Transperitoneal ApproachRami Issa, UK

1535–1545VID–07.03Ureteral Stenting During Endoscopic Extraperitoneal Radical Prostatectomy (EERP): An Easy Solution for a Complex ProblemJuan Peña, Spain

1545–1555VID–07.04Steps and Challenges of Extraperitoneal Robotic Assisted Radical ProstatectomyJuan Peña, Spain

1555–1605VID–07.05Endoscopic Approach as a First Step in Robotic Assisted Radical Prostatectomy After Prostate SurgeryJoan Palou, Spain

1605–1615VID–07.06Extraperitoneal Robot Assisted Radical Prostatectomy RevisitedPN Dogra, India

1615–1625VID–07.07Recognition and Management of Rectal Injury During Robotic ProstatectomyRené Sotelo, Venezuela

1625–1635VID–07.08Better Nerve Handling with Open Prostatectomy? Exploring Retrograde Robotic Radical ProstatectomyRené Sotelo, Venezuela

1635–1645VID–07.09Complications During Robotic Radical ProstatectomyRené Sotelo, Venezuela



TUESDAYOctober 18

1645–1800

SPONSORED SYMPOSIAGlaxoSmithKline

Men with BPH in 2011: Evidence to Support First Treatment Decisions

Chair: Peter Hammerer, Germany

Room: Hall 2Welcome and IntroductionPeter HammererBPH Patients and Current Practice: Is There an Unmet Clinical Need?Interactive discussion moderated by Peter HammererWhat is the Role of Combination Therapy in First Treatment Decisions for BPH?Interactive discussion moderated byJ. Curtis Nickel, CanadaHow has BPH Treatment Changed with Recent Updates in Clinical Guidelines?Interactive discussion moderated by Michael Marberger, Austria

Summary and ConclusionsPeter Hammerer

Sanofi Pasteur

Results and Implications of a Real-World Individual Patient Data Survey: Clinical Practice Gaps in Intermediate- and High-Risk Non-Muscle Invasive Bladder Cancer (NMIBC) Management

Chair: Mark Soloway, USA

Room: Oslo1645–1655Welcome and IntroductionMark Soloway

1655–1705The Need for Bacillus Calmette-Guérin (BCG) for Optimizing Outcomes in NMIBC: Review of Current LiteratureAndreas Böhle, Germany

1705–1715The Optimal Management of NMIBC: Review of Current GuidelinesJoan Palou, Spain

1715–1735Are We Practicing What We Preach? Overview and Key Findings from the International NMIBC Individual Patient Data Survey (IPDS)Fred Witjes, The Netherlands

1735–1750Panel DiscussionAssessing the Care Gap: Comparison of IPDS Results to Recommended Clinical Practice


BERLIN SIU 2011 119

TUESDAYOctober 18

1750–1800Audience DiscussionClosing the Care Gap: How to Improve the Management of NMIBC1800Summary and CloseMark Soloway

1800–2000

SIU WORLD FORUM FOR PATIENTSProstate CancerChair: Kurt Miller, Germany

Room: ICC Lounge

This session will be conducted in German

1830–2300

OPTIONAL ACTIVITIES


Room: Exhibit Hall

BPO/LUTS; Minimally Invasive Surgery; Prostate Cancer

UP–02.001Distribution of Onabotulinumtoxin A in the Human Prostate After Transrectal Injection and Localization of the High-Affinity Receptors for the ToxinTiago Gorgal-Carvalho, Portugal

UP–02.002Open Label, Randomized Clinical Trial To Evaluate the Safety and Efficacy of “Herbmed Plus” for Ureteral Stent Discomfort Against TolterodineSuresh Patankar, India

UP–02.003The Evaluation of Lower Urinary Tract Symptoms in Nigeria: Practice and LimitationsLeslie Akporiaye, Nigeria

UP–02.004Risk Factor Analysis of Patients’ Dissatisfaction After Holmium Laser Enucleation of the Prostate (HoLEP) for Benign Prostatic HyperplasiaKazuhiko Fukumoto, Japan

UP–02.005Preferences with Regard to Position During Digital Rectal Examination and Perceptions of Pain During and After Digital Rectal Examination Among Men with Lower Urinary Tract SymptomsChris F. Heyns, South Africa



TUESDAYOctober 18

UP–02.006Correlation of the Visual Prostate Symptom Score (VPSS) and International Prostate Symptom Score (IPSS) with Uroflow Parameters in Men Presenting with Lower Urinary Tract SymptomsChris F. Heyns, South Africa

UP–02.007Urethral Vibration Under Irrigation: A Possible Parameter for Estimating Urethral FlexibilityKohei Horiuchi, Japan

UP–02.008Patients’ Characteristics and Urodynamic Parameters of Pressure-Flow Study Failure of Patients in Our InstitutionTakeya Kitta, Japan

UP–02.009Clinical Significance of Intravesical Prostatic Protrusion/Prostate VolumeSeung Ki Min, South Korea

UP–02.010Urinary PSA: Marker of Benign Prostatic Hyperplasia?Tomislav Pejcic, Serbia

UP–02.011Biofeedback Treatment for Dysfunctional Voiding Diagnosed in AdulthoodEmin Aydur, Turkey

UP–02.012The Advantages of Bipolar Vaporization in the Therapy of Benign Prostatic HyperplasiaViorel Bucuras, Romania

UP–02.013Bipolar RF Thermotherapy for Chronic Prostatitis: Two Years’ Follow-UpChristian Beck, Germany

UP–02.014Safety of Tamsulosin OCAS™ Plus Solifenacin in Men with LUTS Associated with BPH in the SATURN TrialPhilip van Kerrebroeck, The Netherlands

UP–02.015Outcome and Complications of 323 Cases with 120 W Greenlight™ High-Performance System for Photoselective Vaporization of the Prostate for the Treatment of Benign Prostatic Hyperplasia in a Single CenterWoo Suk Choi, South Korea

UP–02.016Five-Year Follow-Up of 80W Green Light Laser Photoselective Vaporisation of the Prostate: A Prospective Dual Centre ExperienceJudith Dockray, UK

UP–02.017Holmium Laser Enucleation of the Prostate for Prostates Larger Than 100mlTakahiro Haraguchi, Japan

UP–02.018Transurethral Enucleation with Bipolar for Prostatic Hyperplasia Beyond 100 ccKenji Kawamura, Japan

UP–02.019Is TURis-P Really More Bio-Friendly Than Conventional TUR?Shinsuke Hayami, Japan


BERLIN SIU 2011 121

TUESDAYOctober 18

UP–02.020Safety and Efficacy of Holmium Laser Enucleation of the Prostate in Patients on Anticoagulant TherapyTakaharu Ichikawa, Japan

UP–02.021Influence of Preoperative Variables on the Outcome of Holmium Laser Enucleation of the ProstateTae Nam Kim, South Korea

UP–02.022Is it Necessary to Perform Full-Blood-Counts and Serum Electrolytes on All Patients Post TURP?Neil Maitra, UK

UP–02.023Experience of Anteroposterior Dissection HoLEP: The First 65 Cases Performed in a Single CenterShingo Minagawa, Japan

UP–02.024Endoscopic up to 100 gr Prostate Resection Gyrus Versus OPSU: Long-Term ResultsBarbara Cristina Gentile, Italy

UP–02.025Comparative Efficacy of Endoscopic Bipolar vs Monopolar Prostate Resection: Single Centre ExperienceFrancesco Pisanti, Italy

UP–02.026Memokath 045TW Stent in Intractable Bladder Neck Stricture: Preliminary ExperienceCarlo Luigi Augusto Negro, UK

UP–02.027Intermediate-Term Efficacy of Tm:YAG Laser Prostate Vaporesection for Bladder Outlet Obstruction: Initial Experience from a UK Teaching HospitalRaj Pal, UK

UP–02.028The Incidence of Erectile Dysfunction and Retrograde Ejaculation Following Thulium Laser Prostate Vaporesection for Benign Bladder Outflow Obstruction: A Retrospective StudyRaj Pal, UK

UP–02.029Are There Any Predictive Risk Factors for Persistent Bladder Irritative Symptoms After Transurethral Resection of the Prostate?Cristian Gutue, Romania

UP–02.030Transurethral Resection in Saline and Plasma Vaporization of the Prostate: Clinical Evaluation of Safety and Short-Term ResultsVasile Dan Stanca, Romania

UP–02.031Effects of Detrusor Underactivity on Outcome of Transurethral Resection of the Prostate in Patients with Prostate HyperplasiaChoong-Hee Noh, South Korea

UP–02.032Does Anticholinergic Treatment with Tolterodine Improve the Results in BPH Patients Treated with Tamsulosin?Mircea Radu Botoca, Romania



TUESDAYOctober 18

UP–02.033The Change of Quality of Life Due to Urinary Symptoms After Treatment of Lutenizing Hormone Releasing Hormone Agonist Leuprolide Acetate for Patients with Severe BPHJung Moon Heo, South Korea

UP–02.034Multicentre Study on the Efficacy and Tolerability of Permixon® in Patients with Chronic Benign Prostate Conditions Associated with InflammationBarbara Cristina Gentile, Italy

UP–02.035Stratified Analysis of Effect of Silodosin on Symptoms of Benign Prostatic HyperplasiaTetsuo Murai, Japan

UP–02.036Risk Factors for LUTS/BPH Progression: A View from the Urologist’s OfficePredrag Nikic, Serbia

UP–02.037The Association Between the Self-Perception Period of Lower Urinary Tract Symptoms and the International Prostate Symptom ScoreSung Ryul Shim, South Korea

UP–02.038Ketamine Addiction: Need to Raise Awareness of Its Bladder ComplicationsRozh Jalil, UK

UP–02.040Treatment of Interstitial Cystitis with Botulinum Toxin Type A in JapanYoshiko Maeda, Japan

UP–02.041Initial Treatment of Incident Benign Prostatic Hyperplasia Cases in the United States, 2006Alexander McBean, USA

UP–02.042Therapeutic Efficacy of Bipolar Radio Frequency Thermal Treatment for Patients with Benign Prostate HyperplasiaJoonhwa Noh, South Korea

UP–02.043Pubic Symphysitis Following Transurethral Resection of the Prostate: A Rare ComplicationChristopher Ziesel, Germany

UP–02.044Laparoscopic Partial Nephrectomy Using Radiofrequency Ablation: Comparision of Original and Standard TechniquesAlexey Kalpinskiy, Russia

UP–02.046Percutaneous Nephropexy with a Suture Passed Between the Lower and the Upper Pole of the KidneyMohammed Lezrek, Morocco

UP–02.047Experience with Single One Centimeter Port Laparoscopic Radical ProstatectomyChristian Bach, UK

UP–02.048Laparoscopic Management of Pelviureteric Junction ObstructionMohammed Bhuiyan, Bangladesh


BERLIN SIU 2011 123

TUESDAYOctober 18

UP–02.049LESS Transumbilical Adrenalectomy: Initial Experience and Comparison with Conventional LaparoscopyDavid Castelo, Portugal

UP–02.050Surgical Treatment of Renal Hydatid Cyst: Open Surgery or Laparoscopy?Nabil Mhiri, Tunisia

UP–02.051Single Port Laparoscopic Varicocoelectomy: Initial ExperienceRhana Zakri, UK

UP–02.052Video Documentation and Quality Assurance of Extraperitoneal Endoscopic Radical ProstatectomyBheena Karunyam, UK

UP–02.054Effect of Patient-Centered Goal on Postoperative Satisfaction in Patients with HoLEP SurgeryJong Kil Nam, South Korea

UP–02.055No-Clamp, No-Stop Watch Pure Laparo-Endoscopic Single-Site Surgery Partial NephrectomyHemant Nemade, UK

UP–02.056Efficacy of Early Salvage Radiotherapy After Radical Prostatectomy in Patients with Rising PSA Levels Below the Conventional Threshold of 0.2ng/mLLadislav Jarolim, Czech Republic

UP–02.057Single Port Transumbilical Laparoscopic Radical Nephrectomy and Bilateral Ovarian Cystectomy: First Clinical CaseYeh Hong Tan, Singapore

UP–02.058A New Approach of Renal Hilum Control in Retroperitoneoscopic Radical NephrectomyAn Wei, China

UP–02.059Laparoscopic Versus Open Partial NephrectomyAn Wei, China

UP–02.060Combined Robotic Lobectomy and Adrenalectomy for Lung Cancer and Solitary Adrenal MetastasisBertram Yuh, USA

UP–02.061Incidence of Port Site Hernia After Laparoscopic SurgeryMiroslav Zalesky, Czech Republic

UP–02.062Clinical, Biochemical and Radiologic Benefit of the Treatment with Sunitinib in Monotherapy for Patients with Metastatic Castration-Resistant Prostate Cancer After Failure of DocetaxelCristian Vasile Casu, Spain

UP–02.063Evaluation of the Early Impact of the LHRH Analogues Treatment in Prostate Cancer Under Psycho-Cognitive, Emotional and Quality of Life ParametersCristian Vasile Casu, Spain



TUESDAYOctober 18

UP–02.064Safety and Efficacy of Degarelix in the Treatment of Prostate Cancer in a Cohort from a German Office-Based Registry for Uro-Oncological Quality AssuranceGötz Geiges, Germany

UP–02.065Clinical Versus Histological Diagnosis of Advanced Prostate Cancer: Comparative Evaluation of Treatment Outcome After Bilateral OrchidectomyJacques Basson, South Africa

UP–02.066Is Radical Prostatectomy a Viable Treatment Option in Patients with Initial PSA > 20ng/ml?Alexander Hinev, Bulgaria

UP–02.067The Low Dose CDDP+UFT Therapy Brings a Decrease of PSA to the Docetaxel Resistance Prostate CancerFukuta Katsuhiro, Japan

UP–02.068Central Venous Catheter Utilization During the IMPACT (D9902B) Trial: A Review of Central Venous Catheter Incidence and Associated Adverse EventsNeal Shore, USA

UP–02.069Safety of Leukapheresis in Advanced Prostate Cancer Patients Receiving Sipuleucel-TThomas Price USA

UP–02.070Efficacy of Estramustine Phosphate According To Risk Classification of Castration-Resistant Prostate CancerAkinori Minato, Japan

UP–02.071Bipolar Plasma Vaporization in Prostate Cancer Patients: A Palliative Application of a New TechniqueBogdan Florin Geavlete, Romania

UP–02.072Impact of High-Intensity Focused Ultrasound on BALB/c Mice with RenCa TumorAkira Ishikawa, Japan

UP–02.073Treatment Outcomes of Oral Ethinylestradiol for Castration-Resistant Prostate Cancer, and Docetaxel for Relapsed Prostate Cancer After Treatment with EthinylestradiolToru Onita, Japan

UP–02.074Premature Discontinuation of Docetaxel-Based Chemotherapy in Men with Castration-Resistant Prostate CancerSeung Chol Park, South Korea

UP–02.075Ketoconazole Treatment in Castration-Resistant Prostate CancerM. Andreas Roder, Denmark

UP–02.076GTx-758, an Oral ERα Agonist Being Developed for Advanced Prostate Cancer Avoids Many Estrogen Deficiency Side Effects Commonly Observed with ADTRonald Morton, USA

UP–02.077Is Radical Cystectomy a Treatment Option for Very High-Risk T4-Prostate Cancer?Martin Spahn, Germany


BERLIN SIU 2011 125

TUESDAYOctober 18

UP–02.078What Can We Tell Patients Newly Diagnosed with Gleason 8 or 9 Disease? A UK-Population StudyHidekazu Yamamoto, UK

UP–02.079Prognostic Significance of the Quantification of Circulating Tumor Cells in Patients with Metastatic Hormone-Sensitive Prostate CancerLuis Guillermo Celada, Spain

UP–02.080Prognostic Value of Chromogranin A in Prostate Biopsy at the Moment of Diagnosis of Patients with Hormone-Refractory Prostate CancerJavier Casado Varela, Spain

UP–02.081The Association of Serenoa Repens-Selenium-Lycopene Is More Effective than Serenoa Repens Alone in Preventing Testosterone-Induced Prostatic Hyperplasia and PC3 Cell Growth via the Activation of the Apoptotic MachineryGiuseppe Morgia, Italy

UP–02.082Diagnostic Role of GSTP1 CpG Island Hypermethylation Detection in Prostate Cancer PatientsRadu Minciu, UK

UP–02.083Prognostic Significance of Percent Tumor Involvement According to Disease Risk Group in Men Treated with Radical ProstatectomySung Kyu Hong, South Korea

UP–02.084Active Inflammatory State and Reactivity of Normal Prostate Epithelium and Aggressive Prostate CancerVincent Fradet, Canada

UP–02.085Antigen-Specific T-Cell Responses Against Tumor-Antigens Are Controlled by Regulatory T-Cells in Prostate Cancer PatientsBoris Hadaschik, Germany

UP–02.086Comprehensive Analysis of Intratumoral Steroidogenesis in Castration-Resistant Prostate CancerAgus Rizal A.H. Hamid, The Netherlands

UP–02.087Gastrin-Releasing Peptide: Novel Predictor of Castration-Resistant Prostate Cancer?Elmar Heinrich, Germany

UP–02.088Alpha-Type 1 Polarized Dendritic Cells Loaded with Apoptotic Allogeneic Prostate Cancer Cells Can Induce Potent Cytotoxic T Lymphocytes Against Prostate Cancer CellsTaek Won Kang, South Korea

UP–02.089Genetic Differentiation of Prostate Cancer Using CGH for Prognosis EvaluationEveline Hauschild, Germany



TUESDAYOctober 18

UP–02.090Expression of CD147 Protein Is Not Useful as Pre-Surgical Diagnostic Factor in Human Prostate CancerMartin Schmudermaier, Austria

UP–02.091A Proposed New Technique in Prostate Cancer Tissue Bio-Banking: Our Experience with a New ProtocolStefano Picozzi, Italy

UP–02.097Induction of Apoptosis and Enhancement of Chemosensitivity by Downregulating of Apurinic/Apyrimidinic Endonuclease 1/Redox Factor-1 in Castration-Resistant Prostate Cancer CellsChong Koo Sul, South Korea

UP–02.098The Novel AKT-Inhibitor AZD5363 Abrogates Androgen-Receptor Signaling and Delays Hormone-Sensitive and Castration-Resistant Prostate Cancer Progression in vivoChristian Thomas, Germany

UP–02.099Expression of Hepatocyte Growth Factor Activator Inhibitor Type 1 (HAI-1) in Prostate CancerKenji Yasuda, Japan

UP–02.100Antitumor Effect of Sodium Meta-Arsenite on the Prostate Cancer Cell and Its MechanismJu Hyun Lim, South Korea

UP–02.101BK Polyomavirus Infection in Prostate Tissue Derived From Patients with Prostate AdenocarcinomaShan Zhong, China

UP–02.102Lithuania Prostate Cancer Early Diagnosis Program 2006–2010: Trends in ServicesRobertas Adomaitis, Lithuania

UP–02.103The Role of 3T Dynamic-Magnetic Resonance Imaging (MRI) To Avoid Superfluous Prostate BiopsyHiroyuki Amano, Japan

UP–02.104The Significance of Contiguous Tumour Positivity in Needle Biopsies of ProstateChristian Bach, UK

UP–02.105TRUS Prostatic Biopsy: Our Update Protocol for Performing and Processing Prostatic Needle BiopsiesJosé Cadilhe, Portugal

UP–02.106Changes of Transrectal Ultrasonography in Prostatic Cancer Patients Under Hormonal Treatment and RadiotherapyShiou-Sheng Chen, Taiwan

UP–02.107Infectious Complication After Transrectal Ultrasound-Guided Prostate Biopsies: A Review of 1525 CasesCheung Hing Cheng, China


BERLIN SIU 2011 127

TUESDAYOctober 18

UP–02.108Results of a Questionnaire-Based Assessment of the Morbidity of a Modified Transperineal Template-Guided Saturation Prostate Biopsy in 110 Patients with Previous Negative TRUSBKingsley Ekwueme, UK

UP–02.109Outcome of a Modified Transperineal Template-Guided Saturation Repeat Prostate BiopsyKingsley Ekwueme, UK

UP–02.110The Impact of Antibiotic Treatment on the Way to Transrectal Ultrasound Guided Biopsy for Detection of Prostate CancerErkan Erkan, Turkey

UP–02.111Outcomes of Negative TRUS Guided Biopsies with Persistently Elevated PSA (>4 µg/Ml) in Men Suspected of Prostate Cancer: Tayside Population-Based StudyDinesh Ganeswaran, Malaysia

UP–02.112Use of Diffusion-Weighted Magnetic Resonance Imaging To Direct Repeat Prostate Biopsy in Patients with Previous Negative Biopsies and Rising Prostate Specific AntigenSamuel Grimsley, UK

UP–02.113Epidemiological Trends in Prostate Cancer in the South of Tunisia Over the Last 24 YearsNabil Mhiri, Tunisia

UP–02.114Experience of Individual Screening of Prostate Cancer in Southern TunisiaNabil Mhiri, Tunisia

UP–02.115Comparison of Histological Results Performed by Two Pathologists of Histoscanning-Guided Prostate-BiopsiesClaudius Hamann, Germany

UP–02.116Histoscanning-Guided Prostate Biopsy in Comparison to a Systemic 14-Fold Transrectal Prostate BiopsyClaudius Hamann, Germany

UP–02.117Two Different Learning Models in Practicing Real-Time Elastography of the ProstateJulia Heinzelbecker, Germany

UP–02.118Patients Less Than 50 Years: A Time to Change PSA Cutoff Point for Prostate Cancer ScreeningIhab Hekal, Saudi Arabia

UP–02.119Sonographic Changes of the Prostate: An UpdateIhab Hekal, Saudi Arabia



TUESDAYOctober 18

UP–02.120Prognostic Significance of the Number of Biopsies in the Diagnosis of Prostate CancerAlberto Hernando Arteche, Spain

UP–02.121Power Doppler Ultrasonography-Directed Prostate Biopsy in Men with Elevated Serum Prostate Specific Antigen LevelsChristopher Chee Kong Ho, Malaysia

UP–02.122Predictive Impact of Free PSA/Total PSA (%fPSA) on the Development of Prostate Cancer in Men with Baseline PSA Lower Than 2.0ng/Ml: Baseline PSA-Adjusted Case Control StudyKazuto Ito, Japan

UP–02.123Pre-Biopsy PSA Kinetics in Prostate Cancer Screening: Analysis of Toyota Motor Corporation EmployeesYasuaki Kubota, Japan

UP–02.124A Prospective Randomized Trial of Prostate Biopsy Protocols Comparing the Vienna Nomogram and a Standard 10–Core Biopsy SchemeTito Leitão, Portugal

UP–02.125BMI and Bio-Impedance Factors Among Candidates to Prostate Cancer Screening: Implication of Obesity on Actual Cancer DiagnosisIvo Lopes, Portugal

UP–02.126Negative Predictive Value of Prostate Histoscanning (Computer-Aided Tissue Characterization for Detection of Prostate Cancer): Preliminary ResultsOliver Markovsky, Germany

UP–02.127Topical Diltiazem Before Transrectal Ultrasonography Guided Biopsy of the Prostate: A Randomized, Double Blind, Placebo Controlled TrialDaniel Marshall, New Zealand

UP–02.128Prostatic Dynamic Contrast Enhanced MR: Comparison Before and After HIFU Treatment for Prostate CancerBarbara Cristina Gentile, Italy

UP–02.1295 Years Using 2007 Chun’s Nomogram in Diagnosis of Prostatic Cancer at RebiopsyFrancesco Pisanti, Italy

UP–02.130The Use of PSA-IgM in the Diagnosis of Prostate CancerBarbara Cristina Gentile, Italy

UP–02.131Irreversible Electroporation, a Novel Technique for Focal Ablation of Prostate Cancer: Results of an Interim Pilot Safety Study in Low-Risk Patients with PCaMaurizio Brausi, Italy


BERLIN SIU 2011 129

TUESDAYOctober 18

UP–02.132Prostate Cancer Detection Rate: Correlation Between Prostate Volume and Number of Biopsy Positive SamplesBarbara Cristina Gentile, Italy

UP–02.133Real-time Virtual Sonography for Prostate-Targeted Biopsy Based on MRI Data: Evaluation of Accuracy with Resected SpecimensTomoaki Miyagawa, Japan

UP–02.134Bacterial Sepsis Following Prostatic BiopsyStefano Picozzi, Italy

UP–02.135Atypical Small Acinar Proliferation in Extended Transrectal Prostate Biopsy: Meaning and Clinical ImplicationsBogdan Nicolae Pietricica, Spain

UP–02.136Comparison of Various Risk Calculators for Prostate CancerMonique Roobol, The Netherlands

UP–02.137A Randomized, Controlled Trial Comparing Lidocaine Periprostatic Nerve Block and Lidocaine Gel Intrarectally Associated with Tramadol Per Os for Transrectal Ultrasound Guided Biopsy of ProstateSaid Mohammed Moudouni, Morocco

UP–02.138The Prostate Cancer Gene 3 (PCA3) Urine Test: Improving Prediction of Initial Biopsy and ManagementSurayne Segaran, UK

UP–02.139Transperineal Template Guided Saturation Biopsy Should Be Offered to All Men with Very Low Volume Cancer Diagnosed on Conventional TRUS Biopsy and Considering Active SurveillanceHelen Simpson, UK

UP–02.140Comparison of Efficacy of Periprostatic Nerve Block Versus Combination of Periprostatic Nerve Block and Intraprostatic Anaesthesia During Transrectal Ultrasound Guided Prostate BiopsySantosh Kumar Singh, India

UP–02.141TargetScan 3D Mapping Biopsies of the Prostate in Men with Prior Negative BiopsiesSergiy Tadtayev, UK

UP–02.142Prostate Cancer Primary Topographic Prevalence and Volumetry in 1.000 T1-2 CasesStefan Thüroff, Germany

UP–02.143Major Complications and Associated Risk Factors of Transrectal Ultrasound Guided Prostate Needle Biopsy: A Retrospective Study of 611 CasesTatsuya Uesugi, Japan



TUESDAYOctober 18

UP–02.144Intraoperative and Postoperative Complications Encountered in Patients Undergoing Robotic-Assisted Radical Prostatectomy: An Analysis of 2000 Consecutive CasesApostolos P. Labanaris, Germany

UP–02.145The Impact of Prostate Size on Surgical, Oncologic and Functional Outcomes of Patients Undergoing Robotic ProstatectomyApostolos P. Labanaris, Germany

UP–02.146Meanings of the Polyunsaturated Fatty Acid in Patients with Prostate CancerDaisuke Yamada, Japan

UP–02.147Cyclooxygenase-2 Overexpression in Chronic Inflammation Associated with Benign Prostate Hyperplasia: Is It Related to Apoptosis and Angiogenesis of Prostate Cancer?Byung Hoon Kim, South Korea

UP–02.148Probability and Prediction of Gleason Score Migration after Radical ProstatectomyKirill Nyushko, Russia

UP–02.149Evaluation of the Learning Curve of Robotic Assisted Radical Prostatectomies with the Primary Focus on the Positive Surgical Margin RateStefan Siemer, Germany

UP–02.150Combined Oncological and Functional Outcomes 24 Months After Open Radical Prostatectomy: Results from a Contemporary Series of PatientsDavid Castelo, Portugal

UP–02.151Confusion of the PSA Rebound Phenomenon After I-125 Prostate Brachytherapy: A Cohort Study of Minimum 3-Year Follow-UpCristian Vasile Casu, Spain

UP–02.152PSA Bounce After Brachytherapy: Looking for Predicting Factors and CorrelationsCatharina van Herpen, The Netherlands

UP–02.153An International Multi-Centre Phase II Prospective Trial Evaluating Focal Therapy Using High Intensity Focused Ultrasound (Sonablate 500) for Localized Prostate CancerLouise Dickinson, UK

UP–02.154Duration of Androgen Deprivation Therapy with Maximum Androgen Blockade for Localized Prostate CancerNaohiro Fujimoto, Japan

UP–02.155Correlation Between Urinary Continence and Potency Recovery in Patients After Open Radical Retropubic Nerve-Sparing ProstatectomyElena Golubtsova, Russia


BERLIN SIU 2011 131

TUESDAYOctober 18

UP–02.156Improving the Preoperative Consultation Before Radical Prostatectomy Using Multimedia Support: A Randomized Controlled TrialSascha Pahernik, Germany

UP–02.157The Impact of Intermittent Androgen Deprivation Therapy for Biochemical Failure After Radical ProstatectomyTsukasa Igawa, Japan

UP–02.158Avoiding the Transperitoneal Detour: The Extraperitoneal Approach Proves Feasible in Robotic ProstatectomyRami Issa, UK

UP–02.159Multivariate Analysis of Functional Outcomes After Robotic Prostatectomy: Size and Gleason Grade CountsRami Issa, UK

UP–02.160Prognostic Value of Insulin-like Growth Factor II mRNA Binding Protein 3 in Prostate CancerShahrokh F. Shariat, USA

UP–02.161Low Dose Rate Prostate Brachytherapy: Review of Our ExperienceAndrius Ivanauskas, Lithuania

UP–02.162Fiducial Markers for Image Localization Guidance in Prostate Gland RadiotherapyAmir Kaisary, UK

UP–02.163Transurethral Resection of Middle Lobe in Occlusive Trilobal Prostate Gland Prior To BrachytherapyAmir Kaisary, UK

UP–02.164Impact of Increasing Active Surveillance on Pathological Outcome After Radical ProstatectomyMarkos Karavitakis, Greece

UP–02.165Clinical Outcome: SV(+) Localized Advanced Prostate Cancer with PSA Over 50 Treated by HDR (High-Dose-Rate) BrachytherapyIsao Kuroda, Japan

UP–02.166Is There a Role for Routine Pelvic MRI in Intermediate Risk Prostate Cancer?Raj Pal, UK

UP–02.167Prostate Cancer Tumour Volumes and Lymph Node Metastasis: Do We Need MRI?Simon Robinson, UK

UP–02.168Serum Testosterone as a Predictor of Biochemical Failure after Radical Prostatectomy in Patients with Localized Prostate CancerM. Andreas Roder, Denmark

UP–02.169Time Trends in Prostate Cancer Surgery: Data from an Internet-Based Multicenter DatabaseMartin Schostak, Germany



TUESDAYOctober 18

UP–02.170Does Prostate Tumor Proximity to Surgical Margin in pT2 Disease Correlate with Biochemical Recurrence or All-Cause Mortality?Isabell Sesterhenn, USA

UP–02.171Incidence and Management of Vesicourethral Anastomotic Strictures After Radical ProstatectomyHajrudin Spahovic, Bosnia and Herzegovina

UP–02.172The Appropriateness of Active Surveillance and the Impact of Prostate Cancer Gene 3 in Low Risk Prostate Cancer: An Analysis of Expert OpinionMark Speakman, UK

UP–02.173Robotic Radical Prostatectomy: Evaluation of the Learning CurveMiroslav Strbavy, Czech Republic

UP–02.174The Effects of Neoadjuvant Hormonal Therapy on Vascular Endothelial Growth Factor and Microvessel Density in Prostate CancerChong Koo Sul, South Korea

UP–02.175Non-Invasive Therapy of Incidental Prostate Cancer by Robotic High Intensity Focused Ultrasound: 65 Patients Followed 9 YearsStefan Thüroff, Germany

UP–02.176PSA Nadir After TUR and Robotic High Intensity Focused Ultrasound in Localized Prostate Cancer: 677 Monocentric Cases Followed 15 YearsStefan Thüroff, Germany

UP–02.177Outcome of Antegrade Radical Prostatectomy with Intended Wide Resection in Patients with a Pre-Operative Serum Prostate-Specific Antigen Level Higher Than 100 ng/mLShinji Urakami, Japan

UP–02.178Radical Prostatectomy (RP) and Extensive Pelvic Lymphnode Dissection (EPLD) for Clinical T3 (CT3) Prostate Cancer (PCa): Single Center Long-Term ResultsMaurizio Brausi, Italy

UP–02.179Active Surveillance for Prostate CancerJennifer Willder, UK

UP–02.180Initial Experience of Iodine-125 (I-125) Permanent Seed-Implant Brachytherapy for Localized Prostate CancerAkihisa Yao, Japan

UP–02.182Prognostic Value of the Determination of Plasmatic Chromogranin A in Patients with Localized and Metastatic Hormone-Sensitive Prostate CancerJavier Casado Varela, Spain


BERLIN SIU 2011 133

TUESDAYOctober 18

UP–02.183Applicability of PCA3 Gene in the Molecular Detection of Prostate CancerRadu Minciu, UK

UP–02.184Urinary PCA3 and Cancer Progression Under Active Surveillance of Prostate CancerVincent Fradet, Canada

UP–02.185Associations Among Anabolic Endocrine Axes in Patients with Prostate Cancer Receiving Androgen Deprivation TherapyNoboru Hara, Japan

UP–02.186Identification of MAPK10 as Novel Epigenetic Marker for Chromophobe Kidney CancerHyung-Lae Lee, South Korea

UP–02.187Clinical Analysis of Patients with Prostate Cancer Who Initially Demonstrated a Markedly Elevated Prostate Specific Antigen LevelHiroya Mizusawa, Japan

UP–02.189Robotic Prostatectomy: Evaluation of Surgical Margin Status in Patients with Pathological Proven Organ-Confined Disease as well as Extraprostatic ExtensionApostolos P. Labanaris, Germany

UP–02.190Lectin-Based Glycoproteomic Profiling of Serum Samples from Patients with Prostate CancerKeng Lim Ng, Malaysia

UP–02.191Acute Myocardial Infarction Without Cardiogenic Shock Does Not Affect Serum Prostate Specific Antigen Levels: A Case-Control StudyÇetin Volkan Öztekin, Turkey

UP–02.192Radical Prostatectomy in Patients 70 Years or Older: An 18-Year Experience at a Single Private Practice CenterGodofredo Neyra Lee-Eng, Mexico

UP–02.193Soluble Circulating Receptor Endoglin in Patients with Different Prostate Biopsy DiagnosisIvo Lopes, Portugal

UP–02.194Improved Detection of Prostate Cancer by the Combined Application of ERG and AMACR Immunohistochemical Stainings in Prostate Biopsy SpecimensIsabell Sesterhenn, USA

UP–02.195Clinicopathological Correlation of ERG Protein Expression in Single Focus Prostate CancerIsabell Sesterhenn, USA

UP–02.196High-Grade Prostatic Intraepithelial Neoplasia: Incidence, Morphological and Immunohistochemical FeaturesRazvan Bardan, Romania



TUESDAYOctober 18

UP–02.197Diagnosis Difficulties in Subtypes and Variants of Prostate AdenocarcinomaViorel Bucuras, Romania

UP–02.198Trends in Risk Groups in a Series of 1210 Radical ProstatectomiesLuis Busto Martin, Spain

UP–02.199Oncological Outcome of Radical Prostatectomy Patients with PSA 2.5 to 4 and 4–10Luis Busto Martin, Spain

UP–02.200Oncological Outcomes in Young Patients Treated with Low Dose BrachytherapyLuis Busto Martin, Spain

UP–02.201Oxidative Stress and the Study of the Protective Function of Organisms in Patients with Prostate TumorsTeimuraz Chigogidze, Georgia

UP–02.202Analysis of Prostatectomy Specimens from Patients Meeting the Criteria for Active SurveillanceYoussef Dakkak, Morocco

UP–02.203Capturing Re-Admission and Complication Rates from TRUS Biopsy Procedure Using Healthcare Informatics Software ProgrammesDinesh Ganeswaran, Malaysia

UP–02.205Hydro-Dissection Technique for Fast and Safe Transperineal Spacer InjectionGencay Hatiboglu, Germany

UP–02.206Obesity-PSA Relationship: A New EquationIhab Hekal, Saudi Arabia

UP–02.207Prevalence of Histological Prostatitis in Men with Benign Prostatic Hyperplasia or Adenocarcinoma of the Prostate Presenting Without Urinary RetentionAmir Zarrabi, South Africa

UP–02.208Insulin and Insulin Resistance Are Associated with the Advanced Pathological Stage of Prostate Cancer in the Korean PopulationWon Tae Kim, South Korea

UP–02.209Plasma D-dimer Levels in Prostate Cancer Patients Treated with Androgen-Suppression TherapySatoshi Kitahara, Japan

UP–02.210The Effect of Reccurrent Biopsies on Infection Rates, Hematuria, Rectal Hemorrhage and HematospermiaGokhan Koc, Turkey

UP–02.211Effect of the Anesthesia Method Used During Prostate Biopsy on Re-Biopsy DecisionGokhan Koc, Turkey


BERLIN SIU 2011 135

TUESDAYOctober 18

UP–02.212Evaluation of Total Serum Testosterone in Patients with Clinically Localized Prostate CancerChristian Kratzik, Austria

UP–02.213ABETRUS: Randomized Controlled Trial to Investigate the Use of Antibiotics Before Transrectal Ultrasound Guided Biopsy of the Prostate and Effects on PSATricia Kuo, Singapore

UP–02.214New MRI Pre-Planning for Prostate BrachytherapyKatsuyuki Kuratsukuri, Japan

UP–02.215Does Size Matter (in Robotic Prostatectomy)?Saheel Mukhtar, UK

UP–02.216How Intuitive Is Intuitive? An Analysis of Single Surgeon Operative Parameters in Robotic ProstatectomySaheel Mukhtar, UK

UP–02.217The Combination of Real Time Elastography and PCA3 in Urine Detects 97% of Patients with Significant Prostate CancerYngve Nygard, Norway

UP–02.218Surgical and Functional Outcomes Using a Novel Device for Urethro-Vesical Anastomosis in Extraperitoneal Videolaparoscopic ProstatectomyAntonio Luigi Pastore, Italy

UP–02.221Polyestradiol Phosphate (Estradurin®) in Castration Resistant Prostate CancerM. Andreas Roder, Denmark

UP–02.222Active Surveillance for Prostate Cancer: 8-Year Outcomes in a UK District General HospitalSurayne Segaran, UK

UP–02.223Effect of a Suspension Suture in Addition to a Total Anatomical Reconstruction in Robot-Assisted Laparoscopic Prostatectomy: Does It Help Early Continence?Taimur Shah, UK

UP–02.224Prostate Cancer Progression Under Long-Term ADT Treated by Robotic High Intensity Focused Ultrasound (rHIFU): Ten Years’ Efficacy and Side EffectsStefan Thüroff, Germany

UP–02.225Active Surveillance for Low-Risk Prostate Cancer: 3 Years’ Experience at a Teaching HospitalKevin Williams, UK

UP–02.226Impacts of Pathological and Biochemical Outcome of Robotic-Assisted Radical Prostatectomy Versus Radical Retropubic Prostatectomy in High Risk Group of Localized Prostate CancerWen-Chi Chen, Taiwan



TUESDAYOctober 18

UP–02.227A Possibility of Prostate Cancer Chemoprevention by DietHideyuki Akaza, Japan

UP–02.228High Fat Intake Increases Prostatic Specific Antigen in Normal Japanese PopulationFumiyasu Endo, Japan

UP–02.229Anti-Inflammatory Effects of Fish Oil (Omega-3 Fatty Acids) on Normal Human Prostate EpitheliumVincent Fradet, Canada

UP–02.230Local Staging of Prostate Cancer; Correlation Between Endorectal Magnetic Resonance Imaging and Pathological Findings After Radical Prostatectomy in Habitual Clinical UseFrancisco Jose Blasco Casares, Spain

UP–02.231Does Prostate Biopsy Pose Problems in the Staging of Prostate Cancer by Magnetic Resonance Imaging Scan?Ponnambalam Chandrasekar, UK

UP–02.232Are All T3 Prostate Cancers Equal? A Scoring System for Prediction of Treatment Failure in T3a/B Prostate Cancer Following Radical ProstatectomyRami Issa, UK

UP–02.233Prospective Evaluation of the Effectiveness of Low Dose Spinal Saddle Block Anesthesia for Pain Relief During Transrectal Digitally Guided Prostate BiopsyAnselm Okwudili Obi, Nigeria

UP–02.234Tertiary Pattern 5 Is an Indicator of Favorable Prognosis in Gleason 8 and 9 DiseaseHidekazu Yamamoto, UK

UP–02.235Robotic Extended Pelvic Lymphadenectomy for Prostate CancerBertram Yuh, USA

UP–02.236Impact of a Systematic Educational Program To Shorten the Learning Curve for Holmium Laser Enucleation of the ProstateYoshiyuki Shiga, Japan


BERLIN SIU 2011 137

WEDNESDAYOctober 19

0630–0800


IC10: Tips and Tricks in Ileal Neobladder Construction with Nerve and Seminal Vesicle Sparing Cystectomy

Chair: Richard Hautmann, Germany

Room: Salon 11/120630–0650Nerve-Sparing RCXUrs E. Studer, Switzerland

0650–0700Seminal Vesicle-Sparing RCXRichard Hautmann

0700–0715Orthoptopic Reconstruction of Both Sexes: Tricks of the TradeUrs E. Studer

0715–0730Tips and TricksRichard Hautmann

0730–0750Potential ComplicationsBjörn G. Volkmer, Germany


IC11: Management of Urothelial Carcinoma: Stage- and Site-Specific Discussions

Chair: Wassim Kassouf, Canada

Room: Salon 13/140630–0700Practical Tips in the Management of Non-Muscle Invasive Bladder CancerAshish Kamat, USA

0700–0730Optimizing Quality of Care for Muscle-Invasive Bladder CancerWassim Kassouf, Canada

0730–0800Comprehensive Update on Upper Tract Urothelial CarcinomaShahrokh Shariat, USA

IC12: Robot-Assisted Radical CystectomyChair: Juan Palou, Spain

Room: Salon 15/160630–0650RRC Surgical Technique in a Man with or without Nerve Sparing Technique, and the Relation with Functional ResultsJuan Palou

0650–0710RRC in Women with or without Vaginal ResectionMagnus Annerstedt, Sweden

0710–0730Lymphadenectomy: Anatomical Landmarks and Basic Oncological PrinciplesAshok K. Hemal, USA



WEDNESDAYOctober 19

0730–0750Urinary Diversion: Intra or Extracorporeal Diversion in RCC?Peter Wiklund, Sweden

0750–0800Results of Open Cystectomy vs RRC (Complications, Bleeding)Juan Palou

IC13: New Developments in Renal Stone Treatment Surgery

Chair: Jean de la Rosette, The Netherlands

Room: Hall 100630–0700Supine versus Prone PCNLJean de la Rosette

0700–0730Combined PCNL and URSOlivier Traxer, France

0730–0800Drainage After PCNL: Percutaneous, Internal, NoneGlenn Preminger, USA

IC14: Prostatitis, Chronic Pelvic Pain Syndrome and Male Adnexitis

Chairs: J. Curtis Nickel, CanadaT. E. Bjerklund Johansen, Denmark

Room: Salon 17/180630–0700Bacterial Prostatitis: Diagnosis and TherapyFlorian Wagenlehner, Germany

0700–0730Chronic Prostatitis/Chronic Pelvic Pain Syndrome: Clinical Evidence Revisited Provides Rationale for Therapeutic StrategyJ. Curtis Nickel

0730–0800Andrological Implications in Chronic AdnexitisWolfgang Weidner, Germany

0800–1000

PLENARY 3Benign Prostatic HyperplasiaChairs: Paul Abrams, UK

Mostafa Elhilali, Canada

Room: Hall 10800–0810Clinical Pearls: The Past Year in Review: Lower Urinary Tract DysfunctionFrank Lee, UK

0810–0825LUTS Suggestive of BPO: Is a Pressure-Flow Study Always Needed?Paul Abrams, UK

0630–0800

INSTRUCTIONAL COURSES IC10–IC14IC12: Robot-Assisted Radical Cystectomy


BERLIN SIU 2011 139

WEDNESDAYOctober 19

0825–0840BPH and OABLuc Valiquette, Canada

0840–0900AUA Lecture: Medical Therapy for Male LUTS and BPH: An Update in 2011Claus Roehrborn, USA

0900–0915Acute Urinary Retention (AUR) Secondary to BPO John M. Fitzpatrick, Ireland

0915–0945Pro-Con Debate: Is TURP Still the Gold Standard of Surgical Therapy?Moderator: Mostafa Elhilali, CanadaCon: Oliver Reich, GermanyPro: Michael Marberger, Austria

1000–1200


PARALLEL PLENARY 11 StonesChair: Petrisor Geavlete, Romania

Mahesh Desai, India

Room: Hall 71000–1030Panel Discussion Based on Case Presentations: Management of Staghorn Stones TodayChair: Mahesh Desai, IndiaStaghorn Calculus Large Volume/Bilateral StonesTarik Esen, Turkey

Staghorn Calculus with Bleeding Diathesis/AnticoagulantAnup Patel, UKStaghorn Calculus with Renal FailurePetrisor Geavlete, RomaniaStaghorn Calculus: The Planning of Surgery Lap NephrolithotomyNasser Simforoosh, Iran

1030–1045Retrograde Intrarenal Stone SurgeryAnup Patel, UK

1045–1100Combined Percutaneous and Retrograde Ureteroscopic ApproachRoberto M. Scarpa, Italy

1100–1115Laparoscopic Stone RemovalRené Sotelo, Venezuela

1115–1145Pro-Con Debate: ESWL vs. URS for Ureteral StonesModerator: TBCESWL: David Tolley, UKURS: Andreas Gross, Germany

1145–1200Where Is the Place for Medical Stone Therapy (Prevention, Chemolysis)?Glenn Preminger, USA



WEDNESDAYOctober 19

PARALLEL PLENARY 12 Kidney CancerChairs: Jan Breza, Slovakia

Simon Tanguay, Canada

Room: Hall 31000–1015Active Surveillance: In Whom, Outcomes and RisksMichael Jewett, Canada

1015–1030Energy Ablative Therapy: In Whom, Which Access?Michael Marberger, Austria

1030–1045Robotic Tumor Resection: New Standard for Open Surgeons?Joachim W. Thüroff, Germany

1045–1100Management of RCC with IVC ThrombusMarkus Hohenfellner, Germany

1100–1115Metastatic RCC: TKIs, mTOR 1/n Inhibitors or Antibodies?Samir Taneja, USA

1115–1200Panel Discussion Based on Case Presentations: Which Treatment for Which Patient?Moderator: Hein van Poppel, Belgium

Panelists: All

PARALLEL PLENARY 13 Diagnosis of Urothelial TumorsChairs: Imre Romics, Hungary

Fred Witjes, The Netherlands

Room: ICC Lounge1000–1015Urinary MarkersYves Fradet, Canada

1015–1030Fluorescence CystoscopyMarek Babjuk, Czech Republic

1030–1045Optical Coherence TomographySeth Lerner, USA

1045–1100Narrow Band ImagingJean de la Rosette, The Netherlands

1100–1115Confocal Laser EndomicroscopyWolfgang Jäger, Germany

1115–1155Panel Discussion: Clinical Potential and Cost/Benefit AnalysisModerator: Fred WitjesPanelists: All


BERLIN SIU 2011 141

WEDNESDAYOctober 19

1200–1315

BREAK

SPONSORED SYMPOSIUM

Bayer HealthCare

CRPC: An Evolving Treatment ParadigmChair: Kurt Miller, Germany

Room: Stockholm1200-1205IntroductionKurt Miller

1205-1225Introduction to CRPC and Overview of New Treatment OptionsKurt Miller

1225-1245Alpharadin (Radium-223) Preclinical and Early Clinical TrialsSten Nilsson, Sweden

1245-1305Presentation of the ALSYMPCA DataChris Parker, UK

1305-1315Discussion

1315–1445


PARALLEL PLENARY 14Neuro-UrologyChair: Francisco Cruz, Portugal

Reynaldo Gómez, Chile

Room: Hall 71315–1335Pro-Con Debate: How to Detect the “AggressiveDetrusor”

1315–1325Leak Point PressureSophie Fletcher, USA

1325-1335Video UrodynamicsJuergen Pannek, Switzerland

1335-1350Posterior Rhizotomy ± Electrical StimulationHelmut Madersbacher, Austria

1350-1405Botox Detrusor InjectionsKurt McCammon, USA

1405-1420Bladder Augmentation ± Sphincteric AugmentationAnthony Mundy, UK

1420-1445Case Presentations and Discussion



WEDNESDAYOctober 19

PARALLEL PLENARY 15LESS Invasive SurgeryChairs: Claude Abbou, France

Octavio Castillo, Chile

Room: ICC Lounge1315–1330LESSMihir Desai, USA

1330–1345SMARTJens Rassweiler, Germany

1345–1400NOTESRené Sotelo, Venezuela

1400–1415MIESPradeep Rao, India

1415–1445Panel Discussion: Translating the Plethora of Acronyms into Clinical RealityModerator: Gunter Janetschek, AustriaPanelists: All

PARALLEL PLENARY 16Urogenital FistulaChairs: Suzy Elneil, UK

Serigne Gueye, Senegal

Room: Hall 61315–1330Evaluation and Classification of VVFOumarou Sanda Ganda, Niger

1330–1355Surgical Principles and Early Management of VVFSerigne Gueye

1355–1410Iatrogenic Genitourinary Fistula: Clinical Features and ManagementDirk De Ridder, Belgium

1410–1425Global Perspectives on Fistula Care and TrainingSuzy Elneil



BERLIN SIU 2011 143

WEDNESDAYOctober 19

1315–1445

ABSTRACT SESSIONS

PODIUM SESSION 7Prostate Cancer, LocalizedChairs: Gerald Andriole, USA

Felix Chun, Germany

Room: Hall 81315–1325POD–07.01Dose Escalation with High-Dose 3D-Conformal Radiotherapy (HD-3D-CRT) or Low-Dose 3D-Conformal Radiotherapy Plus HDR Brachytherapy (LD-3D-CRT+HDR-B) for Intermediate-or High-Risk Prostate Cancer: Higher PSA Control with Lower ToxicityBenjamin Guix, Spain

1325–1335POD–07.02Positive Surgical Margin at Bladder Neck Is an Independant Predictor of Local Failure and Prostate Cancer Mortality in pT3-Prostate Cancer. Results of a Prospective Single Institution SeriesMartin Spahn, Germany

1335–1345POD–07.03Pathology Results of Radical Prostatectomy in Patients Initially Managed by Active SurveillanceMark S. Soloway, USA

1345–1355POD–07.04Active Surveillance for Prostate Cancer: An Update on the Miami ExperienceMark S. Soloway, USA

1355–1405POD–07.05Radical Prostatectomy for High-Risk, Clinically Localized Adenocarcinoma of the ProstatePaul Cozzi, Australia

1405–1415POD–07.06Inter-Observer Variability in the Interpretation of HistoScanning™ Characterisation of Prostate CancerSuzanne Van Den Heuvel, The Netherlands

1415–1425POD–07.07Long-Term Cancer Outcomes After Radical Prostatectomy and Selective Salvage Radiotherapy in 1670 Pt2-3N0M0 Patients by Margins Status: Quantification of Overtreatment with Adjuvant Radiotherapy for All Positive MarginsVincent Fradet, Canada

1425–1435POD–07.08Morbidity of High Intensity Focused Ultrasound as a Primary Monotherapy for Low-Risk Localized Prostate Cancer: Outcomes from the ENLIGHT TrialCary Robertson, USA



WEDNESDAYOctober 19

1315–1445

MODERATED POSTER SESSION 14Minimally Invasive SurgeryChair: Joachim Thüroff, Germany

Room: Salon 11/12

MP–14.01An Alternative Method for Veress Needle Access To Avoid Insertion ComplicationsCetin Yesilli, Turkey

MP–14.02Open vs Robot-Assisted Laparoscopic Nephron-Sparing Techniques: Are the Tumor-Free Margins Equivalent?Matei Andreoiu, USA

MP–14.03During the Learning Curve, Does the Robot-Assisted Partial Nephrectomy Have Equal Outcomes to the Open Partial Nephrectomy?Thomas Jankowski, Germany

MP–14.04Accuracy of Predictive Scoring Systems in Laparoscopic NephrectomyOmar Jundi, UK

MP–14.05Prospective Comparison of En Bloc Hilar Ligation to Conventional Ligation During Laparoscopic Radical Nephrectomy for Early Renal Cell CarcinomaTae Hyo Kim, South Korea

MP–14.06Techniques for Early Recovery of Continence in Patients with Robotic-Assisted Radical ProstatectomyTae Hyo Kim, South Korea

MP–14.07Robotic Versus Conventional Laparoscopic Pyeloplasty: A Single Surgeon Concurrent Cohort ReviewAmlesh Seth, India

MP–14.08Laparo-Endoscopic Single Site Surgery: The University of South Florida Initial ExperienceAlejandro Rodriguez, USA

MP–14.09Open Conversion Cases During Laparoscopic Surgery: The Sapporo City General Hospital ExperienceToshimori Seki, Japan

MP–14.10Robotic Partial Nephrectomy Using Robotic Bulldog Clamps: Initial SeriesCraig Rogers, USA

MP–14.11Robotic Partial Nephrectomy in Patients with Baseline Renal InsufficiencyCraig Rogers, USA

MP–14.12Intraoperative Finding of Gross Lymph Node Metastasis During Robotic Radical ProstatectomyCraig Rogers, USA


BERLIN SIU 2011 145

WEDNESDAYOctober 19

MP–14.13Robotic Partial Nephrectomy Using a Robotic Ultrasound Probe for Tumor Identification: Initial Series and OutcomesCraig Rogers, USA

MP–14.14Single Port Retroperitoneal Laparoscopic Adrenalectomy for Large Adrenal MassYeh Hong Tan, Singapore

MP–14.15Single Port/LESS Nephrectomy and Nephroureterectomy: Initial Experience in SingaporeYeh Hong Tan, Singapore

MP–14.16Laparoscopic Versus Open Ureteroplasty and Ureterocystanastomosis: Choices for the Treatment of Congenital MegaureterAn Wei, China

1315–1445

MODERATED POSTER SESSION 15 Penile/Testis: Benign & Malignant

DiseaseChairs: Philippe Spiess, USA

Chris Protzel, Germany

Room: Salon 13/14

MP–15.01Prognostic Significance of Extracapsular Spread in Inguinal Nodes in Penile CancerHussain Alnajjar, UK

MP–15.02Long-Term Survival Outcomes of Primary Penile Cancer in a Supra-Regional CentreHussain Alnajjar, UK

MP–15.03Long-Term Follow-Up After Neodynium-YAG Laser Therapy for Penile Squamous Cell CarcinomaRosa Djajadiningrat, The Netherlands

MP–15.04Penile Intraepithelial Neoplasia: Incidence in The NetherlandsEvelien Trip, The Netherlands

MP–15.05Allelic Losses in Apoptosis Regulators Are Frequently Found in Penile CancerChris Protzel, Germany



WEDNESDAYOctober 19

MP–15.06Lymphadenectomy in Penile Carcinomas: Guideline Recommendations Versus Clinical PracticeChris Protzel, Germany

MP–15.07Penis Carcinoma: Retrospective Study of the Last 15 Years in a Central Hospital of Northern PortugalFrederico Teves, Portugal

MP–15.08Repeat Inguinal Lymph Node Dissection for Locally Recurrent Penile Cancer: A Potentially Curative ProcedurePhilippe E. Spiess, USA

MP–15.09Outcome of Using Two-Stage Buccal Mucosal Graft for Replacement of Long Segment of Penile Urethral StrictureTarek Abdelbaky, Egypt

MP–15.12Penile Frenuloplasty: A Safe and Acceptable Alternative to Circumcision for Frenular Pain or ScarringJudith Dockray, UK

MP–15.13Management of Cryptorchidism in Adolescent and Adult MalesChris F. Heyns, South Africa

MP–15.14Epidemiology of Urethral Strictures: Temporal Changes in Etiology and Socio-Demographic DeterminantsJo Van der Merwe, South Africa

MP–15.15Initial Results of Male Circumcision with the Shang Ring™ DeviceAlexander Hinev, Bulgaria

MP–15.16Recurrence Rate for Internal Urethrotomy in Group of Patients with Moderate Uretheral StenosisDimitrije Jeremic, Serbia

MP–15.17Testicular Torsion with Necrotic Outcome: Dilemmas of Surgical TimingChukwudi Okorie, Kenya

MP–15.18Long-Standing Hydrocele in Adult Black Africans: Is Automatic Ordering of Pre-Operative Scrotal Ultrasound Justified?Chukwudi Okorie, Kenya

MP–15.19Management of Testicular Ischaemia Following an Inguinal Hernia RepairTaimur Shah, UK

1315–1445

MODERATED POSTER SESSION 15Penile/Testis: Benign & Malignant Disease


BERLIN SIU 2011 147

WEDNESDAYOctober 19

MP–15.20Long-Term Follow-Up of Cisplatin Combination Chemotherapy in Patients with Disseminated Nonseminomatous Testicular Tumors: Is a Post-Chemotherapy Retroperitoneal Lymphadenectomy Needed After Complete Remission?Djordje Argirovic, Serbia

MP–15.21Two Decades Experience with Single Cycle Adjuvant Chemotherapy in Stage I Non-Seminomatous Testis CancerLuis Ebel, Chile

1315–1445

MODERATED POSTER SESSION 16 Prostate Cancer: Staging, Advanced &

MarkersChairs: Detlef Frohneberg, Germany

Arturo Mendoza-Valdés, Mexico

Room: Salon 15/16

MP–16.01Cellular and Humoral Immune System Activation by Sipuleucel-T: Preliminary Data from the OpenACT Phase 2 TrialDaniel Petrylak, USA

MP–16.02Locally Advanced PCa T3-4 Treated by Robotic High Intensity Focused Ultrasound: 150 Patients Followed 9 YearsStefan Thüroff, Germany

MP–16.03Nadir Prostate Specific Antigen (PSA) Level and Time to PSA Nadir Following Primary Androgen Deprivation Therapy Are the Early Survival Predictors for Prostate Cancer Patients with Bone MetastasisTakeshi Sasaki, Japan

MP–16.04Intermittent Low Dosage Stilboestrol for Invasive Cancer of the ProstateDeen Sharma, Guyana

MP–16.05Cause of Death in Elderly Patients with High-Risk PCa, Treated by Androgen Deprivation Therapy AloneHelen Simpson, UK



WEDNESDAYOctober 19

MP–16.06Changes in Body Composition, Development of Metabolic Syndrome (X) and Pathological Fractures in Men on Long-Term Androgen Deprivation TherapyStanislav Ziaran, Germany

MP–16.07Prognostic Values of AMACR, PSMA, PSCA, EGFR, and Bcl-2 in Patients Undergoing Radical Prostatectomy: A Study with Objective Staining Score of Tissue MicroarrayIn-Chang Cho, South Korea

MP–16.08Is Pro PSA a More Cancer-Specific Form of Prostate Specific Antigen for the Early Detection of Prostate Cancer?Jiri Klecka, Czech Republic

MP–16.09Correlation of PCA3 and MRI with Biopsy OutcomeGisele Leyten, The Netherlands

MP–16.10Expression Profiling of Laser Micro Dissected Prostate Cancer Cells Delineates Genes Associated with Biochemical Recurrence After Radical ProstatectomyMartin Mørck Mortensen, Denmark

MP–16.11Pathologic Outcomes of Patients Who Are Potential Candidates for Active Surveillance or Focal TherapyKirill Nyushko, Russia

MP–16.12Pre-Operative Urinary Prostate Cancer Gene 3 in the Prediction of Small Tumor Volume, Insignificant, Locally Advanced and Aggressive Prostate CancerFelix Chun, Germany

MP–16.13Bone Scan Should No Longer Be the First Staging Test in Prostate CancerLina Maria Carmona, UK

MP–16.14Improved Grouping System Combining Gleason Score for Group IV of TNM Prognostic Grouping for Prostate Cancer: Results from J-CAP DatabaseShiro Hinotsu, Japan

MP–16.15A Critical Analysis of the Performance of MRI and Partin’s Nomogram in Prostate Cancer Patients Undergoing Radical TreatmentVivekanandan Kumar, UK

MP–16.16Younger Patients Have Worse Biochemical Outcome After Radical Prostatectomy in High Risk Prostate CancerSung Kyu Hong, South Korea

MP–16.17Detection of Bone Metastases from Prostate Cancer: A Prospective Study of 99mTc-MDP Whole-Body Bone Scintigraphy, 18F-Fluorocholine PET/CT, 18F-Fluoride PET/CT Compared with MRIMads Hvid Poulsen, Denmark

1315–1445

MODERATED POSTER SESSION 16Prostate Cancer: Staging, Advanced & Markers


BERLIN SIU 2011 149

WEDNESDAYOctober 19

MP–16.18Predicting Low-Volume and Insignificant Prostate Cancer in Core-Needle Biopsies: Is It Possible?M. Andreas Roder, Denmark

MP–16.19Can Pre-Biopsy MRI Accurately Identify Prostate Cancer Location? Imaging in a 140 Patient Cohort when Compared to Subsequent Transperineal Template Guided Saturation BiopsyHelen Simpson, UK

MP–16.20Trends of the Clinical Characteristics and Primary Therapy in Patients with Prostate Cancer in Nara Uro-Oncological Research Group (NUORG)Nobumichi Tanaka, Japan

MP–16.21Achieving the “Bifecta” Using Salvage Cryotherapy for Locally Recurrent Prostate Cancer: Analysis of the COLD Registry DataPhilippe E. Spiess, USA

1315–1445

VIDEO SESSION 8: Miscellaneous TopicsChairs: William J. Lynch, Australia

Steffen Weikert, Germany

Room: Salon 17/181315–1325VID–08.01Retroperitoneal Laparoscopic Living Donor Nephrectomy: A Simple Technique in Cho Ray HospitalTran Sinh, Vietnam

1325–1335VID–08.02Correction of Epispadias in Adult After Failed Repair in ChildhoodMiroslav Djordjevic, Serbia

1335–1345VID–08.03Novel Management of Complicated Cases of Induratio Penis Plastica Using Buccal Mucosa and Geometrical Plaque IncisionAref Elseweifi, Germany

1345–1355VID–08.04Partial Penile Neurectomy for Management of Premature EjaculationAref Elseweifi, Germany



WEDNESDAYOctober 19

1355–1405VID–08.05Gloves Model for Laparoscopic Pyeloplasty TrainingAmit Bhattu, India

1405–1415VID–08.06Y Neobladder: An Easy, Fast and Reliable TechniquePaolo De Stefanis, Italy

1415–1425VID–08.07The Split-Nipple Technique for Ureteral Reimplantation: Endoscopic Aspect and ApplicationsMohammed Lezrek, Morocco

1425–1435VID–08.08Simplified Technique for Parastomal Hernia Repair Following Radical Cystectomy and Ileal Conduit CreationJoan Palou, Spain

1435–1445VID–08.09Laparoscopic Ileal Conduit: An Intracorporeal Uretero-ileal Anastomotic TechniquePaul Rouse, UK

VIDEO SESSION 9Adrenal, Kidney & MiscellaneousChair: Michael Marberger, Australia

Room: Hall 101315–1325VID–09.01Advantages of Single Optical Port in Laparoscopic Bilateral AdrenalectomyMarcos Cepeda Delgado, Spain

1325–1335VID–09.02Robotic Pyelolithotomy and Pyeloplasty in Horseshoe KidneysGianluca D’Elia, Italy

1335–1345VID–09.03Laparoscopic Exeresis of Large Ureterocele, Megaureter and Hydronephrotic KidneyNerea Felip Santamaría, Spain

1345–1355VID–09.04Endoscopic Treatment of Fibroepithelial Polyp of the UreterDario Garcia-Rojo, Spain

1355–1405VID–09.05Minilaparoscopy for the Treatment of Pyeloureteral Junction StenosisMarco Puglisi, Italy

1315–1445

VIDEO SESSION 8Miscellaneous Topics


BERLIN SIU 2011 151

WEDNESDAYOctober 19

1405-1415VID–09.06Laparoscopic Varicocelectomy Using Bipolar Cautery Versus Open Inguinal Technique: A Randomized Clinical TrialHosein Karami, Iran

1415–1425VID–09.07Bipolar Plasma Vaporization of Secondary Bladder Neck SclerosisBogdan Florin Geavlete, Romania

1445–1500

BREAK

1500–1630

GENERAL ASSEMBLY

Room: Hall 3

1800-2000

SIU WORLD FORUM FOR PATIENTSUrinary Incontinence Chair: Jan Roigas

Room: ICC Lounge

This session will be conducted in German

1900–2300

SIU GALA BANQUET

The Schlüterhof German Historic Museum


Room: Exhibit Hall

Pediatric Urology; Penis/Testis/Urethra, Benign Disease; Reconstruction; Renal Transplantation; Sexual Function & Dysfunction; Stones; Testis Cancer; Training and Education; Trauma & Reconstructive Urology; Ureteral Cancer/Renal Pelvis; Urinary Diversion; Urinary Incontinence/Overactive Bladder; Urodynamics

UP–03.001Adult Urological Sarcomas: 20–Year ExperienceManfred P. Wirth, Germany

UP–03.002Application of Method of Continent Urinary Stoma Construction Using Diagonal Tubularization of Ileum SegmentLidia Skobejko-Wlodarska, Poland

UP–03.003Setting-Up of a Pediatric Urological Division in an Adult Urological DepartmentVasile Dan Stanca, Romania

UP–03.004The Use of Kampo Formula (Bupleurum Root Drug Group) in Mentally Retarded Patients with EnuresisKuri Suzuki, Japan

UP–03.005Ingenuity To Treat Pediatric Urological Tumors More Safely and More EffectivelyAtsuko Watanabe, Japan



WEDNESDAYOctober 19

UP–03.006Immunoexpression and Prognostic Value of CD9 in Epidermoid Carcinoma of the PenisLuiz Renato Montez Guidoni, Brazil

UP–03.007Treatment of Carcinoma In-Situ (CIS) of the Penis with Topical Chemotherapy AgentsHussain Alnajjar, UK

UP–03.009Penile Fracture: Why Should It not Be Operated Late?Braiek Salem, Tunisia

UP–03.010Scrotal Surgery After Inguinal Hernia Repair with MeshAleksandar Ilievski, Macedonia

UP–03.011Handling and Outcomes of Male Urinary Incontinence by Suburethral Sling After Radical ProstatectomyEmilio Izquierdo Morejón, Spain

UP–03.012Optical Internal Urethrotomy Revisited: The Modified Way We Do ItSudhir Khanna, India

UP–03.013Efficacy of Holmium Laser Urethrotomy in Combination with Intralesional Triamcinolone in the Treatment of Urethral StrictureSantosh Kumar, India

UP–03.015Is Trans-Obturator Tape (TOT) a Safe and Long-Term Effective Procedure?Shivadeo Bapat, India

UP–03.016Transvaginal Urethral Diverticulectomy Using Small Intestinal Submucosa Interposition GraftKaren De Baets, Belgium

UP–03.017Management of Iatrogenic Ureteral Defects Due to Oncogynecological Surgery and/or Pelvic IrradiationAlexander Hinev, Bulgaria

UP–03.018Management of Difficult Urethrovaginal Fistula Using Peritoneal Flap: Single Centre ExperienceSuresh Patankar, India

UP–03.019Combined Buccal Mucosa Graft Urethroplasty for Refractory Glanular Stricture: Intermediate-Term ResultsApul Goel, India

UP–03.020Post-Circumcision Urethro-Cutaneous Fistula: Attention to Detail Enhances Reconstruction SuccessCharles Mkony, Tanzania

UP–03.021Malignancies in Augmentation Ileocystoplasties: A ReviewChristian Nayar, UK


BERLIN SIU 2011 153

WEDNESDAYOctober 19

UP–03.022Buccal Mucosal Graft in Reconstructive Urology: Uses Beyond Urethral StrictureAbhishek Pandey, Germany

UP–03.023Vessel-Sparing UrethroplastySuresh Patankar, India

UP–03.024Laparoscopic Reconstruction of the Ureter for Recurrent Strictures: An Experimental StudyMahmoud Shalaby, Egypt

UP–03.025Feasibility of Hand-Assisted Laparoscopic Bilateral Native Nephrectomy in Patients with Advanced Kidney DiseaseRavi Barod, UK

UP–03.026Impact of Surgeon Experience on Complication Rates and Functional Outcomes of 484 Deceased Donor Renal Transplants: A Single Center Retrospective StudyHannes Cash, Germany

UP–03.027Renal Transplantation in Patients with Neurogenic Bladder Following Mitrofanoff Continent Urinary DiversionNabil Mhiri, Tunisia

UP–03.028A Procedure To Transplant a Kidney with Short Vein Removing by LaparoscopyTran Sinh, Vietnam

UP–03.029Results of Renal Transplantation in Children with Posterioer Urethral Valves: A Single Center Comparative StudyMohamed Kamal Gheith, Germany

UP–03.035Modified Lich-Grégoir Technique in Renal Transplantation by Assisted Peroperative Transvesical CystoscopyTran Sinh, Vietnam

UP–03.037Erectile Dysfunction and Important Clinical ConnectionsJan Breza, Slovak Republic

UP–03.038Intralbugineous N-butyl-2-cyanoacrylate (Histoacryl) Injection After Subcapsular Orchiectomy To Preserve Testicular Configuration: Experimental StudyFathy Moussa, Egypt

UP–03.039Does Daily Intake of Sildenafil Preserve the Histological Integrity of Corpus Cavernosum After Androgen Deprivation? Experimental StudyFathy Moussa, Egypt

UP–03.040Severe and Long-Standing “Penile Angina” Are Additively Associated with Poor Exercise Performance in Erectile Dysfunction Patients with HypertensionApostolos Rempelakos, Greece



WEDNESDAYOctober 19

UP–03.042Female Genital Sensation: Our Experience with the Genital Sensory AnalayzerGiovanni Alei, Italy

UP–03.0433D-CT Cavernosography in Deep Dorsal VeinYoshito Kusuhara, Japan

UP–03.044Difference of Erectile Function Using IIEF 5 and Erection Hardness Score Before and After TURP in BPH PatientsDoddy Musbadianto Soebadi, Indonesia

UP–03.045Electromyographic Profiles of Corpus Cavernosum (CC-EMG) Before and After Radical Prostatectomy with or without Neurovascular Bundle SparingSasa Vojinov, Serbia

UP–03.047Comparing the Length of Penile Mucosa in Men with and without Premature EjaculationMehdi Faraji Shovey, Iran

UP–03.048Comorbidity Profiles Among Patients with Erectile Dysfunction: A Nationwide Population-Based StudyShun-Fa Hung, Taiwan

UP–03.049Ejaculatory Disorders: Comparison Between South and NorthEkaterina Kulchavenya, Russia

UP–03.050Overactive Bladder as a Reason for Sexual Dysfunction in WomenEkaterina Kulchavenya, Russia

UP–03.051How Does the Addition of Trospium Chloride to the Alpha Blocker Treatment Affect the Sexual Life of Patients with Lower Urinary Tract Symptoms and Overactive Bladder?Hasan Soydan, Turkey

UP–03.052Combination of Andropenis® Penile Extender and Oral Therapy (Peironimev ®) Versus Intralesional Verpamil for Penile Curvature Due to Peyronie’s Disease: Preliminary Results of a Randomized Phase II TrialPaolo Gontero, Italy

UP–03.053Hypogonadism in Patients with ObesityCatalin Pricop, Romania

UP–03.055Original Technique for Penile Lengthening: Ten Years’ ExperienceGiovanni Alei, Italy

UP–03.056Peyronie’s Disease Treatment by Penile Prosthesis Implantation and Tunica Albuginea Incisions without GraftingVladimir Kojovic, Serbia

UP–03.057Early Insertion of Inflatable Penile Prosthesis for Intractable Ischemic PriapismCarlo Luigi Augusto Negro, UK


BERLIN SIU 2011 155

WEDNESDAYOctober 19

UP–03.058A Pilot Study of the Changes in Intrarenal Pressure During the Accordion™ Stop-Gap Device Deployment During Percutaneous NephrolithotomyJoon Jae Park, Singapore

UP–03.059Female Sexual Function After Vaginal Surgery Using Transobturator Mesh for Cystocele and Stress Urinary IncontinenceCristian Gutue, Romania

UP–03.061Melamine-Induced Urolithiasis in a Drosophila ModelWen-Chi Chen, Taiwan

UP–03.062Identification of Conditioning Film Components on Indwelling Ureteral Stents and Their Role in Bacterial AdhesionDirk Lange, Canada

UP–03.064Stone Clearance in Lower Pole Nephrolithiasis after Extra Corporeal Shock Wave Lithotripsy in Elderly PatientsMohamed Abdel Aziz, Saudi Arabia

UP–03.065Outcome of One Stage Ureteroscopy for Bilateral Ureteric StonesEhab Galal, Egypt

UP–03.066Is Routine Post-Operative Renal Tract Stone Culture Necessary?Darrell Allen, UK

UP–03.068Clinical and Radiological Parameters Predicting Spontaneous Passage During Expectant Management for Ureteral StoneKwang Soo Lee, South Korea

UP–03.069Urological Management of Cystine Nephrolithiasis; 20 Years of Experience in Four Different CentresRuud C. Wortel, The Netherlands

UP–03.070Lemon Juice or Potassium Citrate for Recurrent Stone Former: A Prospective, Randomized, Crossover StudyVikas Agarwal, India

UP–03.071A Prospective Randomized Clinical Trial To Compare the Clinical Efficacy and Tolerability of Potassium Citrate Versus Phytotherapy in Medical Management of Minimal Burden (Less Than 8mm) NephrolithiasisIqbal Singh, India

UP–03.072New Management of Upper Urinary Tract Obstruction by Using Allium® StentsJoachim Alefelder, Germany

UP–03.073Perurethral Multimodal Management of Multiple Renal CalculiShivadeo Bapat, India

UP–03.074Stone and Patient Related Factors in Connection with Short-Term Complications Following E.S.W.L. Stone ManagementIonut Dumitru Chira, Romania



WEDNESDAYOctober 19

UP–03.075Extracorporeal Shock Wave Lithotripsy with Siemens Modularis Lithostar Vario: Initial ExperienceErkan Erkan, Turkey

UP–03.076Safer and More Efficient Shock Wave Lithotripsy Using Dornier Lithotripter S IIKazunori Haga, Japan

UP–03.077The Combination of Automatic Vibrator, Diuresis and Inversion for Adjuvant Treatment of Lower Calyceal Stone After Shock Wave LitothripsyLukman Hakim, Indonesia

UP–03.078An Alternative Method in Ureteroscopic Extraction of Ureteral StonesKikyung Kim, South Korea

UP–03.079Safety and Efficiency of a Novel Endoscope for Bladder StoneAihua Li, China

UP–03.080Digital Semirigid Ureteroscopy: A Single Center Experience of 100 CasesPetrisor Aurelian Geavlete, Romania

UP–03.082Percutaneous Nephrolithotomy Under General Versus Spinal-Epidural AnesthesiaCetin Yesilli, Turkey

UP–03.083Study of Phosphocalcium Metabolism and Markers of Bone Modelling in Patients with Calcium LithiasisClara Lahoz Garcia, Spain

UP–03.084Effect of Alendronate Sodium and 2-Year Follow-Up of Patients with Recurrent Calcium NephrolithiasisClara Lahoz Garcia, Spain

UP–03.085One-Day Ureteral Catheter Placement After Ureteroscopic Lithotripsy: A Prospective StudyJeong Man Cho, South Korea

UP–03.086Small Bowel Injury After Extracorporeal Shock Wave Lithotripsy: A Case ReportChien-Ming Huang, Taiwan

UP–03.088Villa Tiberia Experience in the Treatment of Renal Stones with Retrograde Intrarenal SurgeryBarbara Cristina Gentile, Italy

UP–03.089Removing Locking Nephrostomy Tubes-Beware the Retained ThreadSomita Sarkar, UK

UP–03.090Endoscopic Extraction of Bladder Lithiasis Through a Mitrofanoff Continent Diversion: A New Surgical ProcedureNabil Mhiri, Tunisia


BERLIN SIU 2011 157

WEDNESDAYOctober 19

UP–03.091Can a Radiologic Finding Predict the Outcome of Extracorporeal Shockwave Lithotripsy for Ureteral Stone?Kwang Soo Lee, South Korea

UP–03.093Retrograde-Anterograde Combined Catheterization in Ureteral InjuriesOmar Bilal Halawa Gonzalez, Spain

UP–03.094Laser Holmium Retrograde Lithotripsy: A Single-Center ExperiencePaulo Azinhais, Portugal

UP–03.096Minimally Invasive Endourologic Management of Calculi in Continent Urinary Reservoirs: Experiences Using the Swiss Lithoclast® MasterPernille Skjold Kingo, Denmark

UP–03.097Endoscopic Realignment for Obliterative Stenosis of the Posterior Urethra Following Surgery for Benign Enlargement of the ProstateSanjay Kulkarni, India

UP–03.098Transpubic Double Anastomotic Urethroplasty for Exclusion of the Prostatic Urethra Due to TraumaSanjay Kulkarni, India

UP–03.099PCNL: Expanding Scope with the Nephroscope: A Single Centre Experience of 1200 CasesRajesh Kukreja, India

UP–03.100Anti-Retropulsion Devices Increase Stone Fragmentation Efficiency with Holmium:YAG Laser LithotripsyDirk Lange, Canada

UP–03.101Outcome of Percutaneous Management of 118 Kidney Calculi: Staghorn Calculi Still a ChallengeIvo Lopes, Portugal

UP–03.104Percutaneous Nephrolithotomy: Lessons Learned After 3000 ProceduresRazvan Multescu, Romania

UP–03.105Pyelocaliceal Diverticulum: Retrograde Endoscopic Approach of a Rare PathologyRazvan Multescu, Romania

UP–03.106Percutaneous Nephrolithotomy for Staghorn CalculiHoang Nguyen Phuc Cam, Vietnam

UP–03.108The Prevalence of Malignancy in Non-Palpable Testicular Lesions 10mm or Less in SizeRanjan Arianayagam, Australia

UP–03.110Does Cisplatin Based Chemotherapy Effect on Blood Lipid Levels of Patients with Germ Cell Testicular Tumor in Long-Term Follow-Up?Gokhan Koc, Turkey



WEDNESDAYOctober 19

UP–03.111TIN Therapy as Salvage Chemotherapy for Cisplatin Refractory Germ Cell TumorsTerukazu Nakamura, Japan

UP–03.112Redo-Retroperitoneal Lymphadenectomy for Nonseminomatous Germ Cell Testicular Tumors: Clinical Presentation, Patterns of Recurrence and OutcomeDjordje Argirovic, Serbia

UP–03.113Long-Term Follow-Up Using Testicular Sparing Surgery for Malignant and Benign DiseasesGiorgio Bozzini, Italy

UP–03.114Testis-Preserving Surgery in the Management of Leydig Cell Tumours: The Importance of Pre- and Intra-Operative UltrasoundJudith Dockray, UK

UP–03.115Update on Phase 1/2 Evaluation of Chemotherapy Plus Residual Tumour Excision for Testis ConservationTim Oliver, UK

UP–03.116Creation of a Genitourinary Cancer Survivorship Clinic at a Comprehensive Cancer Center: Start-Up Design and Assessment of Met and Unmet Needs of the Target PopulationJohn Davis, USA

UP–03.117Adjuvant Chemotherapy for Upper Tract Urothelial Carcinoma Treated with Nephroureterectomy: Assessment of Adequate Renal Function and Impact on OutcomeWassim Kassouf, Canada

UP–03.118The UroTutor Project: Production of Low-Cost, High-Definition Instructional Videos for Teaching Urology to Medical StudentsChris F. Heyns, South Africa

UP–03.119Complexities of the Learning Curve in Robotic Prostatectomy: How Intuitive Is Intuitive?Rami Issa, UK

UP–03.120Regional Medical Collaboration Guidelines for Lower Urinary Tract Symptoms (LUTS)Fukuji Kondo, Japan

UP–03.121Complications of Continent Catheterizable Channels: A 25–Year ExperienceReynaldo Gómez, Chile

UP–03.122Prostate Myths: What Is the Prostate Awareness in the General Male Population in Turkey?Haluk Kulaksizoglu, Turkey

UP–03.123What is the Best Technique for Primary Closure of the Bladder Neck in Continent Ileovesicostomy?Reynaldo Gómez, Chile


BERLIN SIU 2011 159

WEDNESDAYOctober 19

UP–03.124Bladder Neck Closure for Continent Ileovesicostomy by Transurethral Resection of the Membranous UrethraReynaldo Gómez, Chile

UP–03.125Is YouTube the Future of Patient Information? An Analysis of a Common Urological Surgical Procedure Posted on a Global Video Sharing WebsiteJonathan Kehinde Makanjuola, UK

UP–03.126Google as Open Source Patient Information on Bladder Cancer: Is There Reliable and Safe Information for a Patient with a New Bladder Cancer Diagnosis?Manar Malki, UK

UP–03.127On Global Approaches to Genito-Urology in Context of Health PolicyMichael Ch. Michailov, Germany

UP–03.128Low-Cost Laparoscopic Training for Urological Residents: Time Necessary To Compare to an ExpertRaul Montoya-Chinchilla, Spain

UP–03.129Urogenital Injuries Associated with Diastasis of Pubic Symphysis Caused by Land Mine BlastEmin Aydur, Turkey

UP–03.130To Evaluate Accuracy of Pre-Operative Sonourethrogram and Retrograde Urethrogram in Spongiofibrosis of Urethral Stricture DiseaseShivadeo Bapat, India

UP–03.131Urethral “Sphincter” Strictures Post TURP: “Barbagli” Dorsal Buccal Mucosa Onlay Graft RepairCristian Surcel, Romania

UP–03.132Long-Term Evolution of Missed Genitourinary Trauma Injuries in Serious Polytraumatized Patients: Importance of Tertiary Trauma SurveyDario Garcia-Rojo, Spain

UP–03.133Management of Kidney Trauma in Moroccan Military Active PopulationAbdelaziz Hamdoune, Morocco

UP–03.134Short-Term Outcome, Morbidity and Quality of Life of Artificial Urinary Sphincter: A Retrospective StudyLuis Alex Kluth, Germany

UP–03.135Urology Trauma: Urban Battlefield: Our Experience of Establishing a Urology Trauma Service at a London Major Trauma CentreJonathan Kehinde Makanjuola, UK

UP–03.136The Barbagli Technique: 3-Year Experience with a Modified ApproachDaniel Pfalzgraf, Germany

UP–03.137Urethroplasty with Lingual Mucosa Free Graft-Long Term Results and Operative Techniques UsedElenko Popov, Bulgaria



WEDNESDAYOctober 19

UP–03.138Outcome of Dual Flange Metallic Sphincteric Urethral Stents in the Treatment of Neuropathic Bladder Dysfunction After Spinal Cord InjuryAndre Van Der Merwe, South Africa

UP–03.139Endoscopic Laser Therapy as First-Line Treatment for Upper Urinary Tract Transitional Cell Carcinoma Smaller Than Two CentimetersElodie Beels, Belgium

UP–03.140Endoscopic Laser Therapy as Alternative for Nephroureterectomy in Patients with Upper Urinary Tract Transitional Cell CarcinomaElodie Beels, Belgium

UP–03.141Concomitant Transitional Cell Carcinoma of the Bladder in Patients with Urinary Tract Transitional Cell CarcinomaElodie Beels, Belgium

UP–03.142Upper Urinary Tract TCC Recurrence Rate Following Radical Cystectomy for Bladder Cancer: A Meta-Analysis of 13,185 PatientsGiorgio Bozzini, Italy

UP–03.143Analysis of Lymphadenectomy During Nephroureterectomy for Upper Urinary Tract Urothelial CarcinomaHiroshi Furuse, Japan

UP–03.144Surgical Options in Urothelial Tumors of the Upper Urinary TractAlexander Hinev, Bulgaria

UP–03.145T2 Ureteral Tumor and Severe Hydronephrosis: Poor Prognostic Factors in Upper Urinary Tract Transitional Cell CarcinomaSeung Il Jung, South Korea

UP–03.146The Impact of Intravesical Recurrence on Prognosis After Nephroureterectomy for Upper Urinary Tract Urothelial CancerJunichi Inokuchi, Japan

UP–03.147Predictive Factors for Bladder Recurrence after Radical Nephroureterectomy for Upper Urinary Tract Transitional Cell CarcinomaSe Joong Kim, South Korea

UP–03.148Large Pelvic Masses of Obscure Origin: Urologist’s PerspectiveSantosh Kumar, India

UP–03.149Endoscopic Circumferential Mobilization of Distal Ureter in Laparoscopic Nephro-Ureterectomy: A Safe Option for Suspected CancerRhana Zakri, UK


BERLIN SIU 2011 161

WEDNESDAYOctober 19

UP–03.150The Role of Lymph Node Dissection During Nephroureterectomy in the Management of Upper Urinary Tract Urothelial Carcinoma: The Canadian ExperienceRicardo Rendon, Canada

UP–03.151Significance of Hemoglobin Value Before Gemcitabine/Cisplatin or Carboplatin Treatment as an Independent Prognostic Biomarker in Advanced Urothelial CancerShuichi Morizane, Japan

UP–03.152Prognosis and Prognostic Factors in Renal Pelvis and Ureter TumorsJong Kil Nam, South Korea

UP–03.153Modified Supine Position Hand-Assisted Transperitoneoscopic NephroureterectomySung Hyun Paick, South Korea

UP–03.154Tumor Location, as a Predictor of Recurrence and Cancer-Specific Mortality, in Endourological Treatment of Upper Urinary Tract Urothelial TumorsJoan Palou, Spain

UP–03.155Results of BCG and MMC in Transitional Cell Carcinoma of Upper Urinary Tract: Spanish Cooperative Group Register of Upper Urinary Tract TumorsJoan Palou, Spain

UP–03.156Mitrofanoff’s Continent Urinary Diversion in Patients with Spinal Cord Injury: Indication and ResultsNabil Mhiri, Tunisia

UP–03.157Intradetrusor Injection of Botulinum Neurotoxin Type A in Patients with Idiopathic Detrusor Overactivity Undergoing Radical Retropubic ProstatectomyApostolos P. Labanaris, Germany

UP–03.159Early Experience Robot-Assisted Laparoscopic Radical Cystectomy and Neobladder without RedockingYong Seong Lee, South Korea

UP–03.160Continent Cutaneous Diversion A.M. Lundiana in 200 Patients: Complications from Reservoir and OutletWiking Månsson, Sweden

UP–03.161The Diagnostic Role of Transabdominal Ultrasonographic Bladder Wall Thickness in Female Urinary IncontinenceEmin Aydur, Turkey

UP–03.162Assessment of Effects of Pelvic Floor Muscle Exercises Performed with MusicSatoshi Honda, Japan

UP–03.163Intravesical Intramuscular Botulinumtoxin-A-Injection (IIB-A-I) in Patients with Idiopathic and Neurogenic Detrusor Overactivity: 7 Years of ApplicationChristoph Lang, Germany



WEDNESDAYOctober 19

UP–03.164Long-Term Urodynamic Evaluation in Patients Treated with Transobturator Vaginal Tape (TVT-O) for Urinary IncontinenceMariarita Salvitti, Italy

UP–03.165Urinary Incontinence and Erectile Dysfunction Post-Prostatectomy: Simultaneous or Delayed Surgical Correction?Carlo Luigi Augusto Negro, UK

UP–03.166A Classical Bulking Agent: GAX Collagen: A 10–Year Single Centre ExperienceCristian Persu, Romania

UP–03.167Effectiveness of Biofeedback Training with EXTT-101™ in Female Stress Urinary IncontinenceChong Koo Sul, South Korea

UP–03.168Long-Term Follow-Up of Argus T® (Adjustable Transobturator Sling) for the Treatment of Post-Radical Prostatectomy Urinary IncontinenceFlavio Trigo Rocha, Argentina

UP–03.169Preserved Micturition in Parkinson Patients Treated with Botulinum Toxin for Neurogenic Bladder DysfunctionStephanie Knüpfer, Germany

UP–03.170The Effects of Pelvic Floor Muscle Targeted Pilates Versus Regular Aerobic Exercise on Urinary IncontinenceHaluk Kulaksizoglu, Turkey

UP–03.171Efficacy and Safety of Onabotulinumtoxin A in Patients with Neurogenic Detrusor Overactivity: Pooled Analysis from Two Phase 3 TrialsKarl-Dietrich Sievert, Germany

UP–03.172Pharmacotherapy with Donepezil for Voiding Dysfunction in Down Syndrome PatientsMitsuru Noguchi, Japan

UP–03.173Correlation Between the Overactive Bladder Questionnaire (OAB-Q) and Urodynamic Data of Parkinson’s Disease Patients Affected By Neurogenic Detrusor Overactivity During Antimuscarinic TreatmentAntonio Luigi Pastore, Italy

UP–03.174Sacral Neuromodulation for Urinary and Bowel Control: Indications and First ResultsSilvia Salm, Germany

UP–03.175Granulocyte Macrophage Colony-Stimulating Factor Promotes Early Functional Changes of the Neurogenic Bladder after Compression-Induced Spinal Cord Injury in Awake Sprague-Dawley RatsSang Min Yoon, South Korea


BERLIN SIU 2011 163

WEDNESDAYOctober 19

UP–03.176Suburethral Bone-Screwed Sling in Male Incontinence: Technique and ExperienceAlexander Andrusco, Chile

UP–03.177Minimally Invasive Surgical Treatment of Complex Genital Prolapse in Elderly Women: Impact on Quality of LifeCristian Surcel, Romania

UP–03.178Prognostic Factors for a Successful Therapy of Male Stress Incontinence with the ProACT SystemChristoph Briel, Germany

UP–03.179Effects of Solifenacin on Detrusor Function in Chinese Patients with Symptomatic Overactive BladderYan Chen, China

UP–03.180The Self Anchoring Adjustable Transobturator Male System (ATOMS®) in the Treatment of Stress Urinary Incontinence in Men: A Retrospective Multicenter Study of 99 PatientsKatja Fischereder, Austria

UP–03.181Discrepancy Between Subjective and Objective Outcome of Surgery for Postprostatectomy Incontinence: Do We Need Multiple Outcome Assessments?Henriette Veiby Holm, Norway

UP–03.183The Association Between Urinary Incontinence, Low Back Pain, and RadiculopathyHulagu Kaptan, Turkey

UP–03.184The Prevalence of Incontinence and Overactive Bladder Symptoms Among Randomly Sampled Non-Elderly Female Population and the General Knowledge About Female Urinary Dysfunction in the Female CommunityHaluk Kulaksizoglu, Turkey

UP–03.185Laparoscopic Artificial Urinary Sphincter for Female Stress Urinary Incontinence: Single Center Experience with 39 CasesTito Leitão, Portugal

UP–03.186A Tertiary Experience of Male Bulbar Urethral Closure in Neuropathic and Non-Neuropathic PatientsAidan Noon, UK

UP–03.187Effect of Complete Bladder Neck Preservation on Oncological Outcome, Continence and QOL: A Randomised Controlled TrialJoanne Nyarangi-Dix, Germany

UP–03.188Timing of Repeat Intravesical Botulinum Toxin A Injections for Idiopathic Detrusor Overactivity: Patients’ PerspectivesNiyukta Thakare, UK



WEDNESDAYOctober 19

UP–03.189Do Patients Prefer Being Taught Intermittent Self-Catheterisation Pre-Operatively Before Intravesical Botulinum Toxin A Injections?Niyukta Thakare, UK

UP–03.190Adverse Effects of Tolterodine Tartrate and Solifenacin Succinate on the Central Nervous System in ChildrenMasayuki Tsugaya, Japan

UP–03.191Clinical Experience of Interstitial Cystitis Treated with HydrodistensionYasuyo Yamamoto, Japan

UP–03.192Tibial Nerve Stimulation in Women with Non-Neurogenic Lower Urinary Tract DysfunctionEmin Aydur, Turkey

UP–03.193Surgical Treatment of Stress Urinary Incontinence with the ATOMS® System: One-Year Single Centre ExperienceChristian Martenstein, Germany

UP–03.194Emerging Urological Phenomena in Malaysia? Ketamine-Induced CystitisKeng Lim Ng, Malaysia

UP–03.195Correlation of Urinary Nerve Growth Factor Level with the Response of Antimuscarinic Therapy in Patients with Overactive BladderTeruhiko Yokoyama, Japan

UP–03.196Drug-Taking History in Patients with Refractory Storage SymptomsEmin Aydur, Turkey

UP–03.197Early Clinical Outcome of Fesoterodine 4 Mg Treatment on 304 Patients with Overactive BladderWoo Suk Choi, South Korea

UP–03.198The GnRH-Receptor Antagonist Degarelix Reduces Urodynamic Signs of Detrusor Overactivity in Awake Female RatsGiorgio Gandaglia, Italy

UP–03.199Long-Term Results of Anticholinergic Agents for the Treatment of OAB by Real-Life Clinical PracticeNaoki Itoh, Japan

UP–03.200Brain-Derived Neurotrophic Factor: A New Potential Biomarker of Overactive Bladder SyndromeTiago Lopes, Portugal

UP–03.201Role of the Addition of Trospium Chloride to the Treatment of Patients with Both Low Urinary Tract Symptoms and Overactive BladderHasan Soydan, Turkey

UP–03.202The Efficacy and Safety of Propiverine Hydrochloride in Patients with Overactive Bladder Symptoms Who Responded Poorly to Previous Anticholinergic AgentsMasumori Naoya, Japan


BERLIN SIU 2011 165

WEDNESDAYOctober 19

UP–03.203Role of Myosin Light Chain Kinase and Rho Kinase in Carbachol-Induced Contractions of Human Detrusor Smooth MuscleChris Protzel, Germany

UP–03.204A Flexible Dose Transdermal Oxybutynin Gel for the Treatment of Overactive Bladder: Phase III ResultsDavid Staskin, USA

UP–03.205Nursing Approach to Potential Overactive Bladder Patients: A Prospective StudyKatsuki Tsuchiyama, Japan

UP–03.206Comparison of Two Different Antimuscarinics, Imidafenacin and Solifenacin for Treatment of Overactive Bladder: A Prospective Randomized Controlled StudyAya Ohbatake, Japan

UP–03.207Compensation Mechanisms of the Bladder in Bladder Outlet Obstruction by Concentric and Dilatative VesicomyopathiesSaladin Alloussi, Germany

UP–03.208Non-Invasive Urodynamics: Our ExperienceBarbara Cristina Gentile, Italy

UP–03.211Usefulness of Bladder Capacity and Postvoiding Residual Volume as a Predictor of DHIC in Stroke PatientsHyung-Lae Lee, South Korea

UP–03.212Sacral Deafferentation in Neurogenic Detrusor Overactivity in Spinal Cord Injury and Implant Driven MicturitionJohannes Kutzenberger, Germany

UP–03.213Better Modalities of Catheter Preservation Method Regarding Urinary Tract Infection of the Elderly Person from Clean Intermittent CatheterizationHitoshi Oh-Oka, Japan

UP–03.214The Place of the Ice Water Test During the Urodynamic EvaluationCristian Persu, Romania

UP–03.215Pressure Transmission Through Ureteric Stents: A Novel In-Vivo Human StudyWael Sameh, Egypt

UP–03.216Should Urinalysis Be Routinely Performed Prior To Urodynamic Studies?Niyukta Thakare, UK



BERLIN SIU 2011 167

THURSDAYOctober 20

0800–1200

PLENARY 4Chairs: Mahesh Desai, India

Luc Valiquette, Canada

Room: Hall 10800–0810Clinical Pearls: The Past Year in Review: Stones/EndourologyMatthew Bultitude, UK

0810–0830PAUSA Lecture: Bladder Carcinoma in Africa: Epidemiology and TreatmentIsmail Khalaf, Egypt

0830–0850Evidence-Based Medicine and Its Use in Everyday PracticeJohn M. Fitzpatrick, Ireland

0850–0905Meeting the Challenges of Evidence-Based Prostate Cancer: Early Detection and TreatmentPeter Carroll, USA

0905–1110New Findings/Recommendations from the 2011 International Consultation on Urologic Diseases (ICUD) on Prostate Cancer, Part IIChairs: Gerald Andriole, USA

Manfred P. Wirth, Germany

0905–0920PreventionTimothy Wilt, USA

0920-0940Epidemiology and Natural History of Prostate CancerSeth Strope, USA

0940-0955Biomarker Identification of Active Surveillance CandidatesJack Schalken, The Netherlands

0955-1010Low-Risk Localized PCAPeter Carroll, USA

1010-1025High-Risk Localized PCAWilliam Aronson, USA

1025-1050 Questions and Discussion1050–1110Special Lecture: The Cost of Prostate Cancer HealthcareStephen Riggs, USA

1110–1130UAA Lecture: Holmium Laser Enucleation of the Prostate (HoLEP): Evolution of a Surgical TechniquePeter Gilling, New Zealand

1130–1135FarewellJoachim W. Thüroff, Germany

1135–1145Invitation to SIU 2012 in FukuokaMahesh Desai, IndiaSeiji Naito, Japan



BERLIN SIU 2011 169

READ-BY-TITLE ABSTRACTS


Given space and time constraints, these abstracts could not be scheduled for presentation. Abstracts are listed in order of corresponding author’s last name.

Sexual DysfunctionYasser Abbass, QatarThe Value of Color Doppler Ultrasound (Twinkle Sign) in the Diagnosis of Urinary StonesMohamed Abdallah, EgyptPSA and Prostate CancerAbdalla Abdel Rahman, SudanLaparoscopic Pyeloplasty Initial ExperienceElemam Abdelbaset, EgyptTrends of Genito-Urinary Cancer Among SaudisMohammed Abomelha, Saudi ArabiaA Randomized Clinical Trial of Rectal Antisepsis Prior to Transrectal Ultrasound-Guided Prostate BiopsyZeid AbuGhosh, JordanA Very Rare Congenital Anomaly: An Interesting Case of Bladder and Urethral Agenesis with Solitary Kidney and Ectopic UreterNeeraj Agarwal, IndiaRelationship of Seminal Plasma, Spermatic Vein and Peripheral Blood Levels of IL–6 and TNF-alpha with Semen Parameters in Patients with VaricoceleYadollah Ahmadi AsrBadr, IranThe Effect of Botulinum Toxin A in Treatment of Painful Bladder SyndromeHassan Ahmadnia, Iran

Damaged Extracellular Matrix Alters Localization of DNA Methyltransferase Activity in Bladder Smooth Muscle CellsKaren Aitken, CanadaSexual Problems of Women with Spinal Cord InjuryR. Yavuz Akman, TurkeySexual Activity and Sexual Dysfunction in Men with Spinal Cord InjuriesR. Yavuz Akman, TurkeySerum Zinc Level in Benign Prostatic Hyperplasia in Relation with the Clinical Manifestation IndexHayder Ismael Al Amery, IraqSurgical Treatment of Phimosis of the Clitoris in Woman Presenting Sexual Dysfunction: A Case ReportGiovanni Alei, ItalyInitial Experience of Photodynamic Therapy in Prostate Cancer PatientsBoris Alekseev, RussiaLong-Term Outcome of Randomized Trial Between Cryoablation and External Beam Therapy for Locally Advanced Prostate Cancer (T2c-T3b)Ali Al-Zahrani, CanadaPartial Nephrectomy for Tumors Over 4 cms: Clinical Outcomes and Assesment of Complication Using a Graded ScoreAli Al-Zahrani, Canada




Radical Nephrectomy in Patients with Inferior Vena Cava and Renal Vein Involvement: Clinical Outcomes and Assessment of Complications Using a Graded ScoreAli Al-Zahrani, CanadaRole of Serum and Urinary Carbohydrate Antigen 19–9 in Diagnosis and Follow-Up of Patients with Ureteral StoneErfan Amini ,IranSexual Function after Non-Nerve-Sparing Radical Cystoprostatectomy: A Comparison between Ileal Conduit and Ileal Orthotopic NeobladderErfan Amini, IranPercutaneous Removal of Kidney Sludge Mimicking Complete Bilateral Renal Staghorn StoneMohsen Amjadi, IranThe Influence of Incidentally Found Prostate Cancer on Overall Survival After Cystoprostatectomy at the Institute of Oncology of Vilnius UniversityMarius Anglickis, LithuaniaMultidisciplinary Approach in Urinary Bladder Salvage ManagementTariq Ansari, PakistanLong-Time Follow-Up of Hypospadias Treatment in Semnan Educational HospitalDavood Arab, IranRetrocaval Ureter: Experience with 3 PatientsErsan Arda, TurkeyDo Ureteral Catheterization Procedures Affect Sexual Functions in Patients? A Controlled Prospective StudyErsan Arda, TurkeyQuality of Life Outcomes Following Treatment for Localized and Metastatic Prostate Cancer Patients and Optimal Time for the QuestionnaireErsan Arda, Turkey

How to Improve the Efficacy of Extracorporeal Shock Waves: Application of Focal Energy CoefficientMiguel Angel Arrabal-Polo, SpainThe Role of Intraprostatic Inflammation in the Acute Urinary RetentionSeyed Alaeddin Asgari, IranSevere Complications of Circumcision: An Analysis of 704 CasesSeyed Alaeddin Asgari, IranThe Less Invasive Open PyeloplastySeyed Alaeddin Asgari, IranTreatment of Renal Colic with Papaverine Hydrochloride: A Prospective Double Blind Randomized StudySeyed Alaeddin Asgari, IranSutureless CircumcisionSeyed Alaeddin Asgari, Iran Detrusor Myomectomy: Long-Term Functional ResultsM Z Aslam, UKCombining Endoscopy with Laparascopic Pyeloplasty: Limitations and Challenges of the ProcedureAkram Assem, EgyptThe Role of Urinalysis in Women with Habit of Micturition Postponement and Non-Neurogenic LUTSEmin Aydur, TurkeyEffect of Long-Acting Testosterone Injections for Treatment of Hypogonadism After Brachytherapy for Prostate CancerFelipe Balbontin, ChileCystitis Cystica Masquerading as a Bladder TumorShivadeo Bapat, IndiaA Case of Ureteric Fibroepithelial Polyp with Impacted CalculusShivadeo Bapat, India


BERLIN SIU 2011 171


A Case of Migrated Intra Uterine Contraceptive Device into the Urinary BladderShivadeo Bapat, IndiaA Study of Two Cases of Vesical PheochromocytomaShivadeo Bapat, IndiaThe Most Important Metabolic Risk Factors in Recurrent Urinary Stone Formers in IranAbbas Basiri, IranBrain Metastasis After Radical Cystectomy for Invasive Bladder TumorCatalin Baston, RomaniaProstate Cancer with Neuroendocrine Differentiation: Case PresentationCatalin Baston, RomaniaPrimary Scrotal MelanomaCatalin Baston, RomaniaA Rare Case of Transitional Cell Carcinoma of the Bladder Presenting as Inguinal Lymph Node Metastasis OnlyVikram Batra, IndiaExtended Core TRUS Biopsy: Impact on Preoperative Grading of Adenocarcinoma ProstateAmit Bhattu, IndiaThe Role of Fascin in the Migration and Invasiveness of Prostate CarcinomaJian-Bin Bi, ChinaThe pT1 High Grade Bladder Tumor: Early Versus Deferred CystectomyJulien Branchereau, FranceRight Living Donor Nephrectomy: Is Laparoscopy Possible?Julien Branchereau, France

Incidence of Delirium in Elderly Patients Undergoing Urologic Surgery: The Role of Comprehensive Geriatric Assessment (CGA) to Define a High-Risk Population for DeliriumMaurizio Brausi, ItalyArterio-Venous Fistula with Pseudoaneurysm of Renal Artery: A Rare Complication of Invasive Interventions on the KidneyJan Breza, Slovak RepublicThe First Experiences of Our Centre of Robotic Surgery in Usti Nad Labem, Czech Republic with Robotic Partial NephrectomyMarek Broul, Czech RepublicThree Years’ Experience with HoLEP (Holmium Laser Enucleation of Prostate) with AURIGA XL in BOO: A Well-Established Procedure Especially for a Small Urologic DepartmentJuergen R. Bubeck, GermanyTachypnea as Useful Indicator to Mutiple Organ Dysfunction Syndrome Prevention in Urologic PatientsSorin Bulgariu, RomaniaCharacterization of Single Nucleotide Polymorphisms Within the MMP–1 Promoter Region in Women with and without Pelvic Organ ProlapseLysanne Campeau, USAZinner’s Syndrome: Seminal Vesicle Cyst Associated with Renal AgenesisJuan Pablo Caprini, ArgentinaSalvage Robot Assisted Radical Prostatectomy after Radiation Failure and Focal CryotherapySanket Chauhan, USAEarly Retrograde Nerve Preservation During Robot-Assisted Radical Prostatectomy Improves Potency OutcomesSanket Chauhan, USA




Robotic-Assisted Laparoscopic Dismembered Pyeloplasty (RALDP) for Primary and Secondary Ureteropelvic Junction Obstruction: A Multi-Institutional ExperienceSanket Chauhan, USAIncremental Nerve Preservation During Robot Assisted Radical ProstatectomySanket Chauhan, USARobot Assisted Bladder DiverticulectomySanket Chauhan, USARobot Assisted Simple Prostatectomy: Technique of Vesico-Uretheral AnastomosisSanket Chauhan, USASalvage Robot Assisted Radical Prostatectomy: Multi-institutional OutcomesSanket Chauhan, USASalvage Robot Assisted Radical Prostatectomy: Single Surgeon ExperienceSanket Chauhan, USASyndrome of Endogenous Intoxication in Men with Prostate TumoursTeimuraz Chigogidze, GeorgiaNeoadjuvant Chemotherapy for Locally Advanced and/or Regionally Metastatic Bladder Cancer in ChineseChak Lam Cho, Hong KongLAN in Staghorn CalculiDae Yeon Cho, South KoreaThe Influences of Urinary Stone Components on Outcomes of Electrohydraulic LithotripsySung Tae Cho, South KoreaThe After Effect of Penile Vaselinoma in Case with a Penile FractureSung Tae Cho, South Korea

Comparison of Clinical Results Between TURP and Holmium Laser Enucleation of the Prostate (HoLEP) Based on the Initial Experience on Patients with Obstructive BPHSeong Choi, South KoreaSerum Testosterone Levels Significantly Correlate with Nocturia in Men Aged 40–79 YearsLiao ChunHou, TaiwanThe “Paradoxal” Backwards Movement of Lumbar Ureteral Stones or Fragments after Extracorporeal Shockwave LithotripsyCatalin Ciuta, RomaniaThe Treatment of Hypospadias at the Department of Urology, University of the Free State, South Africa: A Review of 88 CasesFrederik Claassen, South AfricaHolmium Laser Enucleation of the Prostate for BPH: Our Initial ExperienceDorin Claici, RomaniaRadical Perineal Prostatectomy: An Outdated Procedure?Evi Comploj, ItalyEffectiveness and Cost Analysis of Different Methods of Anti-Refluxive Operations in VUR Grade 3 in a Single InstitutionEvi Comploj, ItalyCan DNA Repair and Apoptosis Predict the Hormone Sensitivity/Insensitivity of Prostate Cancer?Alin Adrian Cumpanas, RomaniaPseudotumor of the Urinary Bladder: Not to Be Confused with CancerYoussef Dakkak, Morocco


BERLIN SIU 2011 173


Treatment of Proximal Ureteral Stones by Ureteroscopy: Is this a Good Solution?Youssef Dakkak, MoroccoResults of Percutaneous Nephrolithotripsy (PCNL) of Upper Calices Stone with Subcostal AccessMohammad Reza Darabi Mahboub, IranPCNL in Single-Kidney Patients: Ten Years' ExperienceMohammad Reza Darabi Mahboub, IranSalvage Residual Tumour Resection for NSGCT: Presentation of an Extreme IndicationPaolo De Stefanis, ItalyBone Resorption and Prostate Cancer Metastatic DiseaseYuri Demidko, RussiaArtificial Urinary Sphincter AMS 800 After Failed First Anti-Incontinence Procedures for Post-Prostatectomy Stress Urinary IncontinenceAndrea Di Stasio, ItalyMonitored Anesthesia Care or Subarachnoid Anesthesia in Trans-Obturator Midurethral Sling Procedures? A Randomized Controlled TrialAndrea Di Stasio, ItalyHolmium Enucleation of the Prostate in Treating Patients with BPHAlim Dymov, RussiaLikelihood of Pathologic Stage T0 Urothelial Carcinoma at the Time of Radical CystectomyJohn Eifler, USADoes Capsular Perforation During Transurethral Resection of the Prostate Cause Erectile Dysfunction?Ahmed El-Feel, Egypt

A Mouse Model of Type II Diabetes Induces Erectile DysfunctionRiyad Ellati, USATension-Free Vaginal Tape Versus Rectus Fascial Sling for the Management of Female Genuine Stress Urinary Incontinence: A Comparative Study with 2 Years’ Follow-UpTarek El-Leithy, EgyptEffectiveness of a Single Immediate Mitomycin-C Instillation in Patients with Low-Risk Superficial Bladder Cancer: Short- and Long-Term Follow-UpTarek El-Leithy, EgyptLong Fibroepithelial Polyp as a Cause of Ureteral ObstructionAlireza Farshi Haghro, IranOutcome of Prostate Biopsy in Men Younger than 50 YearsLuis Figueiredo, PortugalCollision Kidney Tumor: Syncronous Ipsilateral Renal Cell Carcinoma and Renal Pelvic Urothelial Carcinoma with Liver MetastasisZoran Filipovic, SerbiaFailure to Perform a Testicular Biopsy Prior to Surgical Correction in Obstructive Azoospermia Results in Unnecessary Operative InterventionsM.A. Fischer, CanadaPartial Nephrectomy Thorough a Small Incision with Renal Parenchymal ClampingAkitoshi Fukatsu, JapanSolo Ultrasonography-Guided Percutanous Nephrolithotomy for Single Stone PelvisWael Gamal, Egypt




Stentless Pediatric Ureteroscopic Holmium: YAG Laser Stone Disintegration: Is Gravels Retrieval an Issue?Wael Gamal, EgyptModified N-Shaped Ileal Neobladder After Radical CystectomyWael Gamal, EgyptPenile Fracture: Long-Term Results of Surgical and Conservative ManagementWael Gamal, EgyptTubularized Incised-Plate (TIP) Repair Augmented by Spongioplasty for Distal and Midpenile HypospadiasWael Gamal, EgyptUreteroscopy with Two Guide Wires: A New TechniqueWael Gamal, EgyptDevelopment of Magnetic Hyperthermia Using Titanium Capsules for Brachytherapy to Treat Prostate CancerTatsuo Gondo, JapanRare Cause of Hematurea: Oopharovesical FistulaHari Govind, IndiaDistal Ureteral Diverticulum Presenting as a Large Pelvic CystArvind Goyal, IndiaFeasibility of Laparoendoscopic Single-Site Radical Nephrectomy for Renal Cell Cancer in Patients with Increased Comorbidities and Previous Abdominal Surgery: Evaluation of Perioperative Results and Short-Term OutcomesFrancesco Greco, GermanyCharacterization of Attenuating Effects of Intravesical Trospium Chloride on the Cholinergic Stimulation of Isolated Whole Pig Bladders: A Pharmacodynamic Model to Design a Intravesical Drug Delivery Device?Joachim Grosse, Germany

Autotransplantation After Severe Avulsion Injury of the Ureter Following UreteroscopyAnil Gulia, IndiaManagement of Chylous Ascites After NephrectomyAnil Gulia, IndiaManagement of Failed UrethroplastyAnil Gulia, IndiaAnalysis of 1200 Cases of Laparoscopic Donor Nephrectomy from a Developing CountryAnil Gulia, IndiaRIRS Before Donor NephrectomyAnil Gulia, IndiaGelatin Matrix Thrombin Sealant (Floseal) Injection to Salvage Refractory Post Renal Biopsy BleedAnil Gulia, IndiaManagement of Iatrogenic Ureteric InjuresBakhman Guliev, RussiaRupture of Continent Urinary ReservoirsBakhman Guliev, RussiaPercutaneous Nephroureterolithtomy for Large Proximal Ureteral StonesBakhman Guliev, RussiaUrodynamic Studies of Orthotopic Neobladder: Updated Experience in Different GroupsBakhman Guliev, RussiaBilateral Simultaneous Percutaneous NephrolithotomyBakhman Guliev, RussiaInterest of the Treatment of Varicocele in Infertile and Azoospermic MenMourad Hadj Slimen, TunisiaPeculiarities of the Association Between Bladder Cancers and Upper Urinary Tract CancerMourad Hadj Slimen, Tunisia


BERLIN SIU 2011 175


Paratesticular Tumors: Report of 12 CasesAbdelaziz Hamdoune, MoroccoTumors of the Urinary Tract: Report of 8 CasesAbdelaziz Hamdoune, MoroccoCombination Chemotherapy with Paclitaxel Plus Gemcitabine in Patients with Metastatic Bladder Cancer, Ureteral and Renal Pelvic Cancer as Second-Line TreatmentKouji Harimoto, JapanAngiotensin-Converting-Enzyme Gene Polymorphism and the Risk of Prostate Cancer in Iranian PatientsMandana Hasanzad, IranEvaluation of a New Technique for Cutaneous Continent Urinary Diversion: The Embedded Nipple TechniqueMohamed Mohie Eldin Hashad, EgyptIleal Cystoplasty According to UsIsa Haxhiu, KosovoDWI- MRI: Single Non-Invasive MRI Technique for Prostate Cancer DiagnosisIhab Hekal, Saudi ArabiaSurgical Management of Undescended Testes in AdultsChris F. Heyns, South AfricaLaparoscopic Partial Nephrectomy: Experience in 118 CasesFumiya Hongo, JapanNon-Disease-Related Prognostic Factors in Locally Advanced Prostate Cancer: A Multi-Center ExperienceChao-Yu Hsu, BelgiumNeoadjuvant Hormonal Treatment Did Not Improve the Outcome in Locally Advanced Prostate Cancer After Radical Prostatectomy: A Multi-Center ExperienceChao-Yu Hsu, Belgium

Huge Vesicle Stones Induced by a Straw: A Case ReportChien-Ming Huang, TaiwanPenis Augmentation by Oil Injection Inducing Foreign Body Granuloma and Dyspareunia: A Case ReportChien-Ming Huang, TaiwanEosinophilic Cystitis Simulating Invasive Bladder CancerChien-Ming Huang, TaiwanA Novel Renal Stones Phantom for Extracorporeal Shock Wave Lithotripsy and Ultrasound StudyChien-Ming Huang, TaiwanAutonomic Dysreflexia during Urodynamic Examinations in Patients with Supra-sacral Spinal Cord InjuryYu-Hui Huang, TaiwanFailed Zuidex Injection for Female Stress Incontinence: What Next?Sarah Huf, United KingdomSerum C-Reactive Protein Is Associated with Storage But Not with Empty Symptoms in Men with Lower Urinary Tract SymptomsShun-Fa Hung, TaiwanEvaluation of the Role of Second TUR for Transurethral Resection of Bladder Tumor in One Piece (TURBO)Hiroshi Ikeda, JapanTUL for Right Upper Ureteral Stone in a Retrocaval Ureter without Surgical CorrectionYoshiyuki Ishiura, JapanOutcomes of Laparoscopic Implementation Program with Successive Addition of Surgeons in a Secondary Hospital: After the First 160 Cases of Laparoscopic Radical ProstatectomyEmilio Izquierdo Morejón, Spain




Active Surveillance in a Community Practice from 2007 to 2011Miles Jackson, CanadaThe Effect of Korean Red Ginseng Extract on Relaxation Response on the Animal Bladder and Prostatic Urethra: In Vitro and In Vivo StudyHoon Ah Jang, KoreaPrognostic Factors for Persistent Storage Symptoms Following Surgical Treatment in Patients with Benign Prostatic ObstructionHoon Ah Jang, KoreaBladder Cancer and Human Papillomavirus Infection: A Meta-Analysis of the Relationship Between ThemAntonio Jimenez-Pacheco, SpainRare Case of Hematuria in a Female PatientAshish Jindal, IndiaOncological Outcomes After Radical Prostatectomy in Locally Advanced Prostate Cancer: A Multi-Center ExperienceSteven Joniau, BelgiumComparative Analysis of Robotic-Assisted Laparoscopic Radical Cystectomy (RARC) and Hand-Assisted Laparoscopic Radical Cystectomy (HALRC) With Extracorporeal Urinary DiversionSeil Jung, South KoreaCarcinoma Virilisation of the Suprarenal GlandMekeme Mekeme Junior Barthelemy, CameroonEtiologies and Management of Hydronephrosis of a Child: Experiment of the General Hospital of YaoundeMekeme Mekeme Junior Barthelemy CameroonCalcium Sensitization by Protein Kinase C Pathway in Contraction of Human and Guinea-Pig Detrusor Smooth Muscle Following Partial Bladder Outlet ObstructionShunichi Kajioka, Japan

The Role of Gap Junction Inhibitor and Tyrosine Kinase Inhibitor in Carbachol Induced Oscillatory and Tonic Contraction in Isolated Pig Detrusor Smooth MuscleShunichi Kajioka, JapanSurgical Treatment for Synchronous Renal Cell CarcinomaBoris Kajmakovic, SerbiaImpact of LUTS/BPH Treatment by Tamsulosin and Solifenacin Combination Therapy on Erectile FunctionSungchul Kam, South KoreaEffect of Tribulus Terrestris Extract in the Corpoal Smooth Muscle of the RabbitSungchul Kam, South KoreaTesticular Catch Up Following Adolescent Varicocele RepairMohammed Kamal, EgyptDiagnostic Value of Helical CT on Stone CompositionOsman Karabacak, TurkeyUrodynamic Findings in Young Men with Chronic Lower Urinary Tract SymptomsHosein Karami, IranUrodynamic Findings in Children with High Grade Vesicoureteral RefluxHosein Karami, Iran Ureterorenoscopy Made Easy with Perioperative Hyocine ButylbromideAnurag Khaitan, IndiaRare Bladder Tumors: Diagnostic DilemmaSudhir Khanna, IndiaRenal Carbuncle with Renal Vein and Inferior Vena Cava Thrombosis: Managed Conservatively by Novel TechniqueSudhir Khanna, India


BERLIN SIU 2011 177


Complications of Open Living Donor Nephrectomy: A Review of 10-Years' ExperienceDinyar Khazaeli, IranPrevalence and Management of Complications of Ureteroscopy: A 7-Year Experience with Introduction of a New Maneuver for Prevention of Ureteral AvulsionDinyar Khazaeli, IranOrthotopic Continent Diversion With Only One Urethral Catheter No Routine Pouch Irrigation With Long-Acting SandostatinMohannad Hatef Khorrami, Iran How Can We Safely Use Ultrasonic Laparoscopic Coagulating Shears?Jae-Sik Kim, South KoreaA Case of Bilateral Ureteral EndometriosisJu Sung Kim, South KoreaThe Importance of Cancer Volume and Percentage of Cancerous Cells as Predictors of BCR of Pathological T2, T3 PCSea Young Kim, South KoreaThe Effects of TOT for Patients of Neuropathic Bladder Including Stress Incontinence: The Results of 5–Year Follow-UpSea Young Kim, South KoreaProstate Cancer Location Concordance Analysis Between Prostate Biopsies and Radical Prostatectomy SpecimensSea Young Kim, South KoreaClinical Efficacy of Tape Cutting as a Treatment for Complication in TOTSea Young Kim, South KoreaInitial Reports for Repair of Bladder Injury Using Laparoendoscopic Single Site Surgery in Comparison to Conventional Laparoscopic RepairTae Hyo Kim, South Korea

The Effects of Various Stressful Conditions on Erection and Manifestation of Oxytocin Positive Neuron of Apomorphine in MiceYoung-Joo Kim South KoreaA New Method of Ureterolysis with Seprafilm Wrap for Retroperitoneal Fibrosis: A Report of Two CasesKyosuke Kimura, JapanNerve Sparing Procedure Improves Early Return of Continence After Robotic-Assisted Radical ProstatectomyYoung Hwii Ko, South KoreaNeoadjuvant Gemcitabine Plus Cisplatin Followed by Radical Cystectomy for cT3 Bladder CancerKiichiro Kodaira, JapanCausative Role of Sexually Transmitted Infections (STI) in Development of Chronic CystitisYulia Kondratyeva, RussiaEndoscopic Management with Holmium Laser of Sub Urethral Tape after Bladder Neck ErosionCharalampos Konstantinidis, GreeceEndoscopic Intradetrusoreal Botulinum Toxin Type A Injection for the Management of Neurogenic Detrusor Overactivity: Technique DemonstrationCharalampos Konstantinidis, GreeceLocal Relapse in Ileum-Neobladder: 2 Cases and a Literature SurveyXaver Krah, GermanyProlonged Postoperative Ileus: Rare, But Do Not Underestimate Complication after Radical ProstatectomyXaver Krah, GermanyMalignant Testicular Sex Cord Stromal TumorXaver Krah, Germany




What’s After Gemcitabin and Platin for Metastatic Transitional Cell CancerXaver Krah, GermanypT0 at Radical Cystectomy: A Review of 14 Studies Encompassing 9623 PatientsPeter Kronenberg, PortugalGigantic Nephro-Thoracic Abscess: A Urologic ChallengePeter Kronenberg, PortugalThree-Dimensional 14-Core Extended Prostate Biopsy Under Local AnesthesiaYuichi Kubo, JapanSexual Health in SiberiansEkaterina Kulchavenya, RussiaUrethral Steinstrasse with Fistula and StrictureSantosh Kumar, IndiaLaparoscopic Resection of Bilateral Large Adrenal GanglioneuromaSantosh Kumar, IndiaEmphysematous Pyelonephritis Following Embolisation of Renal Angiomyolipoma in a Patient Presenting with Massive HematuriaSantosh Kumar, IndiaThe Efficacy of Oral Bisphosphonates for Osteoporosis Induced by Androgen Deprivation Therapy for Localized Prostate CancerIsao Kuroda, JapanPitfalls of Endorectal Magnetic Resonance Imaging in the Preoperative Staging of Pelvic Lymph Nodes in Patients with Prostate CancerApostolos P. Labanaris, GermanyTestis Lymphoma and Spermatic Cord Liposarcoma: A Unique CoexistenceRicardo Leao, Portugal

Causes of Obstructive Azoospermia and Outcome of Microsurgical ReconstructionJoong Shik Lee, South KoreaThe Inverse Technique Can Improve the Safety and Efficacy of the Morcellation in HoLEP for BPHSu Hyung Lee, South KoreaTemsirolimus Treatment in Advanced Renal Cell CarcinomaIvan Levakov, SerbiaTransurethral Intravesical Mesh Removal: Like a Natural Orifice Laparoscopic Single-Site ProcedureMohammed Lezrek, MoroccoIncreased Penile Expression of Transforming Growth Factor and Elevated Systemic Oxidative Stress in Rabbits with Chronic Partial Bladder Outlet ObstructionWei Yu Lin, TaiwanEvaluation of Second-Look Transurethral Resection in Restaging of Patients with Non-Muscle-Invasive-Invasive Bladder CancerMichele Lodde, ItalyPrevalence of Metabolic Syndrome and Prostate CancerDaniel López-Laur, ArgentinaLaparoscopic Nephrectomy: Our Cases and Evaluation of the Learning CurveGiuseppe Lotrecchiano, ItalyUrodynamic Analysis of Voiding Symptoms in Female PatientsJi Lu, ChinaThe Clinical Significance of Bladder Contractility Index in Treating BPHJi Lu, China


BERLIN SIU 2011 179


The Assessment of Transurethral Injection of Botulinum Toxin-A Effect on BPH Refractory to Current Medical Treatment in Poor Surgical CandidatesAli Hamidi Madani, IranPercutaneous Nephrolithotomy in Children by Using Adult Size Instruments: 3 Years' ExperienceRobab Maghsoudi, IranOutcomes of Percutaneous Nephrolithotomy (PCNL) in Patients with Chronic Renal InsufficiencyRobab Maghsoudi, IranComparison of Outcomes of Single-Tract Percutaneous Nephrolithotomy (PCNL) with Multi-Tract PCNL in Patients with Staghorn CalculiRobab Maghsoudi, IranEarly and Late Levels of Prostate Specific Antigen and Testosterone After Renal TransplantReza Mahdavi Zafarghandi, IranThe Role of Transurethral Resection of Prostate in Detecting Prostate Cancer in Patients with Previously Negative Biopsy, Elevated PSA Levels and Positive Lower Urinary Tract SymptomsReza Mahdavi Zafarghandi, IranThe Prevalence and Incidence of Male Infertility in the Russian Federation: A Statistical Review Covering 2006–2009Vigen Malkhasyan, RussiaThe Prevalence and Incidence of, and Mortality for, Urolithiasis in the Russian Federation: A Statistical Review Covering 2006–2009Vigen Malkhasyan, RussiaA Novel Method to Diagnosticate Vasculogenic Erectile Dysfunction by Harmonic Analysis of Penile BioimpedanceTigran Markosyan, Russia

Evaluation of Pleural Injuries after Intercostal Access in Percutaneous NephrostolithotomyBehkam Rezaei Mehr, Iran Micturition EMG in the Diagnosis of Recurrent UTIs of Young WomenSilvia Meier-Drioli, AustriaUpper Urinary Tract Transitional Cell Carcinoma: Location Is not Correlated with PrognosisBogomir Milojevic, SerbiaValue of Urine Interleukins 8, 6, 5 and 4 Levels at Patients with Bladder Carcinoma in Diagnosis and Prognosis of the IllnessRadovan Milosevic, SerbiaSimple Lumbar Ectopia of Left Kidney with Normal Rotation and Real Stone: A Case ReportNasser Mogharabian, IranSuccessful Transplantation of a Split Crossed Fused Lump Type Ectopic Kidney into Two Patients with ESRDNasser Mogharabian, IranSynchronous Contralateral Adrenal Metastasis in a Patient with Renal Cell Carcinoma: A Case ReportNasser Mogharabian, IranThe Comparison between Two Groups of Patients Under Operation and Lithotripsy Due to UT Stones from the Aspect of Epidemiologic Parameters During Years 2003-2006 Admitted at Urology Department of I.R HospitalNasser Mogharabian, IranMicrofluidic Based Multiplex qRT-PCR Identifies Diagnostic and Prognostic Microrna Signatures in Sera of Prostate Cancer PatientsFelix Moltzahn, Switzerland




Efficacy of Intraurethral Mitomycin C Hydrogel in Prevention from Anterior Urethral Stricture Recurrence After Internal UrethrotomyMahmoudreza Moradi, IranAdolescent Varicocele: Long-Term Outcome After Inguinal Varicocelectomy with Loupe MagnificationEssam Moursy, EgyptSpinal Anesthesia and Intercostal Access forPercutaneous NephrolithotomySeyed Habibollah Mousavi-Bahar, IranAnalysis of Detrusor Activity According to Type of Cerebrovascular AccidentsWoong Na, South KoreaThe Influence of Urine Cytology on Patient CareAnmar Nassir, Saudi ArabiaSingle Center Deflux ExperienceDurwood Neal, USA237 Shotgun Pellets Cause Erectile Dysfunction without Other Urological InjuryHemant Nemade, United KingdomAntibiotics without Prescription: A Recipe for ResistanceElie Nemr, LebanonMass Screening of Prostate Cancer in Vietnam: Current Status and Our OpinionsTien De Nguyen, VietnamTherapeutic Efficacy of Bipolar Radio Frequency Thermal Treatment for Patients with Chronic ProstatitisJoonhwa Noh, South KoreaThe Distribution of Non-Malignant Conditions in Patients Referred for Prostate BiopsyAlireza Nouri, Iran

Testicular Fine Needle Aspiration versus Testicular Open Biopsy: Comparable Sperm Retrieval Rate in Selected PatientsMohammad Reza Nowroozi, Iran A Novel Method with Soft Coagulation in Partial NephrectomyAtsuhiko Ochi, JapanEvaluation of Urgency-Like Symptom Using Questionnaires in Benign Prostatic Hyperplasia PatientsHitoshi Oh-Oka, JapanIsolation Sites and Antimicrobial Agent Susceptibility of A. baumannii in My HospitalHitoshi Oh-Oka, JapanThe Effects of Diosmin-Hesperidin on Testicular Damage Induced by Varicocele in an Experimental Rat Varicocele ModelTaylan Oksay, TurkeyA New Experimantal Model of Benign Prostate Hyperplasia in the Ventral Prostate of Wistar Rats by Testosterone UndecanoateTaylan Oksay, TurkeyEvaluation of the Ischemia Reperfusion Injury Level by Johnson Tubular Biopsy Score (JTBS) and Apoptosis in the Experimental Model of Testis TorsionTaylan Oksay, TurkeyMeta-Analysis of Impact of Circumcision and Vitamin D on Occurrence of Prostate Cancer: Could They Act by Suppressing Anaerobes Colonising Areas of Prostatic Proliferative Inflammatory AtrophyTim Oliver, United KingdomTransureteroureterostomy: The “Ugly Duckling” in Ureteral Repair?Robert Oomen, The Netherlands


BERLIN SIU 2011 181


Predicitive Factors for Recovery of Erectile Function After Robot-Assisted Radical ProstatectomyMarcelo Orvieto, USASecond Primary Tumors in Urology: A Hospital-Based Survival AnalysisLuís Pacheco-Figueiredo, PortugalLaparoscopic Intrarenal Partial Nephrectomy in a Lower Pole Complex Cystic MassJoan Palou, SpainRetrospective Study of Different Options in the Management of Non-Muscle Invasive Bladder Cancer T1G3: Maintenance BCG Is Here To StayJoan Palou, SpainInverted Papilloma of the Urinary BladderIoannis Panopoulos, GreecePSA Density (PSAD) as a Powerful Predictor of Extracapsular Extension and Positive Surgical Margins in Patients Undergoing Radical Prostatectomy with PSA Levels Less Than 10 ng/mLByung Hun Park, South KoreaComparison of Clinical Efficacy Between Finasteride and Dutasteride as 5–alpha Reductase InhibitorByung Hun Park, South KoreaComparison of Efficacy Between Tamsulosin Versus Tamsulosin Plus Solifenacin for the Management of Chronic Pelvic Pain SyndromeByung Hun Park, South KoreaVarious Findings of Urodynamic Study in Patients with Cerebrovascular AccidentByung Hun Park, South KoreaFollow-Up Results of CyberKnife for the Treatment of Localized Prostate CancerByung Hun Park, South Korea

New Surgical Mentorship, “Hand Holding Teaching Technique” for Shortening the Learning Curve of HoLEPChang Soo Park, South KoreaThe Relationship Between Metabolic Syndrome and Prostate Volume in Men Under 50 in KoreaKyung Seo Park, Korea, SouthClinical Importance of the Microscopic Focus of Prostate Cancer on a Single Sample of a Trans-Rectal 8-Core BiopsyGiandomenico Passavanti, ItalyLarge Obstructed Upper Ureteric Calculi Laparoscopy vs. URSPrashant Pattnaik, IndiaManagement of Urinary Calculi in Patients with Urinary DiversionsPrashant Pattnaik, IndiaClinical Study of Holmium Laser Vaporization of ProstatePrashant Pattnaik, IndiaPCNL in Modified Supine PositionPrashant Pattnaik, IndiaRetrograde Ureterorenoscopy and Endopyelotomy in Patients with UPJ ObstructionPrashant Pattnaik, IndiaOptimizing Use of Antibiotics in Endourology: A Study Based on Population Based Bacterial Surveillance for Limiting Antibiotic Resistance in IndiaPrashant Pattnaik, IndiaLower Calyceal Calculi: SWL vs. PNL/URSPrashant Pattnaik, IndiaManagement of Symptomatic Small Renal Calculi Unsuitable for ESWLPrashant Pattnaik, India




Fractal Analysis of Uroflow CurvesPetros Pavlopoulos, GreeceSonographic and Clinical Features of Simple Intratesticular CystsPetros Pavlopoulos, GreeceSimultaneous Nephron-Sparing Surgery and Caesarian Section for the Treatment of Renal Cell Carcinoma in PregnancyAmbrosi Pertia, GeorgiaNephron-Sparing Surgery for the Treatment of Renal Cell Carcinoma Between 4 and 7 cm in Greatest DimensionAmbrosi Pertia, GeorgiaAn Approach to Microcarcinoma in Extended Transrectal Prostate BiopsyBogdan Nicolae Pietricica, SpainBladder Outlet Obstruction (BOO) After BPH Surgery: Our Experience Using Holmium LaserFrancesco Pisanti, ItalyTreatment of Uretero-Pelvic Stones: Laser Ureteroscopic Lithotripsy and ESWLFrancesco Pisanti, ItalyNarrow Banding Image (NBI) Technology to Improve Bladder Neoplasm Detection Rate During TURBtFrancesco Pisanti, ItalyOur Experience in Novel Method of Photodynamic Therapy for Superficial Bladder CancerAlexei Plekhanov, RussiaDyslipidemia In Kidney Transplantation Recipients: Evaluation of Risk FactorsGholamreza Pourmand, IranAugmentation of Chimerism by Donor Bone Marrow Cells Infusion in Kidney Allograft RecipientsGholamreza Pourmand, Iran

Exraperitoneal Orthotopic Radical Cystoprostatectomy Approach Can Improve Postoperative MorbidityGholamreza Pourmand, IranIs Anti Thymocyte Globulin Therapy Considered a Risk Factor for Post Kidney Transplantation Cytomegalovirus Infection?Gholamreza Pourmand, IranModified Cut-off Point of Total Prostate-Specific Antigen and Free-to-Total Prostate-Specific Antigen Ratio for Detecting Prostate Cancer: Sensitivity and Specificity EvaluationGholamreza Pourmand, IranPrognostic Significance of Her-2/neu Overexpression in Primary Urothelial Carcinoma of the Bladder: AComparative AnalysisGholamreza Pourmand, IranProspective Evaluation of Serum Triglyceride Concentration and Prostate Cancer Risk in a Multicenter StudyGholamreza Pourmand, IranSerum Calcium as a Protective Marker Against Prostate Cancer: Role of Associated FactorsGholamreza Pourmand, IranSerum Uric Acid as a Risk Predictor for Erectile Dysfunction SeverityGholamreza Pourmand, IranTestosterone Administration Effects on Sexual Function in Aging Males With Symptoms of Late-Onset Hypogonadism and Normal or Subnormal Testosterone Level: a Comparative Analysis Gholamreza Pourmand, IranIs There a Relation Between Post Kidney Transplantation Antithymocyte Globuline Therapy and Wound Healing Disturbance?Gholamreza Pourmand, Iran


BERLIN SIU 2011 183


Sandwiched Tunnel: A Novel Antireflux Ureterointestinal Pouch Anastamosis Approach with Easier Endourologic AccessGholamreza Pourmand, IranManagement of Bosniak Category III Renal CystsXiaojian Qin, ChinaStrategies of Ureteral Stenting Under Cystoscope in Patients with Gynecological CancersXiaojian Qin, ChinaCD276 in Clear Cell Renal Cell Carcinoma: Potential Role in the Development of Tumor-Specific, Vascular-Targeted Therapies and Its EvaluationXiaojian Qin, ChinaRegular Follow-Up Is Warranted in Simple Renal CystsXiaojian Qin, ChinaNumber of Tracts or Stone Size? Which One Influences Outcome of PCNL for Staghorn Renal Stone?Mohammad H Radfar, IranAcupuncture Versus Standard Therapy for Overactive Bladder Using Tolterodine in Overactive Bladder Patients. Effects on Symptom Scores and Bladder Diary ParametersHarrina Rahardjo, IndonesiaTransureteral Ureterolithotripsy of Ureteral Calculi: Which Is Best, Pneumatic or Holmium Laser Technique?Mohamad Reza Razaghi, IranDiode Laser Vaporization of the Prostate in Comparison with Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia: Preliminary Results of a Randomized Clinical TrialMohamad Reza Razaghi, Iran

Renal Transplantation in a Woman with History of Ovarian TumorNouri Rebai, TunisiaPSA: The “Milestone” in UrologyApostolos Rempelakos, GreeceFrom Empiricism to Laparoscopy: The History of HerniaApostolos Rempelakos, GreeceUnilateral Versus Bilateral Tined Lead Stimulation in Patient’s Selection for Sacral Nerve Stimulation: Preliminary ResultsPatrick Richard, CanadaThe DEFI-Study-Dosimetry in Endourologic Fluoroscopic Interventions: Risk of Radiation Exposure for Endourologic PatientsManuel Ritter, GermanyIs There a Difference in the Perception of Pain with Flexible Cystoscopy Between Men and Women and Different Ages?Simon Robinson, UKIncontinence in the InsaneSimon Robinson, UKFertility and RaceSimon Robinson, UKTwenty-Five Years of Research on Stone-Free and Stone-Prone Population Groups: What Has Been Learned?Allen Rodgers, South AfricaPreventive Use of Bisphosphonates Against Bone Deminerealization Promotes Adjuvant Anti-Neoplasic Effect on High-Risk Prostate Cancer PatientsPaulo Rodrigues, Brazil




Benign Prostatic Hyperplasia in Association with Latent Prostate Cancer After the Chernobyl accident in the UkraineAlina Romanenko, UkraineHyperbaric Oxygen Therapy for Radiation-Induced Hemorrhagic CystitisAntonio Romao, PortugalLaparoscopy in the Management of Large Upper Ureteric StonesMamdouh Roshdy, EgyptExpression of Transforming Growth Factor Beta-1 Protein and Its Receptor in Tissues of Patients with Bladder Cancer Associated or Not with SchistosomiasisMamdouh Roshdy, EgyptTGF- ß1 Pathway as Biological Marker of Schistosomal and Non-Schistosomal Bladder CarcinomaMamdouh Roshdy, EgyptEvaluation of Charlson Comorbidity Index and Radical Cystectomy OutcomesIsmail Saad, EgyptThe Association Between Bladder Cancer and a Single Nucleotide Polymorphism (Rs2854744) in the Insulin-Like Growth Factor Binding Protein-3 GeneMohammad Reza Safarinejad, IranAssociation of Genetic Polymorphism of Glutathione S-Transferase (GSTM1, GSTT1, GSTP1) with Bladder Cancer Susceptibility in the Iranian PopulationMohammad Reza Safarinejad, IranThe Effect of Coenzyme Q10 Supplementation on Pregnancy Rate in Infertile Men with Idiopathic Oligoastenoteratozoospermia: An Open Label Prospective StudyMohammad Reza Safarinejad, Iran

Relationship of Insulin-Like Growth Factor (IGF) Binding Protein-3 (IGFBP-3) Gene Polymorphism with the Susceptibility to Development of Prostate Cancer and Influence on Serum Levels of IGF-I, and IGFBP-3Mohammad Reza Safarinejad, IranGlutathione S-Transferase Gene Polymorphisms (GSTM1, GSTT1, GSTP1) and Prostate Cancer: A Case-Control Study in Tehran, IranMohammad Reza Safarinejad, IranRelationship Between Premature Ejaculation and Genetic Polymorphisms of the Dopamine Transporter Gene (SLC6A3) Mohammad Reza Safarinejad, IranRelationship Between Genetic Polymorphisms of Methylenetetrahydrofolate Reductase (C677T, A1298C, and G1793A) as Risk Factors for Idiopathic Male InfertilityMohammad Reza Safarinejad, IranAssociation of Polymorphisms in the Estrogen Receptors Alpha and Beta (ESR1, ESR2) with the Occurrence of Male Infertility and Semen ParametersMohammad Reza Safarinejad, IranAssociation of the (TAAAA)N Repeat and Asp327Asn Polymorphisms in the Sex Hormone-Binding Globulin (SHBG) Gene with Idiopathic Male Infertility and Relation to Serum SHBG ConcentrationsMohammad Reza Safarinejad, IranEffect of Pentoxifylline on Semen Parameters, Reproductive Hormones and Seminal Plasma Antioxidant Capacity in Men with Idiopathic Infertility: A Randomized Double-Blind Placebo-Controlled StudyMohammad Reza Safarinejad, Iran


BERLIN SIU 2011 185


Association of the T-786C, G894T and 4a/4b Polymorphisms of the Endothelial Nitric Oxide Synthase Gene with Vasculogenic Erectile Dysfunction in Iranian SubjectsMohammad Reza Safarinejad, IranSafety and Efficacy of Coenzyme Q10 Supplementation in Early Chronic Peyronie's Disease: A Double-Blind, Placebo-Controlled Randomized StudyMohammad Reza Safarinejad, IranMedium-Term Results of Female Pelvic Floor Reconstruction with Synthetic Meshes: A Clinical Comparison of the Efficacy, the Operating Time and Complications: Our 5–Year ExperienceIoannis Salmas, GreeceComparison of Efficacy and Safety of Minimally Invasive Synthetic Suburethral Sling Operations for Stress Urinary Incontinence in WomenIoannis Salmas, GreeceInitial Experience with Fluorescence In Situ Hybridization (FISH) for Detection of Urothelial Carcinoma of the BladderIliya Saltirov, BulgariaEndothelial Nitric Oxide Synthase Gene Polymorphism and Risk of Prostate Cancer in Iranian PatientsMohammad Sam Zadeh, IranIntracytoplasmic Morphologically Selected Sperm Injection, IMSI in the Management of Refractory Infertile CouplesWael Sameh, EgyptExtracorporeal Shock Wave Therapy (ESWT) Using the Storz Duolith ESWT System to Treat Patients with Peyronie’s Disease (PD)Rafael Sanchez-Salas, France

Initial Experience with Tachosil® in Penile Prosthetic SurgeryRafael Sanchez-Salas, FranceLong-Term Oncologic Outcomes of Patients Treated with High Intensity Focused Ultrasound for Localized Prostate CancerRafael Sanchez-Salas, FranceRobotic Prostatectomy Positive Margins Learning CurveRafael Sanchez-Salas, FrancePioneering Institution Mid- and Long-Term Outcomes of Laparoscopic Radical ProstatectomyRafael Sanchez-Salas, FranceEarly Outcomes of LESS Nephrectomy ExperienceRafael Sanchez-Salas, FranceLaparoscopic Radical Cystectomy and Neoadjuvant Chemotherapy in Invasive Bladder CarcinomaRafael Sanchez-Salas, FrancePredictors of Complete Nerve Sparing During Robot Assisted Radical ProstatectomyOscar Schatloff, USASurgeon’s Intent of Nerve Sparing and Residual Nerve Tissue on Prostatectomy SpecimensOscar Schatloff, USARight Robot Assisted Ureteral Reimplantation with Psoas HitchOscar Schatloff, USAThe Combination of Retroperitoneoscopic and Open Surgery for Partial Nephrectomy: A Minimal-Invasive Technique for Challenging Renal TumorsMeike Schneider, Germany




Comparison Between Transobturator Vaginal Tape Inside Out and Single Incision Sling System in the Treatment of Female Stress Urinary Incontinence: Prospective Randomized StudyJoon Hyung Seo, South KoreaComparison of the Crede Maneuver to the Visualization Technique for Tensioning Single Incision SlingsScott Serels, USAIs Laparoscopic Re-evaluation Justified After Previously Failed Open Exploration for Undescended Testis?Pejman Shadpour, IranManagement of Arteriogenic Erectile Dysfuction (ED)Ali Shamsa, IranPreliminary Results of the Mini Sling Vaginal Tape (Ophira) in the Treatment of Stress Urinary Incontinence in Two Hospitals at Tehran CityFarzaneh Sharifiaghdas, IranCan Lymphovascular and Perineural Invasion Determine the Treatment after Radical Cystectomy?Yi-Jun Shen, ChinaClinical Outcome of Sunitinib Is Associated with Appearance of Hypothyroidism as Adverse Events in Patients with Metastatic Renal Cell Carcinoma in Asian CohortRyoichi Shiroki, JapanComplications in Laparoscopic Transperitoneal Radical NephrectomyDimitar Shishkov, BulgariaCorrelation Between Bladder Wall Thickness and Urodynamic Findings in Patients with Spinal Cord InjuryJose Silva, Brazil

A Novel Risk Stratification System Developed for Transperineal Template Prostate Mapping To Aid Categorisation Intermediate and High Risk Prostate CancerLucy Simmons, United KingdomVisuospatial Representation and Risk Categorization of Individual Cancer Foci on Three-Dimensional Template Guided Prostate Mapping (TPM) BiopsiesParas Singh, United KingdomHigh Prevalence of Systemic Acidosis in Stone Formers Is Not Due To Lactose IntoleranceShrawan Kumar Singh, IndiaMolecular Basis of Aberrant Expression and Activity of Alkaline Phosphate in Renal Cell CarcinomaShrawan Kumar Singh, IndiaUretero-Vaginal Fistula: Results of Laparoscopic Repair at Cho Ray HospitalTran Sinh, VietnamIatrogenic Vesico-Vaginal Fistula Repair: Laparoscopic and Early Intervention at Cho Ray HospitalTran Sinh, VietnamDoes Using the Hypogastric Artery in Kidney Transplantation Cause a Curved Penis?Tran Sinh, VietnamInjection of Bupivacaine Decreases EpiduralMeperidine Requirements After Urologic SurgerySaied Soleymani, IranMuscular Paralysis and Ventilatory Failure Caused by HyperkalemiaSaied Soleymani, IranPredictive Factors Influencing Failure of ESWL in Treating Patients with Ureteral StonePhil Hyun Song, South Korea


BERLIN SIU 2011 187


Anchor Tissue Retrieval Bag for Robot-Assisted Laparoscopic Prostatectomy (RALP)Kurt Strom, USA

180W GreenLight XPS: Laser Photoselective Vaporization of the Prostate (PVP) for Symptomatic Benign Prostatic Hyperplasia (BPH)Kurt Strom, USARetrograde Radical Extraperitoneal Cystectomy vs Trans Peritoneal TechniqueCristian Surcel, RomaniaThe Impact of Bladder Tumors on the Evolution of Upper Urinary Tract TumorsCristian Surcel, RomaniaThe Possibility of Access to the Kidneys from the Posterior Axillary Line in Supine PositionAli Tabibi, IranWe Thought It Was Benign, But It’s Snot!Sergiy Tadtayev, United KingdomUrology Registrar of the Week Rota: Does It Improve Continuity of Care?Sergiy Tadtayev, United KingdomComparing PSA and Free PSA Serum Levels in Fresh and Frozen Blood SamplesRahim Taghavi, IranThe Effect of Acupuncture on Relieving Pain Following Inguinal SurgeriesRahim Taghavi, IranMarginal Cadaveric Pediatric Donors and Adult RecipientsRahim Taghavi, Iran

The Effects of Late Urological Complications on Graft Survival After Kidney Transplantation in Living and Cadaveric Donor Rahim Taghavi, IranManagement of Pediatric Post Traumatic Obliterative Stricture Urethra: Our ExperienceRajeev Puthenveetil Thekumpadam, IndiaManagement of Adolescent Renal Tumor: Our ExperienceRajeev Puthenveetil Thekumpadam, IndiaManagement of Giant Adrenal Cysts: Our ExperienceRajeev Puthenveetil Thekumpadam, IndiaGiant Spermatocytic Seminoma: A Case ReportRajeev Puthenveetil Thekumpadam, IndiaLaparoscopic Assisted Percutaneous Nephrolithotomy (PCNL) in Ectopic Pelvic KidneyRajeev Puthenveetil Thekumpadam, IndiaRecording History: The Living Witness ProgramPeter Thompson, UKIs There a Difference in Quality of Life for Patients Undergoing Urinary Diversion for Benign Versus Malignant Conditions of the Urinary Tract? A 20–Year Single Centre Retrospective Cohort StudyAli Thwaini, UKVaginal Reconstruction with Ileum and Uterus-Neovaginal Anastomosis in Patient with Variant of Rokitansy SyndromeMassimiliano Timpano, ItalyMicrosurgical “Testis Sparing” Surgery for Nonpalpable Hypoechoic Testicular LesionsMassimiliano Timpano, Italy




Sperm Retrieval by Micro-TESE in Patients with Klinefelter SyndromeMassimiliano Timpano, ItalyUropathogenic E. coli Infection Leads to DNA Hypermethylation in Uroepithelial Cells: Consequences for UTI Recurrence Risk?Cornelia Toelg, CanadaScreening and Identification of Renal Cancer Specific Peptide from A Phage Display Peptide LibraryXiangan Tu, ChinaEffect of eIF-4E Inhibition on Heparanase mRNA and Protein Expression In Bladder CancerXiangan Tu, ChinaComparison of Local Anaesthetic Effects of Lidocaine with Tramadol and the Effect of Child Anxiety on Pain Level in Circumcision ProcedureAltug Tuncel, TurkeyCombined Modality Treatment for Prostate Cancer PatientsAlbertas Ulys, LithuaniaEffect of a New Potassium Channel Opener on Clitoral and Vaginal Blood Flow in Spinalized RatsKhaleeq Ur Rehman, PakistanUpper Urinary Tract Urothelial Carcinoma in End-Stage Kidney DiseaseTomas Urge, Czech RepublicThe Role of TRPA1 in the Bladder Cooling Reflex in a Urethane Anaesthetized and Spinal Cord Injury Rat ModelPieter Uvin, BelgiumChanges in Histological Pattern Post-Urethroplasty Using Small Intestinal Submucosa in Rabbits with Injured UrethraGustavo Villoldo, Argentina

Is It Necessary To Screen the Prostate Before TRUS Guided Biopsy?Daohu Wang, ChinaComparing the Efficacy of Biofeedback Therapy in Premature EjaculationHongxiang Wang, ChinaFeasibility Analysis of Carrying Out Group Sensate Focus Exercise in ED Patients in Shanghai RegionHongxiang Wang, ChinaIELT as an Assessment Criterion of Symptoms and Effects of the Type IIIa Prostatitis Patient: A Feasibility StudyHongxiang Wang, ChinaPreliminary Investigation of the Effect of Seminal Plasma Leptin in Promoting Apoptosis of Sperm and Its Possible PathsHongxiang Wang, ChinaThe Role of Integrated Fertility Evaluation in the Diagnosis and Treatment of Male InfertilityHongxiang Wang, ChinaPharmaco-Induced Erections for Penile Color-Duplex Ultrasound: Oral Phosphodiesterase Type 5 Inhibitors or Intracavernosal Injection?Hongxiang Wang, ChinaEffect of Acute Tadalafil on Sperm Motility and Acrosome Reaction: Studies Both In Vitro and VivoHongxiang Wang, ChinaOral Tadalafil Administration Plus Low Dose Vasodilator Injection: A Novel Approach of Erection Induction for Penile Color-Duplex UltrasoundHongxiang Wang, ChinaPreliminarily Studies on the Teaching Reform of Sex and Reproductive Health for College StudentsHongxiang Wang, China


BERLIN SIU 2011 189


Retroperitoneoscopic Partial Adrenalectomy for Aldosteronoma: Clinical Experiences with 163 CasesXiaojing Wang, ChinaRetroperitoneoscopic Surgery for Adrenal Lesions Close to Vena CavaXiaojing Wang, ChinaDiagnosis and Treatment of Malignant Pheochromocytoma: Report of 45 CasesXiaojing Wang, ChinaMinimally Invasive Treatment for Ligation of Ectopic UreterXiaojing Wang, ChinaRetroperitoneoscopic Surgery for Pelvi-Ureteric Junction Obstruction (Crossing Vessels)Xiaojing Wang, ChinaLaparoscopic Surgery for Adrenal MetastasisXiaojing Wang, ChinaRetroperitoneal Laparoscopic Adrenalectomy for Adrenal Microtumors: The Ruijin Clinical Experience in 108 ProceduresXiaojing Wang, ChinaThe Fabrication and Properties of Co-polymer Poly(lactic-co-glycolic acid) Ureteral Stent By ElectrospinningXiaojing Wang, ChinaRenal Access by Urologist Versus Sonographer During Percutaneous NephrolithotomyYanbo Wang, ChinaWhich Factors May Affect Urinary Leakage Following Ultrasound-Guided Percutaneous Nephrolithotomy?Yanbo Wang, ChinaEvaluation of Prostate-Bladder Angle Measured by MRI in the Diagnosis of Benign Prostate ObstructionChun-Xiao Wei, China

Elevated and/or Rising PSA in Presence of Negative Biopsy: Cancer, Inflamation, or Watchful WaitingMohamed Wishahi, EgyptElevated and/or Rising PSA in Presence of Negative Biopsies: Justifications for Total Androgen BlockadeMohamed Wishahi, EgyptLaparoendoscopic Single Site Retroperitoneal Lymph Node Dissection: The Initial ExperienceAbai Xu, ChinaLaparoendoscopic Single Site Extraperitoneal Radical Prostatectomy: Initial Chinese ExperienceAbai Xu, ChinaLaparoendoscopic Single Site Assisted Transsexual Surgery for Male Pseudohermaphroditism: 2 Case ReportsAbai Xu, ChinaEfficacy of Microsurgical Subinguinal Approach TechniqueKohei Yamaguchi, JapanFive-Year Reports on Outcomes of Radical Retropubic ProstatectomyAliasghar Yarmohamadi, IranSalvage Genitourinary Fistula Repair: Our ExperienceAliasghar Yarmohamadi, IranEfficacy of Desmopressin and Celecoxib in Treatment of Nocturia Caused by Benign Prostatic Hyperplasia: Comparative StudyAliasghar Yarmohamadi, IranProspective Randomized Double Blinded Study on Transurethral Bipolar Resection Plus Vaporization (The Hybrid Technique) Versus Resection Only in Treatment of Benign Prostate HyperplasiaSidney Yip, Hong Kong




Effectiveness of a Immediate Mitomycin C Instillation in Patients With Non-Muscle Invasive Bladder Cancer Receiving Periodical Mitomycin C InstillationKwon Young Kee, South KoreaAnalysis of A/G Polymorphism of ARE-I Region on PSA Gene in Iranian Patients with Prostate CancerMohammad Sam Zadeh, IranEnterocystoplasty and Ureterocystoplasty Before Renal Transplantation: A Comparison with the Control GroupReza Mahdavi Zafarghandi, IranThe Effect of Post Renal Transplant Extensive Ureteral Stricture on Patient and Graft SurvivalReza Mahdavi Zafarghandi, IranEarly and Late Levels of Prostate Specific Antigen and Testosterone After Renal TransplantReza Mahdavi Zafarghandi, IranComparing Extracorporeal Shock Wave Lithotripsy and Transureteral Lithotripsy for Treatment of Ureteral Calculi: A Prospective StudyReza Mahdavi Zafarghandi, IranSuccessful Ambulatory Microsurgical Testicular Sperm Extraction (microTESE) in a Community SettingScott Zeitlin, USAImproving the Efficacy of Sorafenib by Transarterial Embolization in Metastatic Renal Cell Carcinoma with Unresectable Primary Tumor: Preliminary Results from a Chinese CenterHai-Liang Zhang, ChinaCombination of Chlortetracycline Hydrochloride Ointment and Urea Cream in Treating Hand-Foot Skin Reaction Caused by Sorafenib in Patients with Metastatic Renal Cell CarcinomaHai-Liang Zhang, China

Retroperitoneoscopic Partial Nephrectomy versus Open Partial Nephrectomy for Small Renal Tumors: Results of a Retrospective Trial of Chinese PatientsLong Zhang, ChinaRetroperitoneoscopic Right Nephrectomy for Living Donor Kidney TransplantH. L. Zhou, ChinaNarrow-Band Imaging Flexible Cystoscopy in the Detection of Clinically Unconfirmed Positive Urine CytologyYiping Zhu, ChinaIs Leaving Expansion Place for Suture in Anastomosis of Vessel Safe and Helpful for Prevention of Stenosis?Afshar Zomorrodi, IranU-Stitch for Evert and Control of Bleeding in the Anastomosing Renal Vein Is Safe and HelpfulAfshar Zomorrodi, Iran24-Hour Heart Rate Variability Parameters in Patients with Lower Urinary Tract Symptoms: A Preliminary StudyOrhan Unal Zorba, TurkeyTransvaginal NOTES Nephrectomy in a Series of 42 Cases: Stepwise Transition from Hybrid to Pure NOTESXiaofeng Zou, ChinaTransvaginal NOTES-Assisted Laparoscopic Adrenalectomy: First Clinical ExperienceXiaofeng Zou, ChinaPure Transvaginal Natural Orifice Transluminal Endoscopic Surgery (NOTES) for Nephrectomy: Report of 5 CasesXiaofeng Zou, China


BERLIN SIU 2011 191


Pure Transvaginal Natural Orifice Transluminal Endoscopic Surgery (NOTES) for Unroofing of Renal Cyst: Report of 4 CasesXiaofeng Zou, ChinaA Novel Approach for Embryonic Natural Orifice Transumbilical Endoscopic Surgery Using Conventional Laparoscopic Instruments in UrologyXiaofeng Zou, ChinaApplication of Embryonic Natural Orifice Transumbilical Endoscopic Surgery in Urology: A Report of 103 CasesXiaofeng Zou, ChinaLaparoendoscopic Single-Site Surgery for Pyelolithotomy and Ureterolithotomy: Report of 24 CasesXiaofeng Zou, ChinaTwo-Trocar Transumbilical Laparoscopic Surgery for High Ligation of Spermatic Vein: Report of 14 CasesXiaofeng Zou, China



BERLIN SIU 2011 193

INDEX OF PRESENTERS AND DISCLOSURES

Last Name First Name Presentation Code Disclosure

Abbass Yasser RBT Not Applicable

Abbou Claude C. PP15 Not Received at Press Time

Abd Alazeez Mohamed MP-03.05 Nothing to Disclose

Abdel Aziz Mohamed UP-01.135, UP-03.064 Not Received at Press Time

Abdel Rahman Abdalla RBT Not Applicable

Abdelbaky Tarek MP-11.09, MP-15.09, UP-01.132 Not Received at Press Time

Abdul Razack Azad Hassan UP-01.017 Nothing to Disclose

Abol-Enein Hassan PL02, PP06 Not Received at Press Time

Abomelha Mohammed RBT Not Applicable

Abrahamsson Per-Anders EAU, PL01 Not Received at Press Time

Abrams Paul PL03, PP04 Not Received at Press Time

AbuGhosh Zeid RBT Not Applicable

Adomaitis Robertas UP-02.102 Nothing to Disclose

Agarwal Vikas MP-05.06, UP-01.099, UP-03.070, VID-06.01 Not Received at Press Time

Ahmadi AsrBadr Yadollah RBT Not Applicable

Ahmadnia Hassan UP-01.110 Not Received at Press Time

Ahmed Irfan UP-01.057 Not Received at Press Time

Ahn Hanjong WUOF1 Nothing to Disclose

Akaza Hideyuki PP08, UP-02.227, WUOF1 Nothing to Disclose

Akman R. Yavuz RBT Not Applicable

Akporiaye Leslie UP-02.003 Not Received at Press Time

Al Amery Hayder Ismael RBT Not Applicable

Albers Peter PP03, WUOF3, WUOF8 Not Received at Press Time

Albertsen Peter PL01, PP08, WUOF2 Not Received at Press Time

Alefelder Joachim UP-03.072 Nothing to Disclose

Alei Giovanni MP-07.18, MP-07.19, RBT, UP-03.042, UP-03.055 Nothing to Disclose

Ali Ahmed A.A. MP-11.06 Nothing to Disclose

Allen Darrell UP-03.066 Not Received at Press Time

Alloussi Saladin UP-03.207 Not Received at Press Time

Almonacid Grunert Jorge Hugo MP-02.01 Not Received at Press Time

Alnajjar Hussain MP-15.01, MP-15.02, UP-02.215, UP-02.216 UP-03.007

Not Received at Press Time

Amano Hiroyuki UP-02.103 Not Received at Press Time

Amini Erfan MP-07.13, UP-03.060 Not Received at Press Time

Amjadi Mohsen MP-10.01 Not Received at Press Time

Anai Satoshi MP-03.06 Not Received at Press Time

Andersson Karl-Erik PP04, PP09 Not Received at Press Time

Andreoiu Matei MP-14.02, UP-01.002 Not Received at Press Time

Andrich Daniela PP10 Not Received at Press Time

Andriole Gerald ICUD1, ICUD2, PP08 Not Received at Press Time

Andrusco Alexander MP-03.07, MP-03.08, MP-03.09UP-03.176 Not Received at Press Time

Angermeier Kenneth GURS Not Received at Press Time

Annerstedt Magnus IC12 Not Received at Press Time

Aoki Yoshitaka MP-11.03 Nothing to Disclose

Aoyagi Teiichiro UP-01.068 Not Received at Press Time





Arab Davood RBT Not Applicable

Arda Ersan RBT Not Applicable

Argirovic Djordje MP-15.20, UP-03.112 Nothing to Disclose

Arianayagam Ranjan UP-03.108 Nothing to Disclose

Arichi Naoko MP-06.01 Nothing to Disclose

Aronson William ICUD2 Nothing to Disclose

Arrabal-Polo Miguel Angel RBT Not Applicable

Artibani Walter EAU Not Received at Press Time

Asgari Seyed Alaeddin RBT, MP-15.11, UP-02.039, UP-03.008, UP-03.063 Not Received at Press Time

Assem Akram RBT Not Applicable

Aydur Emin RBT, UP-01.069, UP-01.070, UP-02.011, UP-03.129 UP-03.161 UP-03.192, UP-03.196


Azinhais Paulo UP-01.028, UP-01.046, UP-01.158, UP-01.198UP-03.094


Babjuk Marek PP13 Not Received at Press Time

Bach Christian UP-02.047, UP-02.104 Not Received at Press Time

Bachmann Alexander IC07 Not Received at Press Time

Badawi Hisham PAUSA Not Received at Press Time

Bancevic Vladimir POD-01.04 Not Received at Press Time

Bapat Shivadeo RBT, UP-01.111, UP-03.015, UP-03.073, UP-03.130 Nothing to Disclose

Barbagli Guido PP10 Not Received at Press Time

Bardan Razvan MP-09.04, UP-02.196 Nothing to Disclose

Bargão Pedro VID-03.04 Not Received at Press Time

Barnes Richard PP05 Not Received at Press Time

Barod Ravi UP-03.025 Not Received at Press Time

Basic Dragoslav MP-06.02 Not Received at Press Time

Basiri Abbas UP-03.067, VID-01.01 Not Received at Press Time

Basson Jacques UP-02.065 Nothing to Disclose

Baston Catalin RBT Not Applicable

Batra Vikram RBT Not Applicable

Baydilli Numan MP-02.03 Nothing to Disclose

Beck Christian UP-02.013 Not Received at Press Time

Bedke Jens DGU Not Received at Press Time

Beels Elodie UP-03.139, UP-03.140, UP-03.141 Not Received at Press Time

Beier Jörn VID-03.05, VID-07.01 Nothing to Disclose

Beisland Christian UP-01.185 Not Received at Press Time

Bhandarkar Ajay MP-01.09, POD-04.01 Not Received at Press Time

Bhattu Amit RBT, VID-04.01, VID-08.05 Not Received at Press Time

Bhuiyan Mohammed MP-01.02, UP-02.048 Not Received at Press Time

Bjerklund Johansen Truls E. IC14 Nothing to Disclose

Black Peter WUOF6 Medical Advisory Board, Grant Funding (July 2011-present): GenomeDx

Black Peter MP-08.12 Nothing to Disclose

Blasco Casares Francisco Jose UP-02.230 Not Received at Press Time

Bolenz Christian POD-01.01 Not Received at Press Time


BERLIN SIU 2011 195



Bonkat Gernot UP-01.012 Not Received at Press Time

Botoca Mircea Radu MP-04.20, MP-10.05, UP-02.032 Nothing to Disclose

Boulalas Ioannis UP-01.018 Nothing to Disclose

Bozzini Giorgio MP-04.04, UP-03.113, UP-03.142 Not Received at Press Time

Brancato Tommaso UP-01.187 Nothing to Disclose

Branchereau Julien RBT Not Applicable

Brandao Luis VID-02.07 Not Received at Press Time

Brandes Steven GURS Not Received at Press Time

Brausi Maurizio MP-02.09, POD-06.01, PL02, RBT, UP-02.131UP-02.178


Brenner Walburgis MP-02.07 Not Received at Press Time

Breza Jan PP12, RBT, UP-01.114, UP-03.037 Not Received at Press Time

Briel Christoph UP-03.178 Not Received at Press Time

Brime Menéndez Ricardo MP-07.06 Not Received at Press Time

Brookman-May Sabine MP-02.10, MP-02.11, UP-01.150 Nothing to Disclose

Broul Marek RBT Not Applicable

Bubeck Juergen R. RBT Not Applicable

Bucuras Viorel UP-02.012, UP-02.197 Not Received at Press Time

Budäus Lars MP-13.01, POD-03.01 Nothing to Disclose

Bultitude Matthew PL04 Not Received at Press Time

Bumbu Gheorghe UP-01.071 Not Received at Press Time

Burks Frank GURS, MP-12.12 Not Received at Press Time

Busto Martin Luis MP-13.15, UP-02.198, UP-02.199, UP-02.200 Not Received at Press Time

Caballero Gine Jose María VID-03.06 Nothing to Disclose

Cabrera Meiras Fernando UP-01.188 Not Received at Press Time

Cadilhe José UP-02.105 Not Received at Press Time

Caione Paolo ESPU, PP02, ST04 Nothing to Disclose

Cakir Omer Onur MP-01.03, MP-13.18 Not Received at Press Time

Cano García María Del Carmen UP-01.151 Registration: Astellas

Carmel Michel UP-01.157 Not Received at Press Time

Carmona Lina Maria MP-05.04, MP-16.13 Not Received at Press Time

Carroll Peter R. ICUD2, PL04 Nothing to Disclose

Casado Varela Javier UP-02.080, UP-02.182 Nothing to Disclose

Cash Hannes UP-01.112, UP-03.026 Not Received at Press Time

Castelo David UP-02.049, UP-02.150 Nothing to Disclose

Castillo Octavio PP06, PP15 Not Received at Press Time

Casu Cristian Vasile UP-01.040, UP-02.062, UP-02.063, UP-02.151 Not Received at Press Time

Çek Mete PP05 Not Received at Press Time

Celada Luis Guillermo UP-02.079 Not Received at Press Time

Cepeda Delgado Marcos MP-01.12, VID-09.01 Nothing to Disclose

Chandrasekar Ponnambalam POD-04.02, UP-02.231 Not Received at Press Time

Charalampous Stavros IC02 Not Received at Press Time

Chauhan Sanket RBT Not Applicable

Chedgy Edmund UP-01.008 Not Received at Press Time

Chen Shiou-Sheng UP-01.130, UP-02.106 Nothing to Disclose





Chen Wen-Chi UP-02.226, UP-03.061 Not Received at Press Time

Chen Yan UP-03.179 Nothing to Disclose

Cheng Cheung Hing MP-12.13, UP-02.107 Nothing to Disclose

Cheng Christopher PP01, PP08, WUOF8 Nothing to Disclose

Chew Ben SUS Consultant: Boston Scientific, Cook Medical, Percutaneous Systems, Poly-Med Inc.

Chigogidze Teimuraz RBT, UP-02.201 Not Received at Press Time

Chihara Yoshitomo MP-04.02 Not Received at Press Time

Chikako Nishihara UP-01.022 Not Received at Press Time

Chira Ionut Dumitru UP-03.074 Not Received at Press Time

Cho Chak Lam RBT Not Applicable

Cho Dae Yeon RBT Not Applicable

Cho Deok Hyun MP-09.09 Not Received at Press Time

Cho In Rae UP-01.171 Not Received at Press Time

Cho In-Chang MP-16.07 Nothing to Disclose

Cho Jeong Man UP-01.007, UP-03.085 Not Received at Press Time

Choi Woo Suk MP-09.10, UP-02.015, UP-03.197 Nothing to Disclose

Chovelidze Shalva UP-01.131 Not Received at Press Time

Chuen Chi Kit MP-02.14 Not Received at Press Time

Chun Felix MP-16.12 Not Received at Press Time

Ciuta Catalin RBT Not Applicable

Claassen Frederik RBT, MP-08.05, MP-11.04, UP-01.175 Not Received at Press Time

Claici Dorin RBT Not Applicable

Coleman Jonathan A. ICUD1 Not Received at Press Time

Coloby Patrick PL02 Not Received at Press Time

Comploj Evi RBT Not Applicable

Cozzi Paul POD-07.05 Not Received at Press Time

Cruz Francisco PP14 Not Received at Press Time

Da Costa Walter UP-01.142, UP-01.189, UP-01.190 Not Received at Press Time

Dabees Khaled PAUSA Not Received at Press Time

Dahlem Roland MP-12.02 Not Received at Press Time

Dahm Philipp IC03 Nothing to Disclose

Dakkak Youssef MP-01.13, RBT, UP-02.202 Not Received at Press Time

Darabi Mahboub Mohammad Reza MP-01.14, UP-03.092 Not Received at Press Time

Davis John UP-03.116, WUOF3 Not Received at Press Time

Davits Robert MP-13.02 Not Received at Press Time

De Baets Karen MP-12.03, UP-03.016 Not Received at Press Time

De La Rosa Kehrmann Federico MP-06.13, MP-06.14 Nothing to Disclose

de La Rosette Jean IC13, PP13 Not Received at Press Time

De Ridder Dirk IC02, PP04, PP16, ST01 Not Received at Press Time

De Stefanis Paolo RBT, VID-02.10, VID-08.06 Not Received at Press Time

Dean John ISSM Not Received at Press Time

Deger Serdar IC07 Not Received at Press Time

D’Elia Gianluca VID-01.02, VID-01.03, VID-01.04, VID-01.05VID-03.01, VID-09.02



BERLIN SIU 2011 197



Delmas Vincent ST01 Not Received at Press Time

Demidko Yuri RBT Not Applicable

Desai Mahesh R. PL04, PP07, PP11 Not Received at Press Time

Desai Mihir Mahesh PP15 Not Received at Press Time

DeVries Catherine R. IC01, MP-11.05, PAUSA Nothing to Disclose

Dickinson Louise MP-03.10, MP-13.03, UP-02.153 Not Received at Press Time

Djajadiningrat Rosa MP-15.03 Nothing to Disclose

Djordjevic Miroslav IC06, VID-08.02 Nothing to Disclose

Djozic Jasenko UP-01.191 Not Received at Press Time

Dobruch Jakub MP-13.04 Not Received at Press Time

Dockray Judith MP-15.12, UP-02.016, UP-03.114 Not Received at Press Time

Dogra Pn VID-02.08, VID-07.06 Not Received at Press Time

Donatucci Craig F. IC08 Not Received at Press Time

Drake Marcus MP-05.01, PP09, ST03 Research, Advisory Board, Speaker (2010-2011): Allergan, Astellas, Pfizer; Advisory Board, Speaker (2010-2011): Ferring

Drasa Kim MP-09.05 Nothing to Disclose

Droller Michael J. WUOF6 Not Received at Press Time

Dusek Pavel UP-01.047 Not Received at Press Time

Dymov Alim RBT Not Applicable

Ebel Ebinger Luis MP-15.21 Not Received at Press Time

Mundorff Nicole IC07 Not Received at Press Time

Eisenberger Mario ICUD1 Not Received at Press Time

Eissa Mohamed PAUSA, PP02 Not Received at Press Time

Ekwueme Elbendary Kingsley UP-02.108, UP-02.109 Nothing to Disclose

Elnady Mohamed MP-09.06 Nothing to Disclose

El-Feel Ahmed RBT Not Applicable

El-Ghoneimi Alaa ESPU Not Received at Press Time

Elhilali Mostafa M. PL03 Advisor: Astellas, GSK, Pfizer, Lumenis

Ellati Riyad RBT Not Applicable

Elmussareh Muhammad MP-02.12, UP-01.154 Nothing to Disclose

Elneil Suzy PP16 Not Received at Press Time

Elrifai Alaa UP-01.097 Nothing to Disclose

Elseweifi Aref VID-08.03, VID-08.04 Not Received at Press Time

Emberton Mark IC09, PP01, WUOF3 Not Received at Press Time

Endo Fumiyasu UP-02.228 Not Received at Press Time

Engel Oliver MP-12.04 Nothing to Disclose

Epplen Robin POD-02.01 Not Received at Press Time

Erkan Erkan MP-01.06, UP-01.029, UP-01.128, UP-02.110UP-03.075


Esen Tarik PP11 Not Received at Press Time

Evans Christopher WUOF4 Speaker (2011): Amgen, Centocor

Eylert Maike MP-04.11 Nothing to Disclose

Fangerau Heiner HISTORY Not Received at Press Time

Faraji Shovey Mehdi UP-03.047 Nothing to Disclose

Farshi Haghro Alireza RBT Not Applicable





Figueiredo Luis MP-07.17, RBT, UP-01.136 Nothing to Disclose

Filipas Dragana ST04 Not Received at Press Time

Filipovic Zoran RBT Not Applicable

Finelli Antonio WUOF5 Not Received at Press Time

Fisch Margit GURS, ESPU, PP02 Not Received at Press Time

Fischer M.A. RBT, UP-01.137 Nothing to Disclose

Fischereder Katja UP-01.072, UP-03.180 Not Received at Press Time

Fitzpatrick John M. PL03, PL04 Not Received at Press Time

Fleshner Neil WUOF1 Not Received at Press Time

Fletcher Sophie PP14 Not Received at Press Time

Fradet Vincent POD-07.07, UP-02.084, UP-02.184, UP-02.229 Not Received at Press Time

Fradet Yves PP13 Not Received at Press Time

Frees Sebastian MP-02.13 Nothing to Disclose

Friedersdorff Frank MP-06.05 Not Received at Press Time

Fu Qiang PP10 Not Received at Press Time

Fujimoto Kiyohide POD-05.02 Nothing to Disclose

Fujimoto Naohiro UP-02.154 Nothing to Disclose

Fukatsu Akitoshi RBT Not Applicable

Fukumoto Kazuhiko UP-02.004 Nothing to Disclose

Fuller Florian VID-02.09 Financial Interest (2011): Karl Storz Endoskope

Fumey Julien MP-06.04 Nothing to Disclose

Furuse Hiroshi UP-03.143 Nothing to Disclose

Gadelmoula Mohamed MP-10.06, UP-01.143 Not Received at Press Time

Galal Ehab UP-03.065 Not Received at Press Time

Galante Romo Isabel POD-01.02 Nothing to Disclose

Gamal Wael RBT Not Applicable

Ganda Oumarou Sanda PP16 Not Received at Press Time

Gandaglia Giorgio UP-03.198 Nothing to Disclose

Ganeswaran Dinesh UP-02.111, UP-02.203 Not Received at Press Time

Ganpule Arvind MP-06.06, MP-06.07, MP-11.01, UP-01.194VID-04.02


Garcia-Rojo Dario UP-01.073, UP-01.176, UP-03.132, VID-09.04 Nothing to Disclose

Garcia-Segui Alejandro VID-02.03, VID-06.03 Nothing to Disclose

Garde Hector UP-01.041 Nothing to Disclose

Gardiner Robert Frank WUOF3 Not Received at Press Time

Gaston Richard PP06 Not Received at Press Time

Geavlete Bogdan POD-05.03, POD-04.04, POD-05.08, UP-02.071 VID-09.07

Speaker (2009-2010): General Electric Healthcare Speaker (2010-2011): Olympus

Geavlete Petrisor Aurelian MP-01.18, MP-01.20, PP11, UP-03.080 Not Received at Press Time

Geiges Götz UP-02.064 Not Received at Press Time

Gelman Joel GURS Not Received at Press Time

Gentile Barbara Cristina MP-10.09, MP-10.10, MP-10.11, MP-13.10POD-01.06, UP-01.074, UP-02.024, UP-02.034UP-02.128, UP-02.130, UP-02.132, UP-03.088 UP-03.208



BERLIN SIU 2011 199



Ghicavii Vitalii MP-09.07 Not Received at Press Time

Gilling Peter PL04, UP-01.030, UP-01.113 Investigator (2008-2010): Pacific Edge Ltd., Tristel Ltd.

Goel Apul UP-03.019 Not Received at Press Time

Golab Adam UP-01.100 Not Received at Press Time

Golubtsova Elena UP-02.155 Not Received at Press Time

Gomez Illanes Reynaldo PP10, PP14, UP-03.121, UP-03.123, UP-03.124 Not Received at Press Time

Gontero Paolo MP-04.13, UP-01.066, UP-03.052 Not Received at Press Time

González Christopher GURS Not Received at Press Time

Gorgal-Carvalho Tiago MP-05.07, UP-01.195, UP-02.001 Nothing to Disclose

Gormley E. Ann PP09 Not Received at Press Time

Govind Hari RBT Not Applicable

Goyal Arvind RBT Not Applicable

Grimsley Samuel MP-04.12, UP-02.112 Nothing to Disclose

Gross Andreas PP11 Not Received at Press Time

Gudbrandsdottir Gigja UP-01.140, UP-01.141 Not Received at Press Time

Gueye Serigne IC01, PAUSA, PP16 Not Received at Press Time

Guidoni Luiz Renato Montez UP-03.006 Not Received at Press Time

Guix Benjamin POD-07.01 Not Received at Press Time

Gupta Manu POD-04.08 Not Received at Press Time

Guspanov Renat MP-13.16 Not Received at Press Time

Gutschi Thomas UP-01.155 Not Received at Press Time

Gutue Cristian Stefan UP-02.029, UP-03.059 Not Received at Press Time

Haab François UP-02.014 Not Received at Press Time

Hadaschik Boris POD-02.02, UP-02.085 Advisor (2010-2011): MedCom; Advisor (2011): Janssen-Cilag, Sanofi-Aventis, Teva

Hadj Slimen Mourad RBT Not Applicable

Haerlin Ulrich UP-01.013 Nothing to Disclose

Haga Kazunori UP-03.076 Nothing to Disclose

Hakim Lukman UP-03.077 Nothing to Disclose

Halawa Gonzalez Omar Bilal UP-03.093 Not Received at Press Time

Ham Won Sik MP-09.12 Nothing to Disclose

Hamann Claudius UP-02.115, UP-02.116 Not Received at Press Time

Hamdoune Abdelaziz RBT, UP-03.133 Not Received at Press Time

Hamid Agus Rizal UP-02.086 Not Received at Press Time

Hamidi Madani Ali UP-02.204 Not Received at Press Time

Hammerer Peter PP01 Advisor (2005-2011): Takeda; Advisor (2008-2011): Allergan, B&K, GlaxoSmithKline, Lilly, Pfizer, Sanofi; Advisor (2011): Millenium

Hammoud Khaled Mursi MP-01.01, MP-11.12, UP-01.059, UP-01.075 Nothing to Disclose

Hampel Christian PP04, PP09, ST01, ST03 Not Received at Press Time

Hara Noboru UP-02.185 Not Received at Press Time

Haraguchi Takahiro UP-02.017 Nothing to Disclose

Harimoto Kouji RBT Not Applicable

Harza Mihai Christian MP-06.03 Not Received at Press Time

Hasanzad Mandana RBT Not Applicable





Hashmi Altaf MESOT Not Received at Press Time

Hassan Mohammed UP-01.153 Nothing to Disclose

Hatiboglu Gencay UP-01.144, UP-02.205 Nothing to Disclose

Hattori Kazunori MP-04.19 Not Received at Press Time

Hauschild Eveline UP-02.089 Not Received at Press Time

Hautmann Richard E. IC10, PL02, PP06, WUOF7 Nothing to Disclose

Haxhiu Isa RBT Not Applicable

Hayami Shinsuke UP-02.019 Nothing to Disclose

Heidenreich Axel PP03 Not Received at Press Time

Heinrich Elmar MP-13.05, UP-02.087 Nothing to Disclose

Heinzelbecker Julia UP-02.117 Nothing to Disclose

Hekal Ihab MP-13.17, RBT, UP-02.206UP-02.118, UP-02.119


Hemal Ashok K. IC05, IC12 Not Received at Press Time

Heo Jung Moon UP-02.033 Not Received at Press Time

Hernando Arteche Alberto MP-03.11, UP-02.120 Nothing to Disclose

Herr Harry PL02, PP03 Nothing to Disclose

Herrmann Edwin DGU Not Received at Press Time

Heyns Chris F. MP-15.13, PP05, RBT, UP-02.005UP-02.006, UP-03.118

Nothing to Disclose

Hilton Paul PP09 Not Received at Press Time

Hinev Alexander MP-15.15, UP-02.066, UP-03.017, UP-03.144 Company Speaker Honorarium (2011): Eli Lilly; Trial Participa-tion (2010-2011): Hexal AG, Innovacell Biotechnologie; Travel Grant (2010): Bayer Schering Pharma; Travel Grant (2011): Astellas, Eli Lilly, Pfizer

Hinotsu Shiro MP-16.14 Not Received at Press Time

Hirano Yasuhiro MP-04.07 Nothing to Disclose

Ho Christopher Chee Kong

UP-02.121 Nothing to Disclose

Höfner Klaus PP04 Advisor: GlaxoSmithKline (2007-2011), Lilly (2010-2011), Pfizer (2004-2011), Neomedic (2010-2011)

Hohenfellner Markus PP12 Not Received at Press Time

Hollowell Jean PP02 Not Received at Press Time

Holm Henriette Veiby UP-03.181 Nothing to Disclose

Honda Satoshi UP-03.162 Nothing to Disclose

Hong Sung Kyu MP-16.16, UP-02.083 Not Received at Press Time

Horie Shigeo WUOF1 Nothing to Disclose

Horiuchi Kohei UP-02.007 Nothing to Disclose

Horwich Alan PP03 Nothing to Disclose

Hsu Chao-Yu RBT Not Applicable

Huang Chien-Ming RBT, UP-03.086 Not Received at Press Time

Hubert Jacques IC05 Not Received at Press Time

Hübner Wilhelm A. ST01 Not Received at Press Time

Hudak Steven MP-12.15 Nothing to Disclose

Hung Shun-Fa RBT, UP-03.048 Not Received at Press Time

Hussein Alayman MP-07.04 Not Received at Press Time


BERLIN SIU 2011 201



Iatsyna Oleksandr POD-01.05 Not Received at Press Time

Ichikawa Takaharu UP-02.020 Not Received at Press Time

Igawa Tsukasa UP-02.157 Nothing to Disclose

Ignjatovic Ivan VID-02.04 Not Received at Press Time

Iizuka Jumpei UP-01.156 Not Received at Press Time

Ikeda Hiroshi RBT Not Applicable

Ilievski Aleksandar UP-03.010 Nothing to Disclose

Inokuchi Junichi UP-03.146 Nothing to Disclose

Ishikawa Akira UP-02.072 Nothing to Disclose

Ishimura Takeshi MP-06.09 Not Received at Press Time

Ishiura Yoshiyuki RBT Not Applicable

Ishizuka Osamu UP-01.009 Nothing to Disclose

Isotalo Taina SUS Nothing to Disclose

Issa Rami POD-05.01, POD-06.02, UP-01.098, UP-02.158UP-02.159, UP-02.232, UP-03.119, VID-07.02


Ito Kazuto UP-02.122 Nothing to Disclose

Itoh Naoki UP-03.199 Nothing to Disclose

Ivanauskas Andrius UP-02.161 Not Received at Press Time

Iwata Tsuyoshi MP-13.08 Nothing to Disclose

Izaki Hirofumi UP-01.003 Not Received at Press Time

Izquierdo Morejón Emilio RBT, UP-03.011 Speaker (2011): GlaxoSmithKline; Registration (2011): Astellas

Izumi Kazuyoshi MP-07.09 Nothing to Disclose

Jacqmin Didier EAU Not Received at Press Time

Jäger Wolfgang PP13 Not Received at Press Time

Jalil Rozh UP-02.038 Not Received at Press Time

Janetschek Günter PP07, PP15 Not Received at Press Time

Jankowski Thomas MP-14.03 Not Received at Press Time

Jardin Alain HISTORY Not Received at Press Time

Jarolim Ladislav UP-02.056 Nothing to Disclose

Jefferies Edward POD-03.03 Nothing to Disclose

Jeong Min Su MP-05.05 Nothing to Disclose

Jeremic Dimitrije MP-15.16 Nothing to Disclose

Jewett Michael A. S PP03, PP12, WUOF5 Not Received at Press Time

Jha Akhileshwar MP-11.08 Nothing to Disclose

Jimenez-Pacheco Antonio RBT Not Applicable

Jindal Ashish RBT Not Applicable

Jo Jung Ki MP-03.14, MP-07.11, UP-01.211 Not Received at Press Time

Jones J. Stephen IC03 Not Received at Press Time

Joniau Steven RBT, POD-03.02 Not Received at Press Time

Jordan Gerald H. PL01, SUS Not Received at Press Time

Jundi Omar MP-14.04 Nothing to Disclose

Jung Seung Il UP-03.145 Not Received at Press Time

Junior Barthelemy Mekeme Mekeme MP-03.17, RBT, UP-01.076 Not Received at Press Time

Junker Kerstin DGU, UP-01.172 Not Received at Press Time

Kaisary Amir UP-02.162, UP-02.163 Not Received at Press Time





Kajioka Shunichi RBT Not Applicable

Kalpinskiy Alexey UP-01.196, UP-02.044 Not Received at Press Time

Kamal Mohammed RBT Not Applicable

Kamal Gheith Mohamed UP-03.029 Not Received at Press Time

Kamat Ashish IC11 Scientific Study/Trial/Research Support: Adolor, Bioniche/Endo, Celgene, Alere Inc.; Consultant, Advisor: Achimedes, Inc., Endo Pharm., Tetralogic Phar., AstraZeneca, Precision Therapeutics; Meeting Participant/Honoraria: GE Healthcare

Kang Taek Won UP-02.088 Not Received at Press Time

Kapoor Anil WUOF5 Not Received at Press Time

Kaptan Hulagu UP-03.183 Not Received at Press Time

Karami Hosein UP-03.209, UP-03.210, VID-06.04 VID-06.05, VID-09.06


Karavitakis Markos UP-02.164 Not Received at Press Time

Karunyam Bheena UP-02.052 Not Received at Press Time

Kassouf Wassim IC11, UP-03.117 Nothing to Disclose

Kato Masashi UP-01.197 Not Received at Press Time

Kato Yuji MP-01.16 Nothing to Disclose

Katsuhiro Fukuta UP-02.067 Nothing to Disclose

Kawamura Kenji UP-02.018 Not Received at Press Time

Kawamura Sadafumi MP-03.13 Nothing to Disclose

Kawanishi Yasuo MP-07.10 Nothing to Disclose

Keil Christian MP-01.10 Consultant, Advisory Board Member (2010-2011): EMS Medical S.A.

Keil Christian MP-01.04 Not Received at Press Time

Khalaf Ismail PL04, PP06 Not Received at Press Time

Khanna Sudhir MP-08.09, MP-08.10, RBT UP-03.012 Not Received at Press Time

Khazaeli Dinyar RBT, UP-03.095 Not Received at Press Time

Khorrami Mohannad Hatef UP-03.158 Not Received at Press Time

Khoury Antoine E. ESPU, PP02, ST04 Not Received at Press Time

Kiel Anne UP-01.048 Not Received at Press Time

Kikugawa Tadahiko UP-01.019 Not Received at Press Time

Kim Byung Hoon UP-01.037, UP-01.180, UP-02.147 Not Received at Press Time

Kim Hong Sup MP-08.04 Not Received at Press Time

Kim Ju Sung RBT Not Applicable

Kim Kikyung UP-03.078 Not Received at Press Time

Kim Sang Deuk UP-01.060 Not Received at Press Time

Kim Se Joong UP-03.147 Nothing to Disclose

Kim Tae Hyo RBT, MP-14.05, MP-14.06 Not Received at Press Time

Kim Tae Nam UP-02.021 Nothing to Disclose

Kim Taek Sang MP-04.05 Not Received at Press Time

Kim Won Tae UP-02.208 Nothing to Disclose

Kimura Kyosuke RBT Not Applicable

Kingo Pernille Skjold UP-03.096 Not Received at Press Time

Kitahara Satoshi UP-02.209 Not Received at Press Time

Kitta Takeya UP-01.081, UP-02.008 Nothing to Disclose


BERLIN SIU 2011 203



Klecka Jiri MP-16.08 Not Received at Press Time

Klingler Christoph H. PP07 Advisory: Coloplast and Allergan; Educational services: Ferring Pharmaceuticals; Advisory and Educational services: Astellas

Klotz Laurence PL01, POD-03.04, PP01, WUOF1-8 Not Received at Press Time

Kluth Luis Alex MP-12.16, MP-12.17, POD-04.03 UP-03.134 Not Received at Press Time

Knüchel-Clarke Ruth PL02 Nothing to Disclose

Knüpfer Stephanie UP-03.169 Not Received at Press Time

Koc Gokhan MP-08.01, MP-10.19, MP-10.20, UP-01.115UP-01.116, UP-02.210, UP-02.211, UP-03.110


Kodaira Kiichiro RBT Not Applicable

Kodama Ronald GURS Not Received at Press Time

Kogan Barry A. ESPU, MP-11.07, PP02 Consutant in Study Design: Watson Pharmaceuticals (2011-2012); Shareholder: United Urology (2011)

Kojovic Vladimir MP-07.20, UP-03.056 Nothing to Disclose

Kölbl Heinz ICSSUFU, PP09, ST03 International Advisory Board: Astellas (2011)

Kondo Fukuji UP-03.120 Not Received at Press Time

Konety Badrinath IC03, WUOF7 Speaker: Amgen (2011); Consultant: Spectrum Pharm (2011)

Konstantinidis Charalampos RBT Not Applicable

Kozal Sebastien MP-12.05 Nothing to Disclose

Krah Xaver RBT Not Applicable

Kratzik Christian UP-02.212 Not Received at Press Time

Krishnamurthi Venkatesh MP-06.10, MP-06.11 Not Received at Press Time

Kronenberg Peter RBT, UP-01.049 Nothing to Disclose

Kubota Yasuaki UP-02.123 Nothing to Disclose

Kukreja Rajesh MP-10.07, UP-03.099 Not Received at Press Time

Kulaksizoglu Haluk UP-01.014, UP-03.122, UP-03.170, UP-03.184 Not Received at Press Time

Kulchavenya Ekaterina ISSM, MP-08.13, RBT, UP-01.117, UP-01.118UP-01.119, UP-03.049, UP-03.050

Nothing to Disclose

Kulkarni Jagdeesh MP-13.09 Not Received at Press Time

Kulkarni Ravindra SS Not Received at Press Time

Kulkarni Sanjay PP10, UP-03.097, UP-03.097 Not Received at Press Time

Kumar Pardeep POD-06.03 Not Received at Press Time

Kumar Santosh RBT, UP-01.061, UP-03.013, UP-03.148 Not Received at Press Time

Kumar Vivekanandan MP-16.15 Not Received at Press Time

Kuo Tricia UP-02.213 Not Received at Press Time

Kuratsukuri Katsuyuki UP-02.214 Not Received at Press Time

Kuroda Isao RBT, UP-02.165 Not Received at Press Time

Kusuhara Yoshito UP-03.043 Nothing to Disclose

Kutzenberger Johannes UP-03.212 Not Received at Press Time

Labanaris Apostolos P. RBT, MP-03.12, UP-02.144, UP-02.145, UP-02.189UP-03.157


Läckgren Göran ESPU Not Received at Press Time

Laguna Pilar PP07 Not Received at Press Time

Lahoz Garcia Clara MP-07.14, MP-08.07, MP-08.08UP-03.083, UP-03.084

Nothing to Disclose

Lambert Sarah PP02 Nothing to Disclose





Lammers Rianne Janna Marie POD-05.07 Nothing to Disclose

Lang Christoph MP-05.08, UP-03.163 Nothing to Disclose

Lange Dirk MP-01.17, MP-01.19, UP-03.062 UP-03.100 Not Received at Press Time

Lange Paul ICUD1, PP03 Not Received at Press Time

Leao Ricardo RBT Not Applicable

Leclair Marc David ESPU, PP02 Not Received at Press Time

Lee Changho POD-03.05 Not Received at Press Time

Lee Frank PL03 Not Received at Press Time

Lee Hyung-Lae UP-02.186, UP-03.211 Not Received at Press Time

Lee Joong Shik RBT Not Applicable

Lee Kwang Soo UP-03.068, UP-03.091 Not Received at Press Time

Lee Sang-Cheol MP-01.11 Nothing to Disclose

Lee Yong Seong UP-03.159 Not Received at Press Time

Leitão Tito UP-02.124, UP-03.185 Nothing to Disclose

Lemack Gary ICSSUFU Speaker, Consultant (2 years): Pfizer; Speaker (2 years): Astel-las; Clinical Trial, Consultant (2 years): Allergan; Clinical Trial (2 years): Contura

Lerner Seth P. POD-05.06, PP13 Not Received at Press Time

Levakov Ivan RBT Not Applicable

Leyten Gisele MP-16.09 Nothing to Disclose

Leyton Rodrigo IC02 Not Received at Press Time

Lezrek Mohammed RBT, UP-02.046, VID-06.06, VID-06.07, VID-06.08 VID-08.07

Nothing to Disclose

Li Aihua UP-03.079, VID-06.02 Nothing to Disclose

Lim Ju Hyun MP-04.10, UP-02.100 Nothing to Disclose

Lopes Ivo POD-02.05, UP-02.125, UP-02.193 UP-03.101 Not Received at Press Time

Lopes Tiago UP-03.200 Not Received at Press Time

Lu Ji RBT Not Applicable

Lu Shing-Hwa MP-05.09, UP-01.015 Not Received at Press Time

Lynch William J. PP01 Not Received at Press Time

Madersbacher Helmut PP14 Not Received at Press Time

Maeda Yoshiko UP-02.040 Nothing to Disclose

Maghsoudi Robab UP-02.053, UP-03.087, UP-03.102 Not Received at Press Time

Mahdavi Zafarghandi Reza MP-06.12, MP-10.12, RBT, UP-03.030, UP-03.031 Not Received at Press Time

Maitra Neil UP-02.022 Not Received at Press Time

Makanjuola Jonathan Kehinde UP-03.125, UP-03.135 Not Received at Press Time

Maki Yoshio UP-01.101 Not Received at Press Time

Malki Manar UP-03.126 Not Received at Press Time

Mansson Wiking PL02, UP-03.160 Not Received at Press Time

Mante Sunny Doodu PAUSA Surgeon (2004-2011): West African LF Project

Marberger Michael PL03, PP01, PP12 Not Received at Press Time

Markovsky Oliver UP-02.126 Not Received at Press Time

Marri Rajendar UP-01.085 Not Received at Press Time

Marshall Daniel UP-02.127 Nothing to Disclose

Martenstein Christian UP-03.193 Not Received at Press Time


BERLIN SIU 2011 205



Martins Francisco IC06 Not Received at Press Time

Maruschke Matthias UP-01.146 Not Received at Press Time

Masri Marwan MESOT Not Received at Press Time

Matin Surena IC05, WUOF8 Nothing to Disclose

Matsuyama Hideyasu UP-01.062 Not Received at Press Time

Mattioli Stefano MP-09.14 Not Received at Press Time

Mayr Roman MP-04.08, UP-01.042 Not Received at Press Time

McBean Alexander UP-02.041 Nothing to Disclose

McCammon Kurt GURS, IC02, PP14 Not Received at Press Time

McDonald Jean PAUSA Nothing to Disclose

Mehrallivand Sherif UP-01.200 Not Received at Press Time

Mendoza-Valdes Arturo PL02, PP08, WUOF1 Not Received at Press Time

Merlini Emilio ESPU Not Received at Press Time

Mhiri Nabil MP-02.04, MP-06.20, MP-06.21, MP-08.02UP-02.050, UP-02.113, UP-02.114, UP-03.027UP-03.090, UP-03.156


Mian Badar POD-02.03, UP-01.020 Not Received at Press Time

Michailov Michael Ch. UP-03.127 Nothing to Disclose

Michel Maurice-Stephan DGU Not Received at Press Time

Mikami Kazuya UP-01.045 Not Received at Press Time

Miller Kim MP-16.01 Not Received at Press Time

Min Seung Ki MP-08.15 Not Received at Press Time

Min Seung Ki UP-02.009 Not Received at Press Time

Minagawa Shingo UP-02.023 Not Received at Press Time

Minato Akinori UP-02.070 Nothing to Disclose

Minciu Radu UP-02.082, UP-02.183 Not Received at Press Time

Mitsui Yozo MP-03.01 Nothing to Disclose

Miura Takeshi MP-03.18 Not Received at Press Time

Miyagawa Tomoaki UP-02.133 Nothing to Disclose

Miyaji Yoshiyuki UP-01.159 Nothing to Disclose

Mizusawa Hiroya UP-02.187 Nothing to Disclose

Mkony Charles UP-03.020 Nothing to Disclose

Mogharabian Nasser RBT, UP-03.103 Not Received at Press Time

Mohanty Nayan MP-07.15, MP-09.15, UP-01.050 Not Received at Press Time

Molimard Benoit POD-02.04 Not Received at Press Time

Moll Friedrich H. HISTORY Not Received at Press Time

Montorsi Francesco IC04 Not Received at Press Time

Montoya-Chinchilla Raul UP-03.128 Not Received at Press Time

Moradi Mahmoudreza MP-12.01 Not Received at Press Time

Moreira Pedro UP-01.133 Not Received at Press Time

Morey Allen GURS, IC06, PP10 Speaker, Consultant: American Medical Systems (2010-2011); Speaker: GlaxoSmithKline (2010-2011)

Morgia Giuseppe UP-01.039, UP-02.081 Not Received at Press Time

Morizane Shuichi UP-03.151 Not Received at Press Time

Mortensen Martin Mørck MP-16.10 Nothing to Disclose





Morton Ronald POD-03.06, UP-02.076 GTX, Inc. (2007-2011)

Moudouni Said Mohammed POD-06.04, UP-02.137 Not Received at Press Time

Mousavi-Bahar Seyed Habibollah MP-01.21 Not Received at Press Time

Moussa Fathy UP-03.038, UP-03.039 Not Received at Press Time

Mukhtar Saheel POD-01.07, UP-01.051, UP-01.052 Not Received at Press Time

Müller Georg MP-08.16 Not Received at Press Time

Müller Stefan C. DGU Not Received at Press Time

Multescu Razvan MP-10.13, UP-03.104, UP-03.105 VID-05.07 Nothing to Disclose

Mundy Anthony PP04, PP14 Not Received at Press Time

Murai Tetsuo UP-02.035 Not Received at Press Time

Muschter Rolf EAU Not Received at Press Time

Naber Kurt PP05 Not Received at Press Time

Nagao Kazuhiro MP-06.16 Nothing to Disclose

Nakajima Fumio MP-09.08 Not Received at Press Time

Nakamura Nobuyuki UP-01.102 Not Received at Press Time

Nakamura Terukazu UP-03.111 Nothing to Disclose

Nakano Yuzo UP-01.123 Not Received at Press Time

Nakatsuji Hiroyoshi UP-01.021 Not Received at Press Time

Nam Jong Kil UP-02.054, UP-03.152 Not Received at Press Time

Naoya Masumori UP-03.202 Nothing to Disclose

Nasu Yoshitsugu MP-08.17 Not Received at Press Time

Nativ Ofer SUS Nothing to Disclose

Nayar Christian UP-03.021 Not Received at Press Time

Neal Durwood MP-12.18, RBT Not Received at Press Time

Negro Carlo Luigi Augusto MP-05.13, MP-06.17, SUS, UP-01.010, UP-01.064UP-02.026, UP-03.057 UP-03.165


Neisius Andreas MP-09.16 Nothing to Disclose

Nemade Hemant POD-06.07, RBT, UP-01.086, UP-01.087, UP-01.089UP-01.203 UP-01.208, UP-02.055


Nestler Sebastian UP-01.160 Not Received at Press Time

Neymeyer Joerg MP-01.05, UP-01.082, UP-01.103VID-05.08, VID-05.09

Nothing to Disclose

Neyra Lee-Eng Godofredo UP-02.192 Not Received at Press Time

Ng Ada MP-10.14, UP-01.104 Not Received at Press Time

Ng Keng Lim UP-02.190, UP-03.194 Nothing to Disclose

Nguyen Phuc Cam Hoang UP-01.161, UP-03.106 Not Received at Press Time

Nicholas Rebecca UP-01.105 Not Received at Press Time

Nickel J. Curtis IC14, MP-08.18 Not Received at Press Time

Nijman Rien ESPU Not Received at Press Time

Nikic Predrag UP-02.036 Not Received at Press Time

Nishiyama Toru UP-01.106 Not Received at Press Time

Nita Gheorghe MP-05.14, UP-01.202 Nothing to Disclose

Nitkaliyev Kairat UP-01.065 Nothing to Disclose

Noguchi Mitsuru UP-03.172 Not Received at Press Time

Noh Choong-Hee MP-08.22, MP-09.03, UP-02.031 Not Received at Press Time


BERLIN SIU 2011 207



Noh Joonhwa RBT, UP-02.042 Not Received at Press Time

Nomikos Michael MP-10.15, MP-10.16 Nothing to Disclose

Noon Aidan UP-03.186 Not Received at Press Time

Nouri Alireza RBT Not Applicable

Nowroozi Mohammad Reza UP-01.134 Not Received at Press Time

Nozawa Masahiro UP-01.201 Nothing to Disclose

Nyarangi-Dix Joanne UP-03.187 Not Received at Press Time

Nygard Yngve UP-02.217 Nothing to Disclose

Nyushko Kirill MP-16.11, UP-02.148 Not Received at Press Time

Obara Kenji MP-11.10 Nothing to Disclose

Obi Anselm Okwudili UP-02.233 Nothing to Disclose

Ochi Atsuhiko RBT Not Applicable

Ogawa Osamu PP04 Nothing to Disclose

Ogawa Teruyuki UP-01.016 Not Received at Press Time

Ohbatake Aya UP-03.206 Not Received at Press Time

Ohira Shin MP-03.19, UP-01.107 Not Received at Press Time

Oh-Oka Hitoshi RBT, MP-09.17, UP-01.124, UP-03.213 Nothing to Disclose

Okamura Takehiko MP-04.01 Nothing to Disclose

Okorie Chukwudi MP-15.17, MP-15.18 Nothing to Disclose

Olapade-Olaopa E.Oluwabunmi PAUSA Not Received at Press Time

Olbert Peter DGU Nothing to Disclose

Oliver Tim RBT, UP-03.115 Not Received at Press Time

Onita Toru UP-02.073 Not Received at Press Time

Oomen Robert MP-07.21, RBT Nothing to Disclose

Orsolya Martha MP-08.14, MP-11.02 Not Received at Press Time

Ota Tomonori UP-01.207 Nothing to Disclose

Ozok Hakki Ugur UP-01.033 Not Received at Press Time

Öztekin Çetin Volkan UP-02.191 Nothing to Disclose

Pacheco-Figueiredo Luís RBT Not Applicable

Pahernik Sascha UP-01.173, UP-02.156 Not Received at Press Time

Paick Sung Hyun UP-03.153 Nothing to Disclose

Pal Raj UP-02.027, UP-02.028, UP-02.166 Not Received at Press Time

Palou Joan IC12, PL02, POD-01.08, RBT, UP-01.067, UP-01.147UP-03.154, UP-03.155, VID-07.05, VID-08.08


Pandey Abhishek MP-12.06, UP-03.022 Not Received at Press Time

Pannek Juergen PP14 Not Received at Press Time

Panopoulos Ioannis RBT Not Applicable

Pansadoro Vito PL02, ST06 Not Received at Press Time

Park Chang Myon MP-16.22, RBT, UP-02.237, UP-03.054 Not Received at Press Time

Park Jae Shin MP-11.11, POD-04.07 Not Received at Press Time

Park Joon Jae UP-03.058 Not Received at Press Time

Park Kyung Seo RBT, MP-08.03 Not Received at Press Time

Park Seung Chol MP-08.19, UP-02.074 Not Received at Press Time

Passavanti Giandomenico RBT, UP-01.125 Nothing to Disclose

Pastore Antonio Luigi MP-03.20, UP-01.023, UP-02.218, UP-03.173 Not Received at Press Time





Patankar Suresh POD-04.05, POD-06.05, UP-02.002, UP-03.018UP-03.023

Nothing to Disclose

Patel Anup PP11 Travel Remuneration: EAU Research Foundation

Patrascoiu Titus MP-12.11 Speaker: Astellas, AstraZeneca

Pattnaik Prashant RBT Not Applicable

Pejcic Tomislav UP-02.010, VID-05.05 Nothing to Disclose

Peña González Juan Antonio VID-05.02, VID-05.03, VID-05.04VID-07.03, VID-07.04


Persu Cristian UP-03.166, UP-03.214 Not Received at Press Time

Pertia Ambrosi RBT Not Applicable

Perugia Giacomo UP-01.108 Nothing to Disclose

Petri Eckhard PP09, ST03 Nothing to Disclose

Pfalzgraf Daniel UP-03.136 Not Received at Press Time

Picozzi Stefano MP-01.07, MP-04.14, POD-01.09, UP-02.091UP-02.134


Pietricica Bogdan Nicolae RBT, UP-02.135 Nothing to Disclose

Pisanti Francesco MP-05.10, MP-05.11, MP-05.12, RBT, UP-01.063UP-02.025 UP-02.129, VID-02.01, VID-02.02


Polascik Thomas IC09, PP01 Not Received at Press Time

Pompeo Antonio Carlos Lima PP06 Nothing to Disclose

Popeneciu Ionel Valentin MP-05.15 Not Received at Press Time

Popov Elenko UP-03.137 Nothing to Disclose

Porru Daniele UP-01.077 Not Received at Press Time

Poulsen Mads Hvid MP-16.17 Not Received at Press Time

Pourmand Gholamreza MP-04.03, MP-06.18, MP-07.08, POD-01.03, RBTUP-02.219, UP-02.220, UP-02.094, UP-02.095UP-03.033, UP-03.034, UP-03.046


Preminger Glenn IC13, PP11 Not Received at Press Time

Price Thomas UP-02.069 Not Received at Press Time

Pricop Catalin UP-03.053 Not Received at Press Time

Protzel Chris MP-06.19, MP-15.05, MP-15.06, UP-03.203 Not Received at Press Time

Pruthi Raj S. PP06 Not Received at Press Time

Pshikhachev Akhmed MP-08.06 Not Received at Press Time

Puglisi Marco VID-01.06, VID-09.05 Nothing to Disclose

Qayyum Tahir UP-01.053 Nothing to Disclose

Rabii Redouane PP05 Not Received at Press Time

Radavoi George Daniel MP-03.21, UP-01.005, UP-01.177 Not Received at Press Time

Radfar Mohammad UP-03.107 Not Received at Press Time

Radmayr Christian ESPU Not Received at Press Time

Rafiq Muhammad UP-01.058 Not Received at Press Time

Rajpal Sanjay MP-08.20, UP-01.088 Not Received at Press Time

Ramsay J. W. A. PP03 Not Received at Press Time

Rao Pradeep MP-05.16, PP15 Not Received at Press Time

Rasheed Taha Mohamed UP-01.083 Not Received at Press Time

Rassweiler Jens J. PP07, PP15 Not Received at Press Time

Rawlinson Alexander UP-01.054 Nothing to Disclose


BERLIN SIU 2011 209



Razaghi Mohamad Reza MP-09.18, UP-03.081 Not Received at Press Time

Rebai Nouri RBT Not Applicable

Recker Franz WUOF2 Not Received at Press Time

Reich Oliver PL03 Not Received at Press Time

Reiss Philip MP-12.19 Not Received at Press Time

Rempelakos Apostolos RBT Not Applicable

Rempelakos Apostolos UP-01.090, UP-01.091, UP-01.092, UP-01.093UP-01.094, UP-03.040


Rendon Ricardo UP-01.181, UP-01.193, UP-03.150 Not Received at Press Time

Resende Alexandre UP-01.078 Nothing to Disclose

Rezaei Mehr Behkam MP-10.17 Not Received at Press Time

Riedl Markus UP-01.204 Not Received at Press Time

Riggs Stephen ICUD2, PP03 Not Received at Press Time

Robertson Cary POD-07.08 Not Received at Press Time

Robinson Simon RBT, MP-03.22, MP-13.11, UP-02.167 Nothing to Disclose

Roder M. Andreas MP-16.18, UP-02.075, UP-02.168, UP-02.221 Nothing to Disclose

Rodriguez Alejandro MP-14.08 Nothing to Disclose

Roehrborn Claus G. MP-05.18, MP-05.17, MP-13.12MP-13.13, PL03, POD-04.06


Rogers Craig IC05, MP-14.10, MP-14.11, MP-14.12, MP-14.13POD-06.06


Romics Imre PP13, UP-01.095 Not Received at Press Time

Roobol Monique IC03, ICUD1, UP-02.136, WUOF2 Not Received at Press Time

Roos Frederik UP-01.148 Not Received at Press Time

Rouse Paul VID-04.04, VID-04.05, VID-08.09 Laparoscopic Video Fellowship (2010-2011): Kings College Hospital/Ethicon

Rovner Eric ICSSUFU Consultant, Course Faculty (2009-present): American Medical Systems; Consultant, Study Investigator (2009-present): Allergan, Johnson and Johnson, Tengion; Consultant, Study Investigator, Speaker, Symposia (2009-present): Pfizer, Astellas; Study Investigator (2009-present): Contura

Rowland Randall G. PP06 Nothing to Disclose

Saad Fred WUOF4 Consultant, Research (present): Amgen, Janssen, Novartis, Sanofi-Aventis

Sabnis Ravindra MP-01.15, VID-04.03, MP-06.08 Not Received at Press Time

Sadeghi-Nejad Hossein IC08 Not Received at Press Time

Saeed Bassam MESOT Not Received at Press Time

Safarinejad Mohammad Reza MP-07.01, MP-07.02, MP-07.03, MP-07.05MP-07.07, MP-07.12, UP-01.024, UP-01.025 UP-01.138, UP-02.092, UP-02.093, UP-03.041


Sakano Shigeru UP-01.174 Nothing to Disclose

Sakuyama Gaku MP-09.01 Nothing to Disclose

Salem Braiek UP-03.009 Not Received at Press Time

Salm Silvia UP-03.174 Nothing to Disclose

Salmas Ioannis RBT Not Applicable

Saltirov Iliya RBT Not Applicable

Salvitti Mariarita UP-01.004, UP-01.032, UP-01.199, UP-03.164 Not Received at Press Time





Sam Zadeh Mohammad RBT, UP-02.096, RBT, MP-04.06, MP-12.07 Not Received at Press Time

Sameh Wael UP-01.162, UP-03.215 Not Received at Press Time

Sampson Natalie DGU Nothing to Disclose

Sanda Martin G. PP08 Not Received at Press Time

Sangar Vijay PL02 Nothing to Disclose

Santamaría Nerea Felip VID-09.03 Nothing to Disclose

Santucci Richard A. GURS, PP10 Nothing to Disclose

Sarkar Somita UP-01.152, UP-01.163, UP-01.192, UP-03.089 Not Received at Press Time

Sasaki Takeshi MP-16.03 Nothing to Disclose

Sato Fuminori MP-03.02, UP-01.055 Not Received at Press Time

Scardino Peter T. PL01, PP08 Not Received at Press Time

Scarpa Roberto Mario PP11 Not Received at Press Time

Schaefer Werner ICSSUFU Not Received at Press Time

Schalken Jack ICUD2 Not Received at Press Time

Schatloff Oscar RBT Not Applicable

Schmid Marianne UP-01.164 Not Received at Press Time

Schmudermaier Martin UP-01.121, UP-01.122, UP-02.090 Not Received at Press Time

Schnalke Thomas HISTORY Not Received at Press Time

Schoensee Bernhard MP-05.19 Not Received at Press Time

Schostak Martin UP-02.169 Nothing to Disclose

Schröder Fritz EAU, PL01 Not Received at Press Time

Schwaab Thomas WUOF5 Nothing to Disclose

Segaran Surayne UP-02.222, UP-02.138 Nothing to Disclose

Segawa Takehiko UP-01.043 Not Received at Press Time

Seki Toshimori MP-14.09 Nothing to Disclose

Sesterhenn Isabell UP-02.170, UP-02.194, UP-02.195 Not Received at Press Time

Seth Amlesh MP-10.08, MP-12.08, MP-14.07, UP-01.034VID-03.07


Shabsigh Ahmad PP08 Not Received at Press Time

Shadpour Pejman MP-11.13 Not Received at Press Time

Shah Taimur MP-15.19, UP-02.223 Nothing to Disclose

Shalaby Mahmoud UP-03.024 Not Received at Press Time

Shamsa Ali RBT Not Applicable

Shariat Shahrokh F. IC11, POD-05.04 POD-05.05, UP-01.120UP-02.160, WUOF6


Sharifiaghdas Farzaneh UP-01.079 Not Received at Press Time

Sharlip Ira D. IC01, IC08, PP05 Not Received at Press Time

Sharma Deen MP-16.04 Not Received at Press Time

Shiga Yoshiyuki UP-02.236 Not Received at Press Time

Shim Sung Ryul UP-02.037 Nothing to Disclose

Shin Hong Seok MP-05.20 Not Received at Press Time

Shiroki Ryoichi RBT Not Applicable

Shishkov Dimitar RBT Not Applicable

Shore Neal UP-02.068 Not Received at Press Time


BERLIN SIU 2011 211



Shoskes Daniel PP05 Advisor: Farr Laboratories (ongoing); Financial Interest: Triurol (ongoing)

Siemens D. Robert WUOF4 Not Received at Press Time

Siemer Stefan MP-04.09 Not Received at Press Time

Siemer Stefan PP06, UP-02.149 Not Received at Press Time

Sievert Karl-Dietrich UP-03.171 Not Received at Press Time

Sim Allen POD-02.06 Not Received at Press Time

Simforoosh Nasser IC07, MESOT, PP11 Not Received at Press Time

Simmons Lucy MP-03.15, MP-03.16, RBT Not Received at Press Time

Simpson Helen MP-05.21, MP-16.05, MP-16.19, UP-02.139 Nothing to Disclose

Singh Harvinder MP-09.02 Not Received at Press Time

Singh Iqbal UP-01.035, UP-03.071 Nothing to Disclose

Singh Paras MP-13.19, RBT Nothing to Disclose

Singh Santosh Kumar MP-01.22, UP-02.140 Not Received at Press Time

Singla Ajay IC02, PP09 Consultant and Speaker: American Medical Systems (5 years)

Sinh Tran RBT, UP-03.028, UP-03.035, VID-08.01 Nothing to Disclose

Skakkebaek Niels E. PP03 Not Received at Press Time

Skobejko-Wlodarska Lidia MP-11.15, UP-03.002 Nothing to Disclose

Smolski Michal MP-03.23 Not Received at Press Time

Soebadi Doddy Musbadianto UP-03.044 Not Received at Press Time

Soleymani Saied MP-04.15, RBT Not Received at Press Time

Soloway Mark S. MP-13.06, MP-13.07, PL02, POD-07.03, POD-07.04 Not Received at Press Time

Sorg Rüdiger MP-02.08, UP-01.149 Yes

Sotelo Rene PP07, PP11, PP15, VID-01.07, VID-02.06, VID-03.02VID-03.03, VID-04.06, VID-04.07, VID-05.01VID-05.06, VID-06.09, VID-07.07, VID-07.08VID-07.09


Souza Escandon Alejandro MP-04.21 Not Received at Press Time

Soydan Hasan UP-01.129, UP-03.201, UP-03.051 Not Received at Press Time

Spahn Martin MP-03.03, POD-07.02, UP-02.077 Not Received at Press Time

Spahovic Hajrudin MP-01.08, UP-01.001, UP-02.171 Not Received at Press Time

Speakman Mark POD-02.07, UP-02.172 Research Funding, Advisory Board (2009- 2011): GenProbe; Research Funding, Presentations, Advisory Board (2004-2011): Astellas

Spiess Philippe E. MP-16.21 Advisory Board Member (2010-present): COLD Registry

Spiess Philippe E. MP-15.08, UP-01.205 Nothing to Disclose

Stanca Vasile Dan UP-02.030, UP-03.003 Not Received at Press Time

Staskin David UP-03.204 Not Received at Press Time

Steffens Joachim MP-12.09 Nothing to Disclose

Stein Raimund ESPU, PP02, ST04 Not Received at Press Time

Steinsvik E. Andreas Svaboe MP-07.16 Nothing to Disclose

Stenzl Arnulf PP06 Not Received at Press Time

Sternberg Cora PL02 Not Received at Press Time

Stöckle Michael PP08 Not Received at Press Time

Strbavy Miroslav UP-02.173 Nothing to Disclose

Strope Seth A. ICUD2 Not Received at Press Time





Studer Urs E. IC10, PL02, PP06, WUOF4, WUOF7 Not Received at Press Time

Sugimoto Morito UP-01.165, UP-01.166 Not Received at Press Time

Sul Chong Koo UP-02.097, UP-03.167, UP-02.174 Not Received at Press Time

Sun Fu-Kang UP-01.006 Not Received at Press Time

Sun Yinghao PP11 Not Received at Press Time

Surcel Cristian UP-01.011, UP-01.038, UP-01.080, UP-01.182UP-01.183, UP-01.184, UP-03.131, UP-03.177

Nothing to Disclose

Suzuki Kuri UP-03.004 Nothing to Disclose

Tabibi Ali UP-01.109 Not Received at Press Time

Tadtayev Sergiy RBT, UP-02.141 Nothing to Disclose

Taghavi Rahim MP-06.15, UP-02.188, UP-03.032, UP-03.014 Not Received at Press Time

Tahmatzopoulos Anastasios MP-12.10 Not Received at Press Time

Takagi Toshio UP-01.167, UP-01.168, UP-01.169, UP-01.206 Not Received at Press Time

Takemura Masahiko MP-02.05 Not Received at Press Time

Takenaka Toichi PL01 Not Received at Press Time

Takezawa Yutaka MP-02.06 Not Received at Press Time

Tan Yeh Hong MP-14.14, MP-14.15, UP-02.057 Not Received at Press Time

Tanabe Kazunari IC07 Not Received at Press Time

Tanaka Nobumichi MP-16.20 Not Received at Press Time

Tanaka Toshiaki UP-01.178 Nothing to Disclose

Taneja Samir ICUD1, PP12 Not Received at Press Time

Tanguay Simon PP12 Not Received at Press Time

Teloken Claudio ISSM Not Received at Press Time

Teves Frederico MP-15.07 Nothing to Disclose

Tewari Ashutosh IC04, ST02 Sponsored Research: Astellas (2011), Pfizer (2008-2011), NIH/NCI (Present), Prostate Cancer Foundation (Present); Director: Global Prostate Cancer Research Foundation (Present)

Thakare Niyukta UP-01.126, UP-03.188, UP-03.189, UP-03.216 Nothing to Disclose

Thekumpadam Rajeev Puthenveetil RBT Not Applicable

Theodosiou Alexandros UP-01.139 Not Received at Press Time

Thomas Christian MP-03.04, UP-02.098 Nothing to Disclose

Thompson Peter ICUD1, RBT Not Received at Press Time

Thüroff Joachim W. PL01, PL02, PL04, PP12, ST02 Nothing to Disclose

Thüroff Stefan MP-16.02, UP-02.142, UP-02.175, UP-02.176UP-02.224

Nothing to Disclose

Thwaini Ali RBT Not Applicable

Tilki Derya UP-01.036, WUOF3 Not Received at Press Time

Timpano Massimiliano RBT Not Applicable

Tolley David PP11 Not Received at Press Time

Tombal Bertrand EAU Not Received at Press Time

Tonshal Sanjeev MP-10.18 Nothing to Disclose

Touma Naji MP-02.15 Not Received at Press Time

Trachtenberg John PP01, WUOF4 Not Received at Press Time

Traxer Olivier IC13 Not Received at Press Time

Trigo Rocha Flavio UP-03.168 Not Received at Press Time


BERLIN SIU 2011 213



Trigo Rocha Flavio VID-02.05 Not Received at Press Time

Trip Evelien MP-15.04 Nothing to Disclose

Tsuchiyama Katsuki UP-03.205 Not Received at Press Time

Tsugaya Masayuki UP-03.190 Nothing to Disclose

Tuerk Ingolf PP07 Not Received at Press Time

Tulic Cane UP-01.145 Not Received at Press Time

Tunn Ralf ICSSUFU Not Received at Press Time

Uchida Toyoaki MP-13.14 Nothing to Disclose

Uemura Hirotsugu WUOF1 Advisor (2011): Astellas, Ono Pharm; Speaker (2009-2011): Bayer, Pfizer, Novartis, Takeda; Research Grant (2009): AstraZeneca

Uesugi Tatsuya UP-02.143 Not Received at Press Time

Ulys Albertas RBT Not Applicable

Uno Hiromi POD-02.08 Nothing to Disclose

Unteregger Gerhard DGU Not Received at Press Time

Urakami Shinji UP-02.177 Not Received at Press Time

Urge Tomas RBT Not Applicable

Valiquette Luc PL03, PL04 Not Received at Press Time

Vallo Stefan UP-01.026 Nothing to Disclose

Van Den Heuvel Suzanne POD-07.06 Not Received at Press Time

Van Der Merwe Andre IC07, UP-03.138 Not Received at Press Time

Van Der Merwe Jacobus MP-12.14, MP-15.14 Not Received at Press Time

Van Herpen Catharina UP-02.152 Not Received at Press Time

Van Kerrebroeck Philip MP-05.03 Not Received at Press Time

Van Oort Inge WUOF3 Not Received at Press Time

Van Poppel Hendrik EAU, PP08, PP12, WUOF5 Member of Advisory Board: Antigenics, AstraZeneca, Wyeth, Bayer, Cougar Biotechnology, Janssen-Cilag, Dendreon, OncoMethylome, Bristol-Myers; Expert in the Field: Astellas; Consultant: Ferring, Amgen, Ipsen

Varshney Anil Kumar MP-05.22, MP-05.23 Nothing to Disclose

Vasavada Sandip ICSSUFU Not Received at Press Time

Vaz Igor PP10 Not Received at Press Time

Venderbos Lionne POD-02.09 Not Received at Press Time

Veneziano Domenico VID-04.08 Nothing to Disclose

Villa Luca MP-02.02 Study Sponsor: Recordati

Villers Arnauld PP01, PP08 Not Received at Press Time

Vojinov Sasa UP-03.045 Nothing to Disclose

Volkmer Bjoern IC10 Not Received at Press Time

Wadhwa Karan UP-01.056 Not Received at Press Time

Wagenlehner Florian DGU, IC14 Not Received at Press Time

Waldinger Marcel D. IC08 Not Received at Press Time

Walz Peter DGU Not Received at Press Time

Wang Hongxiang RBT Not Applicable

Ward John F. IC09 Not Received at Press Time

Watanabe Atsuko UP-03.005 Not Received at Press Time





Watya Stephen IC01 Not Received at Press Time

Weber H. Matthias UP-01.096 Not Received at Press Time

Wei An MP-14.16, UP-02.058, UP-02.059 Not Received at Press Time

Weidner Wolfgang DGU, EAU, IC14 Not Received at Press Time

Weiss Robert MP-04.16 Not Received at Press Time

Wiegel Thomas PL01, PP08 Not Received at Press Time

Wiklund Peter IC04, IC12, PP06 Not Received at Press Time

Willder Jennifer UP-02.179 Nothing to Disclose

Williams Kevin UP-02.225 Nothing to Disclose

Wilt Timothy J. ICUD2 Not Received at Press Time

Wirth Manfred P. DGU, ICUD1, ICUD2, MP-04.17, MP-04.18, MP-10.04MP-13.20, MP-13.21, PL01, UP-03.001


Wischnack Mee-Na Nina UP-01.127 Not Received at Press Time

Wishahi Mohamed RBT Not Applicable

Witjes J. Alfred PP13, WUOF6 Lecture Honorarium: GE (2011), photocure (2010)

Wortel Ruud C. UP-03.069 Not Received at Press Time

Wozniak Pavo UP-01.044 Not Received at Press Time

Wu Chun-Te UP-01.027 Not Received at Press Time

Wu Wei-Che MP-10.02 Nothing to Disclose

Wuerstle Melanie MP-09.13 Nothing to Disclose

Wullich Bernd DGU Not Received at Press Time

Wyndaele Jean Jacques MP-05.02 Not Received at Press Time

Xu Abai RBT Not Applicable

Yachia Daniel SUS Not Received at Press Time

Yamada Daisuke UP-02.146 Not Received at Press Time

Yamaguchi Kohei RBT Not Applicable

Yamamoto Hidekazu UP-02.234, UP-02.078 Not Received at Press Time

Yamamoto Yasuyo UP-03.191 Not Received at Press Time

Yao Akihisa UP-02.180 Not Received at Press Time

Yarmohamadi Aliasghar RBT, UP-01.084, UP-02.181 Not Received at Press Time

Yasuda Kenji UP-02.099 Nothing to Disclose

Yeboah Edward Donkor MP-09.11 Nothing to Disclose

Yesilli Cetin MP-14.01, UP-03.082 Nothing to Disclose

Yokomizo Akira UP-01.179 Nothing to Disclose

Yokoyama Teruhiko MP-08.21, UP-03.195 Not Received at Press Time

Yoon Jong Hyun MP-08.11 Nothing to Disclose

Yoon Sang Min UP-03.175 Not Received at Press Time

Young Kee Kwon RBT Not Applicable

Yu Cheong UP-01.031 Nothing to Disclose

Yuh Bertram UP-01.209, UP-02.235, UP-02.060 Nothing to Disclose

Zakri Rhana UP-01.210, UP-02.051, UP-03.149 Not Received at Press Time

Zalesky Miroslav UP-02.061 Not Received at Press Time

Zarrabi Amir PP05, UP-02.207 Nothing to Disclose

Zeitlin Scott RBT Not Applicable

Zengerling Friedemann DGU Not Received at Press Time


BERLIN SIU 2011 215



Zhang Hai-Liang RBT Not Applicable

Zhong Shan UP-02.101 Not Received at Press Time

Ziaran Stanislav MP-16.06 Not Received at Press Time

Ziesel Christopher MP-11.16, UP-02.043 Not Received at Press Time

Zomorrodi Afshar RBT, UP-03.036 Not Received at Press Time





Documents

SATURDAY WUOF PROGRAMME October 15 - Hashemite … · WUOF PROGRAMME 5th Global Uro-Oncology Meeting Under the auspices of ... 0815–1000 SESSION ONE Prostate Cancer Prevention Moderator: